US20200129170A1 - Tissue Anchors - Google Patents

Tissue Anchors Download PDF

Info

Publication number
US20200129170A1
US20200129170A1 US16/729,780 US201916729780A US2020129170A1 US 20200129170 A1 US20200129170 A1 US 20200129170A1 US 201916729780 A US201916729780 A US 201916729780A US 2020129170 A1 US2020129170 A1 US 2020129170A1
Authority
US
United States
Prior art keywords
tissue
inventive concept
anchor
tissue anchor
deployment tool
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US16/729,780
Inventor
Michael Gilmore
Paolo DENTI
Kevin LYNN
Idan Tobis
Evin Donnelly
Charlotte MURPHY
Thomas Campbell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
4Tech Inc
Original Assignee
4Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4Tech Inc filed Critical 4Tech Inc
Priority to US16/729,780 priority Critical patent/US20200129170A1/en
Assigned to 4TECH INC. reassignment 4TECH INC. CHANGE OF ADDRESS Assignors: 4TECH INC.
Assigned to 4TECH INC. reassignment 4TECH INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DENTI, Paolo, TOBIS, IDAN, CAMPBELL, THOMAS, DONNELLY, EVIN WILLIAM, GILMORE, MICHAEL, LYNN, KEVIN, MURPHY, Charlotte
Publication of US20200129170A1 publication Critical patent/US20200129170A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/068Surgical staplers, e.g. containing multiple staples or clamps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/10Surgical instruments, devices or methods, e.g. tourniquets for applying or removing wound clamps, e.g. containing only one clamp or staple; Wound clamp magazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2478Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00292Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
    • A61B2017/003Steerable
    • A61B2017/00305Constructional details of the flexible means
    • A61B2017/00309Cut-outs or slits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00477Coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00592Elastic or resilient implements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00615Implements with an occluder on one side of the opening and holding means therefor on the other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00632Occluding a cavity, i.e. closing a blind opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0409Instruments for applying suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0417T-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0419H-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/044Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors with a threaded shaft, e.g. screws
    • A61B2017/0443Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors with a threaded shaft, e.g. screws the shaft being resilient and having a coiled or helical shape in the released state
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0464Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B2017/0496Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B2017/0645Surgical staples, i.e. penetrating the tissue being elastically deformed for insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B2017/0649Coils or spirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0091Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section

Abstract

Apparatus is provided that includes an implantable tissue anchor for delivery in a constrained state within a deployment tool. The implantable tissue anchor includes an anchor shaft and a tissue-coupling element, which extends from a distal end of the anchor shaft. The tissue-coupling element includes a wire and a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire. The tissue-coupling element is shaped as an open shape that is generally orthogonal to the anchor shaft when the tissue anchor is unconstrained by the deployment tool. Other embodiments are also described.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • The present application:
  • (a) claims priority from U.S. Provisional Application 62/167,660, filed May 28, 2015; and
  • (b) is a continuation-in-part of International Application PCT/IB2015/002354, filed Dec. 2, 2015, which claims priority from (i) U.S. Provisional Application 62/086,269, filed Dec. 2, 2014, and (ii) U.S. Provisional Application 62/167,660, filed May 28, 2015.
  • The present application is related to an international patent application entitled, “Off-center tissue anchors with tension members,” filed on even date herewith, which claims priority from the above-mentioned applications.
  • All of the above-mentioned applications are assigned to the assignee of the present application and are incorporated herein by reference.
  • FIELD OF THE APPLICATION
  • The present invention relates generally to tissue anchors, and specifically to tissue anchors for implantation in soft tissue, such as cardiac tissue.
  • BACKGROUND OF THE APPLICATION
  • Tissue anchors are used for anchoring elements, such as electrode leads or sutures, to tissue, such as bone or soft tissue.
  • SUMMARY OF THE APPLICATION
  • Some embodiments of the present invention provide a tissue anchor that comprises (a) an anchor shaft, (b) a tissue anchor head connected to a proximal portion of the anchor shaft, and (c) a tissue-coupling element, which extends from a distal end of the anchor shaft, and which comprises a wire, which is shaped as an open loop having more than one turn when the tissue anchor is unconstrained by a deployment tool. Typically, the tissue anchor further comprises a flexible elongate tension member, which is typically distinct from the wire of the tissue-coupling element, and which is fixed to a site on the open loop and crosses at least a portion of the open loop when the tissue anchor is unconstrained by the deployment tool. The flexible elongate tension member typically includes (a) a distal portion that is fixed to a site on the open loop, (b) a proximal portion, which has a longitudinal segment that runs alongside at least a portion of the anchor shaft, and (c) a crossing portion, which (i) is disposed between the distal and the proximal portions along the flexible elongate tension member, and (ii) crosses at least a portion of the open loop when the tissue anchor is unconstrained by the deployment tool.
  • Tension is applied to the tissue-coupling element of the tissue anchor via the flexible elongate tension member. The applied tension is resisted by the outward force of the open loop. The applied tension compresses and stiffens the open loop. This arrangement of tension distribution may overcome any natural tendency of the open loop to straighten if tension were to be applied along the central longitudinal axis via the anchor shaft, and thus may allow the application of a greater load to the open loop. It is noted that the maximum design stiffness of the open loop is constrained by the need for the open loop to be straightened for delivery in a deployment shaft of the deployment tool.
  • For some applications, the tissue-coupling element is off-center with respect to a central longitudinal axis of the anchor shaft. This off-centeredness allows the tissue-coupling element to be rotated during implantation so as to avoid contact with a sensitive anatomic structure, such as a blood vessel. The off-centeredness of the tissue-coupling element thus allows the surgeon to select an anchoring site from a plurality of anchoring sites around an exit site of the tissue anchor on the heart wall, without the need to relocate the exit site by removing the tissue-coupling element and again penetrating the deployment tool through the heart wall to redeliver the tissue-coupling element. The off-centeredness of the tissue-coupling element allows for the biasing of the tissue-coupling element away from the exit site, by rotating the tissue-coupling element to find a point of minimal impact on the cardiac circulation.
  • For some applications, a deployment tool is provided for delivering the tissue anchor, while in a constrained state, through a wall of a heart of a subject, typically by advancing a sharp distal piercing tip of the deployment tool through the wall. A surgeon, after delivering the tissue-coupling element through the wall of the heart, ascertains whether the tissue-coupling element overlies a coronary blood vessel, such as the right coronary artery (RCA). If the tissue-coupling element overlies the coronary blood vessel, the surgeon rotates the tissue anchor until the tissue-coupling element no longer overlies the coronary blood vessel. The surgeon then brings the tissue-coupling element into contact with an external surface of the heart, by applying tension the anchor head in the heart chamber.
  • Without the techniques of the present invention, the tissue-coupling element might inadvertently compress a blood vessel, which might result in cardiac complications including but not limited to angina, myocardial infarction, reduced blood flow, and/or a reduction in circulation efficiency in cardiac tissue. Removal of such an improperly positioned tissue-coupling element might be required, which might result in additional complications and injury to the patient.
  • For some applications, the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed. The flexible elongate tension member comprises a locking stopper, which is axially fixed to the proximal or the crossing portion of the flexible elongate tension member. The locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage. The locking stopper limits the total load that can be applied to the open loop by the flexible elongate tension member, thereby reducing excessive, unnecessary strain on the open loop. Additional load (tension) that is applied by the flexible elongate tension member pulls on the entire tissue anchor, and does not further increase the load applied across the open loop.
  • Typically, the tissue anchor is configured to allow relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member when the tissue anchor is unconstrained by the deployment tool. Such axial motion allows tension to be applied to the flexible elongate tension member without also being applied to the anchor shaft, and allows the open loop to be unwound and the flexible elongate tension member to be disposed alongside a portion of the flexible elongate tension member. Typically, the longitudinal segment of the proximal portion of the flexible elongate tension member is coupled in sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool. For some applications, the tissue anchor comprises one or more annular elements, which are disposed around the at least a portion of the anchor shaft, and couple the flexible elongate tension member in the sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool. For example, the annular elements may comprise one or more collars, loops, or rings.
  • In experiments on porcine heart cadavers conducted by the inventors, a tissue anchor comprising the spiral and the flexible elongate tension member remained firmly implanted in tissue of the ventricular wall, without damaging the tissue, and without fracturing of the tissue anchor under high loads. The inventors found that loads of up to 25 N could be safety applied. It was noted that the tension applied through the flexible elongate tension member was of a magnitude of three times that of the load that could be applied through the central longitudinal axis of the anchor shaft.
  • In some applications of the present invention, the tissue-coupling element is shaped as an open shape when the tissue anchor is unconstrained by the deployment tool. The flexible elongate tension member (a) extends from a distal site on the open shape, the distal site located within 7 mm of a distal end of the open shape, and (b) includes a proximal portion, which has a longitudinal segment that runs alongside at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool. For some applications, the distal site on the open shape is at the distal end of the open shape. For some applications, the wire is shaped so as to define a channel (i.e., the wire is tubular), and the flexible elongate tension member passes through at least a portion of the channel.
  • For some applications, a tissue anchor system is provided, which comprises (a) a first off-center tissue anchor, such as described above, (b) a second tissue anchor, and (c) one or more tethers, which are configured to couple (i) the anchor head of first tissue anchor to (ii) the second tissue anchor. For some applications, the second tissue anchor comprises a helical tissue-coupling element. For other applications, the second tissue anchor comprises a stent. For applications in which the tissue anchor comprises the flexible elongate tension member, as described above, the one or more tethers are fixed to the flexible elongate tension member. When tension is applied to the one or more tethers, the tension is transmitted to the flexible elongate tension member, rather than to the anchor shaft via the anchor head.
  • There is therefore provided, in accordance with an inventive concept 1 of the present invention, apparatus for delivery in a constrained state within a deployment tool, the apparatus including a tissue anchor, which includes:
  • an anchor shaft;
  • a tissue-coupling element, which (a) extends from a distal end of the anchor shaft, (b) includes a wire, and (c) is shaped as an open shape when the tissue anchor is unconstrained by the deployment tool; and
  • a flexible elongate tension member, which (a) extends from a distal site on the open shape, the distal site located within 7 mm of a distal end of the open shape, and (b) includes a proximal portion, which has a longitudinal segment that runs alongside at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool,
  • wherein the tissue anchor is configured to allow relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member when the tissue anchor is unconstrained by the deployment tool.
  • Inventive concept 2. The apparatus according to inventive concept 1, wherein a radius of the flexible elongate tension member is less than a radius of the wire.
    Inventive concept 3. The apparatus according to inventive concept 2, wherein the radius of the flexible elongate tension member is less than 50% of the radius of the wire.
    Inventive concept 4. The apparatus according to inventive concept 1, wherein the anchor shaft includes a sealing element.
    Inventive concept 5. The apparatus according to inventive concept 1, wherein the anchor shaft has a central longitudinal axis that is straight when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 6. The apparatus according to inventive concept 1, wherein the anchor shaft and the tissue-coupling element are integral to one another.
    Inventive concept 7. The apparatus according to inventive concept 1, wherein a cross-sectional area of the wire is at least 0.09 mm2.
    Inventive concept 8. The apparatus according to inventive concept 7, wherein the cross-sectional area of the wire is no more than 2.9 mm2.
    Inventive concept 9. The apparatus according to inventive concept 1, wherein the flexible elongate tension member includes Nitinol.
    Inventive concept 10. The apparatus according to inventive concept 1, wherein the open shape is an open loop having more than one turn when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 11. The apparatus according to inventive concept 10, wherein the open loop is shaped as a spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 12. The apparatus according to inventive concept 11, wherein the spiral is shaped as a three-dimensional spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 13. The apparatus according to inventive concept 11, wherein the spiral is shaped as an elliptical spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 14. The apparatus according to inventive concept 10, wherein the open loop is shaped as a three-dimensional open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 15. The apparatus according to inventive concept 14, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the three-dimensional open loop, measured in parallel to a central longitudinal axis of the anchor shaft, is between 1 and 5 mm, and
  • a greatest lateral dimension of the three-dimensional open loop, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 16. The apparatus according to inventive concept 10, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop is shaped so as to define an outermost turn and a second-to-outermost at least partial turn, and
  • the outermost turn at least partially overlaps the second-to-outermost at least partial turn.
  • Inventive concept 17. The apparatus according to inventive concept 10, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop is shaped so as to define one or more curved segments and one or more straight segments.
    Inventive concept 18. The apparatus according to inventive concept 17, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop is shaped so as to define the one or more curved segments and two or more straight segments.
    Inventive concept 19. The apparatus according to inventive concept 10, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop has a greatest lateral dimension, measured perpendicular to a central longitudinal axis of the anchor shaft, and
  • a distance between (a) a radially-outer end of the open loop and (b) a radially-inner-most point of the open loop, measured perpendicular to the central longitudinal axis, is equal to at least 30% of the greatest lateral dimension.
  • Inventive concept 20. The apparatus according to inventive concept 19, wherein a ratio of the greatest longitudinal dimension and the greatest lateral dimension is between 1:2 and 1:18 when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 21. The apparatus according to inventive concept 10, wherein the wire extends from the distal end of the anchor shaft at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 22. The apparatus according to inventive concept 21, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop surrounds a center point, and the wire does not intersect the center point.
    Inventive concept 23. The apparatus according to inventive concept 10, wherein the wire extends from the distal end of the anchor shaft at a radially-inner end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 24. The apparatus according to any one of inventive concepts 1-23, wherein the distal site is located within 3 mm of the distal end of the open shape.
    Inventive concept 25. The apparatus according to inventive concept 24, wherein the distal site on the open shape is at the distal end of the open shape.
    Inventive concept 26. The apparatus according to any one of inventive concepts 1-23, wherein, when the tissue anchor is unconstrained by the deployment tool, (a) a line segment that terminates at (i) the distal site on the open shape and (ii) a proximal end of the tissue-coupling element may have a total length that equals a percentage of (b) a total length of the tissue-coupling element, measured the along tissue-coupling element, the percentage between 25% and 75%.
    Inventive concept 27. The apparatus according to any one of inventive concepts 1-23, wherein the wire is shaped so as to define a channel, and wherein the flexible elongate tension member passes through at least a portion of the channel.
    Inventive concept 28. The apparatus according to inventive concept 27, wherein the flexible elongate tension member passes through the entire channel, and the distal site on the open shape is a distal-end opening of the open shape.
    Inventive concept 29. The apparatus according to inventive concept 28, wherein a distal end portion of the flexible elongate tension member is fixed at or beyond a proximal end of the open shape.
    Inventive concept 30. The apparatus according to inventive concept 27, wherein the channel has a proximal lateral opening within 7 mm of a proximal end of the wire, and wherein the proximal portion of the flexible elongate tension member passes through the proximal lateral opening.
    Inventive concept 31. The apparatus according to inventive concept 30, wherein the proximal portion of the flexible elongate tension member passes through the proximal lateral opening and through a proximal-end opening of the channel.
    Inventive concept 32. The apparatus according to inventive concept 27, wherein the channel has a lateral opening at the site, and wherein the distal portion of the flexible elongate tension member passes through the lateral opening.
    Inventive concept 33. The apparatus according to inventive concept 27,
  • wherein the tissue-coupling element further includes a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire,
  • wherein the distal site is on the tip,
  • wherein the tip is shaped so as to define an extension of the channel, and
  • wherein the flexible elongate tension member passes through a portion of the tip in the extension of the channel, and exits the tip at the distal site.
  • Inventive concept 34. The apparatus according to any one of inventive concepts 1-23,
  • wherein the wire is shaped so as to define first and second major opposing surfaces connected by first and second minor opposing surfaces,
  • wherein the first and the second major opposing surfaces and the first and the second minor opposing surfaces extend along at least 90% of a total length of the wire, and
  • wherein a total surface area of the first minor opposing surface is less than 10% of a total surface area of the major opposing surface.
  • Inventive concept 35. The apparatus according to inventive concept 34, wherein the wire is shaped so as to define an opening within 7 mm of a proximal end of the wire, and wherein the proximal portion of the flexible elongate tension member passes through the opening.
    Inventive concept 36. The apparatus according to inventive concept 34, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 37. The apparatus according to inventive concept 34, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 0.25 and 5 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 38. The apparatus according to inventive concept 34, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 5 and 15 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 39. The apparatus according to any one of inventive concepts 1-23,
  • wherein, extending along at least 90% of a total length of the wire, the wire has a greatest major dimension and a greatest minor dimension perpendicular to the greatest major dimension, and
  • wherein the greatest major dimension equals at least 150% of the greatest minor dimension.
  • Inventive concept 40. The apparatus according to inventive concept 39, wherein the wire is shaped so as to define an opening within 7 mm of a proximal end of the wire, and wherein the proximal portion of the flexible elongate tension member passes through the opening.
    Inventive concept 41. The apparatus according to inventive concept 39, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 42. The apparatus according to inventive concept 39, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 0.25 and 5 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 43. The apparatus according to inventive concept 39, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 5 and 15 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 44. The apparatus according to any one of inventive concepts 1-23,
  • wherein at a plurality of locations along the wire, a cross section of the wire, taken perpendicular to a longitudinal axis of the wire, has a shape that has at least one straight side.
  • Inventive concept 45. The apparatus according to inventive concept 44, wherein the at least one straight side has a length of at least 3 mm.
    Inventive concept 46. The apparatus according to any one of inventive concepts 1-23, wherein the wire is shaped so as to define a proximal opening within 7 mm of a proximal end of the wire, and wherein the proximal portion of the flexible elongate tension member passes through the proximal opening.
    Inventive concept 47. The apparatus according to any one of inventive concepts 1-23, wherein the longitudinal segment of the proximal portion of the flexible elongate tension member is coupled in sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 48. The apparatus according to inventive concept 47, wherein the tissue anchor includes one or more annular elements, which are disposed around the at least a portion of the anchor shaft, and couple the flexible elongate tension member in the sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 49. The apparatus according to any one of inventive concepts 1-23, wherein a proximally-facing surface defined by the tissue-coupling element is concave when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 50. The apparatus according to any one of inventive concepts 1-23, wherein a proximally-facing surface defined by the tissue-coupling element is convex when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 51. The apparatus according to any one of inventive concepts 1-23, wherein the apparatus further includes one or more tethers, which are fixed to the flexible elongate tension member.
    Inventive concept 52. The apparatus according to any one of inventive concepts 1-23,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the apparatus further includes:
      • a second tissue anchor, which is separate and distinct from the first tissue anchor; and
      • one or more tethers, which are configured to couple (a) the flexible elongate tension member to (b) the second tissue anchor.
        Inventive concept 53. The apparatus according to inventive concept 52, wherein the one or more tethers are fixed to (a) the flexible elongate tension member and (b) the second tissue anchor.
        Inventive concept 54. The apparatus according to inventive concept 52, wherein the one or more tethers are (a) fixed to the second tissue anchor and (b) not fixed to the anchor shaft of the first tissue anchor.
        Inventive concept 55. The apparatus according to inventive concept 52, wherein the second tissue anchor includes a helical tissue-coupling element.
        Inventive concept 56. The apparatus according to inventive concept 52, wherein the second tissue anchor includes a stent.
        Inventive concept 57. The apparatus according to any one of inventive concepts 1-23,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the apparatus further includes a second tissue anchor, which is separate and distinct from the first tissue anchor, and
  • wherein the flexible elongate tension member is coupled to the second tissue anchor.
  • Inventive concept 58. The apparatus according to inventive concept 57, wherein the flexible elongate tension member is fixed to the second tissue anchor.
    Inventive concept 59. The apparatus according to any one of inventive concepts 1-23, wherein, when the tissue-coupling element is constrained by the deployment tool, a longitudinal portion of the flexible elongate tension member runs alongside a portion of the wire.
    Inventive concept 60. The apparatus according to any one of inventive concepts 1-23, wherein application to the flexible elongate tension member of a distally-directed force of at least 1 N while the tissue anchor is unconstrained draws the distal end of the open shape toward the distal end of the anchor shaft.
    Inventive concept 61. The apparatus according to any one of inventive concepts 1-23, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 62. The apparatus according to inventive concept 61, wherein at least 95% of the area of the projection of the tissue-coupling element on the plane would fall within the first angle.
    Inventive concept 63. The apparatus according to inventive concept 61, wherein at least 80% of the area of the projection of the tissue-coupling element on the plane would fall within a third angle of 150 degrees in the plane having the vertex at the central longitudinal axis.
    Inventive concept 64. The apparatus according to any one of inventive concepts 1-23,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed,
  • wherein the flexible elongate tension member includes a locking stopper, which is axially fixed to the flexible elongate tension member, and
  • wherein the locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage.
  • Inventive concept 65. The apparatus according to any one of inventive concepts 1-23, wherein the tissue-coupling element further includes a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire.
    Inventive concept 66. The apparatus according to inventive concept 65, wherein the distal site is on the tip.
    Inventive concept 67. The apparatus according to inventive concept 65, wherein the tip is shaped so as to define a guidewire lumen therethrough.
    Inventive concept 68. The apparatus according to inventive concept 65, further including the deployment tool, which includes a deployment shaft shaped so as to define a deployment-shaft lumen, wherein the deployment shaft has a deployment-shaft outer cross-sectional area which equals between 90% and 110% of the greatest tip outer cross-sectional area, and wherein the tip is shaped so as to removably engage a distal end of the deployment shaft.
  • There is further provided, in accordance with an inventive concept 69 of the present invention, apparatus for delivery in a constrained state within a deployment tool, the apparatus including a tissue anchor, which includes:
  • an anchor shaft having a central longitudinal axis;
  • a tissue-coupling element, which (a) extends from a distal end of the anchor shaft, and (b) includes a wire, wherein when the tissue anchor is unconstrained by the deployment tool: (a) the wire is shaped as an open shape, and (b) if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, the open shape would surround between 170 and 355 degrees of a point in the plane; and
  • a flexible elongate tension member, which includes (a) a distal portion that is fixed to a site on the wire, (b) a proximal portion, which has a longitudinal segment that runs alongside at least a portion of the anchor shaft, and (c) a crossing portion, which (i) is disposed between the distal and the proximal portions along the flexible elongate tension member, and (ii) crosses at least a portion of the open shape when the tissue anchor is unconstrained by the deployment tool, wherein the tissue anchor is configured to allow relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member when the tissue anchor is unconstrained by the deployment tool.
  • Inventive concept 70. The apparatus according to inventive concept 69,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed,
  • wherein the flexible elongate tension member includes a locking stopper, which is axially fixed to the proximal or the crossing portion of the flexible elongate tension member, and
  • wherein the locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage.
  • Inventive concept 71. The apparatus according to inventive concept 69, wherein the open shape is shaped as a portion of a circle or a portion of an ellipse when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 72. The apparatus according to inventive concept 69, wherein the point falls on a projection onto the plane of a line segment that terminates at (a) the site on the wire and (b) a proximal end of the wire when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 73. The apparatus according to inventive concept 69, wherein the site on the wire is at a distal end of the wire.
    Inventive concept 74. The apparatus according to inventive concept 73, wherein the wire is shaped so as to define a channel, through which a portion of the flexible elongate tension member passes and exits the wire at the distal end of the wire.
    Inventive concept 75. The apparatus according to inventive concept 69, wherein a radius of the flexible elongate tension member is less than a radius of the wire.
    Inventive concept 76. The apparatus according to inventive concept 75, wherein the radius of the flexible elongate tension member is less than 50% of the radius of the wire.
    Inventive concept 77. The apparatus according to any one of inventive concepts 69-76, wherein, when the tissue anchor is unconstrained by the deployment tool, (a) a line segment that terminates at (i) the site on the wire and (ii) a proximal end of the tissue-coupling element may have a total length that equals a percentage of (b) a total length of the tissue-coupling element, measured the along tissue-coupling element, the percentage between 25% and 75%.
    Inventive concept 78. The apparatus according to any one of inventive concepts 69-76, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 0.25 and 5 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • There is still further provided, in accordance with an inventive concept 79 of the present invention, apparatus for delivery in a constrained state within a deployment tool, the apparatus including a tissue anchor, which includes:
  • an anchor shaft;
  • a tissue-coupling element, which (a) extends from a distal end of the anchor shaft, and (b) includes a wire, which is shaped as an open loop having more than one turn when the tissue anchor is unconstrained by the deployment tool; and
  • a flexible elongate tension member, which includes (a) a distal portion that is fixed to a site on the open loop, (b) a proximal portion, which has a longitudinal segment that runs alongside at least a portion of the anchor shaft, and (c) a crossing portion, which (i) is disposed between the distal and the proximal portions along the flexible elongate tension member, and (ii) crosses at least a portion of the open loop when the tissue anchor is unconstrained by the deployment tool,
  • wherein the tissue anchor is configured to allow relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member when the tissue anchor is unconstrained by the deployment tool.
  • Inventive concept 80. The apparatus according to inventive concept 79, wherein the open loop is shaped as a spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 81. The apparatus according to inventive concept 80, wherein the spiral is shaped as a three-dimensional spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 82. The apparatus according to inventive concept 80, wherein the spiral is shaped as an elliptical spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 83. The apparatus according to inventive concept 79, wherein the open loop is shaped as a three-dimensional open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 84. The apparatus according to inventive concept 83, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the three-dimensional open loop, measured in parallel to a central longitudinal axis of the anchor shaft, is between 1 and 5 mm, and
  • a greatest lateral dimension of the three-dimensional open loop, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 85. The apparatus according to inventive concept 79, wherein the site is on an outermost turn of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 86. The apparatus according to inventive concept 79, wherein the site is on a second-to-outermost turn of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 87. The apparatus according to inventive concept 79, wherein a radius of the flexible elongate tension member is less than a radius of the wire.
    Inventive concept 88. The apparatus according to inventive concept 87, wherein the radius of the flexible elongate tension member is less than 50% of the radius of the wire.
    Inventive concept 89. The apparatus according to inventive concept 79, wherein, when the tissue anchor is unconstrained by the deployment tool and the flexible elongate tension member is tensioned straight, if the tissue-coupling element and the flexible elongate tension member were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, an angle between (a) the flexible elongate tension member and (b) a tangent to the open loop at the site would be between 70 and 90 degrees.
    Inventive concept 90. The apparatus according to inventive concept 79, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop is shaped so as to define an outermost turn and a second-to-outermost at least partial turn, and
  • the outermost turn at least partially overlaps the second-to-outermost at least partial turn.
  • Inventive concept 91. The apparatus according to inventive concept 79, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop is shaped so as to define one or more curved segments and one or more straight segments.
    Inventive concept 92. The apparatus according to inventive concept 91, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop is shaped so as to define the one or more curved segments and two or more straight segments.
    Inventive concept 93. The apparatus according to inventive concept 79, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop has a greatest lateral dimension, measured perpendicular to a central longitudinal axis of the anchor shaft, and
  • a distance between (a) a radially-outer end of the open loop and (b) a radially-inner-most point of the open loop, measured perpendicular to the central longitudinal axis, is equal to at least 30% of the greatest lateral dimension.
  • Inventive concept 94. The apparatus according to inventive concept 93, wherein a ratio of the greatest longitudinal dimension and the greatest lateral dimension is between 1:2 and 1:18 when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 95. The apparatus according to inventive concept 79, wherein the anchor shaft includes a sealing element.
    Inventive concept 96. The apparatus according to inventive concept 79, wherein the anchor shaft has a central longitudinal axis that is straight when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 97. The apparatus according to inventive concept 79, wherein the anchor shaft and the tissue-coupling element are integral to one another.
    Inventive concept 98. The apparatus according to inventive concept 79, wherein a cross-sectional area of the wire is at least 0.09 mm2.
    Inventive concept 99. The apparatus according to inventive concept 98, wherein the cross-sectional area of the wire is no more than 2.9 mm2.
    Inventive concept 100. The apparatus according to inventive concept 79, wherein the flexible elongate tension member includes Nitinol.
    Inventive concept 101. The apparatus according to any one of inventive concepts 79-100, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 102. The apparatus according to inventive concept 101, wherein at least 95% of the area of the projection of the tissue-coupling element on the plane would fall within the first angle.
    Inventive concept 103. The apparatus according to inventive concept 101, wherein at least 80% of the area of the projection of the tissue-coupling element on the plane would fall within a third angle of 150 degrees in the plane having the vertex at the central longitudinal axis.
    Inventive concept 104. The apparatus according to any one of inventive concepts 79-100,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed,
  • wherein the flexible elongate tension member includes a locking stopper, which is axially fixed to the proximal or the crossing portion of the flexible elongate tension member, and
  • wherein the locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage.
  • Inventive concept 105. The apparatus according to inventive concept 104, wherein the locking stopper is axially fixed to the proximal or the crossing portion of the flexible elongate tension member at a distance of between 7 and 22 mm from the site on the open loop.
    Inventive concept 106. The apparatus according to inventive concept 104, wherein, if the tissue-coupling element were straightened in an elongated configuration, the locking stopper would be a distance of between 7 and 12 mm from the passage.
    Inventive concept 107. The apparatus according to any one of inventive concepts 79-100, wherein the site on the open loop is a first site on the open loop, and wherein, when the tissue anchor is unconstrained by the deployment tool and the flexible elongate tension member is tensioned straight:
  • the open loop surrounds a center point,
  • the wire extends from the distal end of the anchor shaft at a second site on the open loop, and
  • if the tissue-coupling element and the flexible elongate tension member were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, an angle between the first and the second sites, having a vertex at the center point, would be between 130 and 180 degrees.
  • Inventive concept 108. The apparatus according to inventive concept 107, wherein the angle is between 150 and 180 degrees.
    Inventive concept 109. The apparatus according to inventive concept 108, wherein the angle is between 170 and 180 degrees.
    Inventive concept 110. The apparatus according to inventive concept 107, the second site is at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 111. The apparatus according to any one of inventive concepts 79-100, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop surrounds a center point, and
  • (a) a site distance between the site and the distal end of the anchor shaft is greater than (b) a center-point distance between the center point and the distal end of the anchor shaft, when the tissue anchor is unconstrained by the deployment tool.
  • Inventive concept 112. The apparatus according to inventive concept 111, wherein the site distance equals at least 150% of the center-point distance, when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 113. The apparatus according to inventive concept 112, wherein the site distance equals at least 175% of the center-point distance when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 114. The apparatus according to any one of inventive concepts 79-100, wherein the longitudinal segment of the proximal portion of the flexible elongate tension member is coupled in sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 115. The apparatus according to inventive concept 114, wherein the tissue anchor includes one or more annular elements, which are disposed around the at least a portion of the anchor shaft, and couple the flexible elongate tension member in the sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 116. The apparatus according to any one of inventive concepts 79-100, wherein the flexible elongate tension member is not fixed to any portion of the open loop beyond 2 mm from the site on the open loop, measured when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 117. The apparatus according to any one of inventive concepts 79-100, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop has a greatest lateral dimension, measured perpendicular to a central longitudinal axis of the anchor shaft, and
  • the flexible elongate tension member is not fixed to any portion of the open loop beyond a distance from the site on the open loop, wherein the distance equals 30% of the greatest lateral dimension.
  • Inventive concept 118. The apparatus according to any one of inventive concepts 79-100, wherein the flexible elongate tension member is fixed to the open loop only at the site on the open loop.
    Inventive concept 119. The apparatus according to any one of inventive concepts 79-100, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop has a greatest lateral dimension, measured perpendicular to a central longitudinal axis of the anchor shaft, and
  • the at least a portion of the open loop crossed by the crossing portion has a length that equals at least 50% of the greatest lateral dimension.
  • Inventive concept 120. The apparatus according to inventive concept 119, wherein the length of the at least a portion of the open loop crossed by the crossing portion equals at least 75% of the greatest lateral dimension when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 121. The apparatus according to inventive concept 120, wherein the length of the at least a portion of the open loop crossed by the crossing portion equals at least 90% of the greatest lateral dimension when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 122. The apparatus according to any one of inventive concepts 79-100, wherein the wire extends from the distal end of the anchor shaft at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 123. The apparatus according to inventive concept 122, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop surrounds a center point, and the wire intersects the center point.
    Inventive concept 124. The apparatus according to inventive concept 122, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop surrounds a center point, and the wire does not intersect the center point.
    Inventive concept 125. The apparatus according to any one of inventive concepts 79-100, wherein the wire extends from the distal end of the anchor shaft at a radially-inner end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 126. The apparatus according to any one of inventive concepts 79-100, wherein a proximally-facing surface defined by the tissue-coupling element is concave when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 127. The apparatus according to any one of inventive concepts 79-100, wherein a proximally-facing surface defined by the tissue-coupling element is convex when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 128. The apparatus according to any one of inventive concepts 79-100, wherein the apparatus further includes one or more tethers, which are fixed to the flexible elongate tension member.
    Inventive concept 129. The apparatus according to any one of inventive concepts 79-100,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the apparatus further includes:
      • a second tissue anchor, which is separate and distinct from the first tissue anchor; and
      • one or more tethers, which are configured to couple (a) the flexible elongate tension member to (b) the second tissue anchor.
        Inventive concept 130. The apparatus according to inventive concept 129, wherein the one or more tethers are fixed to (a) the flexible elongate tension member and (b) the second tissue anchor.
        Inventive concept 131. The apparatus according to inventive concept 129, wherein the one or more tethers are (a) fixed to the second tissue anchor and (b) not fixed to the anchor shaft of the first tissue anchor.
        Inventive concept 132. The apparatus according to inventive concept 129, wherein the second tissue anchor includes a helical tissue-coupling element.
        Inventive concept 133. The apparatus according to inventive concept 129, wherein the second tissue anchor includes a stent.
        Inventive concept 134. The apparatus according to any one of inventive concepts 79-100,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the apparatus further includes a second tissue anchor, which is separate and distinct from the first tissue anchor, and
  • wherein the flexible elongate tension member is coupled to the second tissue anchor.
  • Inventive concept 135. The apparatus according to inventive concept 134, wherein the flexible elongate tension member is fixed to the second tissue anchor.
    Inventive concept 136. The apparatus according to any one of inventive concepts 79-100, wherein, when the tissue-coupling element is constrained by the deployment tool, a longitudinal portion of the flexible elongate tension member runs alongside a portion of the wire.
    Inventive concept 137. The apparatus according to any one of inventive concepts 79-100, for use with a guidewire,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define:
      • a first passage, in which the proximal portion of the flexible elongate tension member is slidably disposed,
      • a second passage, in which a proximal portion of the wire of the tissue-coupling element is fixedly disposed, and
      • a third passage, sized for slidable passage therethrough of the guidewire, and
  • wherein the first, the second, and the third passages have respective, different central longitudinal axes.
  • Inventive concept 138. The apparatus according to inventive concept 137, wherein the third passage has an inner diameter of between 0.25 and 0.75 mm.
    Inventive concept 139. The apparatus according to inventive concept 137, wherein a proximal end of the second passage is closed.
    Inventive concept 140. The apparatus according to any one of inventive concepts 79-100, wherein the wire is shaped so as to define a channel, which has a lateral opening at the site, and wherein the distal portion of the flexible elongate tension member passes through the lateral opening.
    Inventive concept 141. The apparatus according to inventive concept 140, wherein the distal portion of the flexible elongate tension member passes through the lateral opening and extends distally through at least a portion of the channel.
    Inventive concept 142. The apparatus according to inventive concept 141, wherein the distal portion of the flexible elongate tension member extends distally through the at least a portion of the channel to at least within 7 mm of a distal end of the wire.
    Inventive concept 143. The apparatus according to inventive concept 141, wherein the distal portion of the flexible elongate tension member extends distally through the at least a portion of the channel to the distal end of the wire.
    Inventive concept 144. The apparatus according to any one of inventive concepts 79-100,
  • wherein the wire is shaped so as to define first and second major opposing surfaces connected by first and second minor opposing surfaces,
  • wherein the first and the second major opposing surfaces and the first and the second minor opposing surfaces extend along at least 90% of a total length of the wire, and
  • wherein a total surface area of the first minor opposing surface is less than 10% of a total surface area of the major opposing surface.
  • Inventive concept 145. The apparatus according to inventive concept 144, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 146. The apparatus according to any one of inventive concepts 79-100,
  • wherein, extending along at least 90% of a total length of the wire, the wire has a greatest major dimension and a greatest minor dimension perpendicular to the greatest major dimension, and
  • wherein the greatest major dimension equals at least 150% of the greatest minor dimension.
  • Inventive concept 147. The apparatus according to inventive concept 146, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 148. The apparatus according to any one of inventive concepts 79-100, wherein at a plurality of locations along the wire, a cross section of the wire, taken perpendicular to a longitudinal axis of the wire, has a shape that has at least one straight side.
    Inventive concept 149. The apparatus according to inventive concept 148, wherein the at least one straight side has a length of at least 3 mm.
  • There is additionally provided, in accordance with an inventive concept 150 of the present invention, apparatus for delivery in a constrained state within a deployment tool, the apparatus including a tissue anchor, which includes:
  • an anchor shaft;
  • a tissue-coupling element, which (a) extends from a distal end of the anchor shaft, (b) includes a wire and a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire, and (c) is shaped as an open shape when the tissue anchor is unconstrained by the deployment tool; and
  • a flexible elongate tension member, which includes (a) a distal portion that is fixed to a site on the open shape, (b) a proximal portion, which has a longitudinal segment that runs alongside at least a portion of the anchor shaft, and (c) a crossing portion, which (i) is disposed between the distal and the proximal portions along the flexible elongate tension member, and (ii) crosses at least a portion of the open shape when the tissue anchor is unconstrained by the deployment tool,
  • wherein the tissue anchor is configured to allow relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member when the tissue anchor is unconstrained by the deployment tool.
  • Inventive concept 151. The apparatus according to inventive concept 150, wherein the greatest tip outer cross-sectional area equals at least 200% of the average anchoring-element outer cross-sectional area.
    Inventive concept 152. The apparatus according to inventive concept 150, wherein the greatest tip outer cross-sectional area is greater than 1 mm2.
    Inventive concept 153. The apparatus according to inventive concept 150, wherein the tip includes a frustoconical portion.
    Inventive concept 154. The apparatus according to inventive concept 150, wherein the tip is shaped so as to define a guidewire lumen therethrough.
    Inventive concept 155. The apparatus according to inventive concept 154, wherein the tip has a central longitudinal axis, which (a) passes through a distal end-opening of the guidewire lumen, and (b) does not pass through a proximal end-opening of the guidewire lumen.
    Inventive concept 156. The apparatus according to inventive concept 155, wherein a center of the distal end-opening of the guidewire lumen is disposed within 1 mm of the central longitudinal axis of the tip.
    Inventive concept 157. The apparatus according to inventive concept 155, wherein the central longitudinal axis of the tip passes through the distal end of the wire.
    Inventive concept 158. The apparatus according to inventive concept 150, wherein the distal portion of the flexible elongate tension member at least partially runs along the open shape between the site and the tip.
    Inventive concept 159. The apparatus according to inventive concept 158, wherein the distal portion of the flexible elongate tension member, at one or more locations along the distal portion, is fixed to the tip.
    Inventive concept 160. The apparatus according to inventive concept 159, wherein the tip is shaped so as to define a tension-member lumen therethrough, and wherein the distal portion of the flexible elongate tension member passes through at least a portion of the tension-member lumen.
    Inventive concept 161. The apparatus according to inventive concept 150, further including the deployment tool, which includes a deployment shaft shaped so as to define a deployment-shaft lumen, wherein the deployment shaft has a deployment-shaft outer cross-sectional area which equals between 90% and 110% of the greatest tip outer cross-sectional area, and wherein the tip is shaped so as to removably engage a distal end of the deployment shaft.
    Inventive concept 162. The apparatus according to inventive concept 161, wherein the tip is shaped so as to define a guidewire lumen therethrough, wherein the deployment shaft is shaped so as to define a guidewire opening through a wall of the deployment shaft, and wherein the guidewire opening reaches the distal end of the deployment shaft.
    Inventive concept 163. The apparatus according to inventive concept 150, for use with a guidewire,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define:
      • a first passage, in which the proximal portion of the flexible elongate tension member is slidably disposed,
      • a second passage, in which a proximal portion of the wire of the tissue-coupling element is fixedly disposed, and
      • a third passage, sized for slidable passage therethrough of the guidewire, and
  • wherein the first, the second, and the third passages have respective, different central longitudinal axes.
  • Inventive concept 164. The apparatus according to inventive concept 163, wherein the third passage has an inner diameter of between 0.25 and 0.75 mm.
    Inventive concept 165. The apparatus according to inventive concept 163, wherein a proximal end of the second passage is closed.
    Inventive concept 166. The apparatus according to inventive concept 150, wherein the open shape is an open loop having more than one turn when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 167. The apparatus according to inventive concept 166, wherein the open loop is shaped as a spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 168. The apparatus according to inventive concept 167, wherein the spiral is shaped as a three-dimensional spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 169. The apparatus according to inventive concept 167, wherein the spiral is shaped as an elliptical spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 170. The apparatus according to inventive concept 166, wherein the open loop is shaped as a three-dimensional open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 171. The apparatus according to inventive concept 170, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the three-dimensional open loop, measured in parallel to a central longitudinal axis of the anchor shaft, is between 1 and 5 mm, and
  • a greatest lateral dimension of the three-dimensional open loop, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 172. The apparatus according to inventive concept 166, wherein the site is on an outermost turn of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 173. The apparatus according to inventive concept 166, wherein, when the tissue anchor is unconstrained by the deployment tool and the flexible elongate tension member is tensioned straight, if the tissue-coupling element and the flexible elongate tension member were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, an angle between (a) the flexible elongate tension member and (b) a tangent to the open loop at the site would be between 70 and 90 degrees.
    Inventive concept 174. The apparatus according to inventive concept 166, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop is shaped so as to define an outermost turn and a second-to-outermost at least partial turn, and
  • the outermost turn at least partially overlaps the second-to-outermost at least partial turn.
  • Inventive concept 175. The apparatus according to inventive concept 166, wherein the site on the open loop is a first site on the open loop, and wherein, when the tissue anchor is unconstrained by the deployment tool and the flexible elongate tension member is tensioned straight:
  • the open loop surrounds a center point,
  • the wire extends from the distal end of the anchor shaft at a second site on the open loop, and
  • if the tissue-coupling element and the flexible elongate tension member were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, an angle between the first and the second sites, having a vertex at the center point, would be between 130 and 180 degrees.
  • Inventive concept 176. The apparatus according to inventive concept 175, wherein the second site is at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 177. The apparatus according to inventive concept 166, wherein the wire extends from the distal end of the anchor shaft at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 178. The apparatus according to inventive concept 166, wherein the wire extends from the distal end of the anchor shaft at a radially-inner end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 179. The apparatus according to inventive concept 150, wherein a radius of the flexible elongate tension member is less than a radius of the wire.
    Inventive concept 180. The apparatus according to inventive concept 179, wherein the radius of the flexible elongate tension member is less than 50% of the radius of the wire.
    Inventive concept 181. The apparatus according to inventive concept 150, wherein the anchor shaft has a central longitudinal axis that is straight when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 182. The apparatus according to inventive concept 150, wherein the anchor shaft and the tissue-coupling element are integral to one another.
    Inventive concept 183. The apparatus according to any one of inventive concepts 150-182, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 184. The apparatus according to inventive concept 183, wherein at least 95% of the area of the projection of the tissue-coupling element on the plane would fall within the first angle.
    Inventive concept 185. The apparatus according to inventive concept 183, wherein at least 80% of the area of the projection of the tissue-coupling element on the plane would fall within a third angle of 150 degrees in the plane having the vertex at the central longitudinal axis.
    Inventive concept 186. The apparatus according to any one of inventive concepts 150-182,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed,
  • wherein the flexible elongate tension member includes a locking stopper, which is axially fixed to the proximal or the crossing portion of the flexible elongate tension member, and
  • wherein the locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage.
  • Inventive concept 187. The apparatus according to inventive concept 186, wherein the locking stopper is axially fixed to the proximal or the crossing portion of the flexible elongate tension member at a distance of between 7 and 22 mm from the site on the open shape.
    Inventive concept 188. The apparatus according to inventive concept 186, wherein, if the tissue-coupling element were straightened in an elongated configuration, the locking stopper would be a distance of between 7 and 12 mm from the passage.
    Inventive concept 189. The apparatus according to any one of inventive concepts 150-182, wherein the longitudinal segment of the proximal portion of the flexible elongate tension member is coupled in sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 190. The apparatus according to inventive concept 189, wherein the tissue anchor includes one or more annular elements, which are disposed around the at least a portion of the anchor shaft, and couple the flexible elongate tension member in the sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 191. The apparatus according to any one of inventive concepts 150-182, wherein the apparatus further includes one or more tethers, which are fixed to the flexible elongate tension member.
    Inventive concept 192. The apparatus according to any one of inventive concepts 150-182,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the apparatus further includes:
      • a second tissue anchor, which is separate and distinct from the first tissue anchor; and
      • one or more tethers, which are configured to couple (a) the flexible elongate tension member to (b) the second tissue anchor.
        Inventive concept 193. The apparatus according to inventive concept 192, wherein the one or more tethers are fixed to (a) the flexible elongate tension member and (b) the second tissue anchor.
        Inventive concept 194. The apparatus according to inventive concept 192, wherein the one or more tethers are (a) fixed to the second tissue anchor and (b) not fixed to the anchor shaft of the first tissue anchor.
        Inventive concept 195. The apparatus according to inventive concept 192, wherein the second tissue anchor includes a helical tissue-coupling element.
        Inventive concept 196. The apparatus according to inventive concept 192, wherein the second tissue anchor includes a stent.
        Inventive concept 197. The apparatus according to any one of inventive concepts 150-182,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the apparatus further includes a second tissue anchor, which is separate and distinct from the first tissue anchor, and
  • wherein the flexible elongate tension member is coupled to the second tissue anchor.
  • Inventive concept 198. The apparatus according to inventive concept 197, wherein the flexible elongate tension member is fixed to the second tissue anchor.
    Inventive concept 199. The apparatus according to any one of inventive concepts 150-182, wherein, when the tissue-coupling element is constrained by the deployment tool, a longitudinal portion of the flexible elongate tension member runs alongside a portion of the wire.
    Inventive concept 200. The apparatus according to any one of inventive concepts 150-182, wherein the wire is shaped so as to define a channel, which has a lateral opening at the site, and wherein the distal portion of the flexible elongate tension member passes through the lateral opening.
    Inventive concept 201. The apparatus according to inventive concept 200, wherein the distal portion of the flexible elongate tension member passes through the lateral opening and extends distally through at least a portion of the channel.
    Inventive concept 202. The apparatus according to inventive concept 201, wherein the distal portion of the flexible elongate tension member extends distally through the at least a portion of the channel to at least within 7 mm of a distal end of the wire.
    Inventive concept 203. The apparatus according to inventive concept 201, wherein the distal portion of the flexible elongate tension member extends distally through the at least a portion of the channel to the distal end of the wire.
  • There is yet additionally provided, in accordance with an inventive concept 204 of the present invention, a method including:
  • providing a tissue anchor, which includes (a) an anchor shaft, (b) a tissue-coupling element, which (i) extends from a distal end of the anchor shaft, and (ii) includes a wire, and (c) a flexible elongate tension member;
  • introducing, during a transcatheter procedure, the tissue anchor into a cardiac chamber of a heart of a subject, while the tissue-coupling element is constrained by a deployment tool;
  • delivering the tissue-coupling element through a wall of the heart; and
  • at least partially releasing the tissue anchor from the deployment tool such that (a) the tissue-coupling element is unconstrained by the deployment tool, (b) the tissue-coupling element is shaped as an open shape, (c) the flexible elongate tension member extends from a distal site on the open shape, the distal site located within 7 mm of a distal end of the open shape, (d) a longitudinal segment of a proximal portion of the flexible elongate tension member runs alongside at least a portion of the anchor shaft, and (e) the tissue anchor allows relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member.
  • Inventive concept 205. The method according to inventive concept 204, further including, after delivering the tissue-coupling element through the wall of the heart, at least partially compressing the open shape by applying tension to the flexible elongate tension member.
    Inventive concept 206. The method according to inventive concept 204, further including, after delivering the tissue-coupling element through the wall of the heart, at least partially compressing the open shape and pulling the tissue-coupling element against an external surface of the heart, by applying tension to the flexible elongate tension member.
    Inventive concept 207. The method according to inventive concept 204, further including, after delivering the tissue-coupling element through the wall of the heart, drawing the distal end of the open shape toward the distal end of the anchor shaft by applying, to the flexible elongate tension member, a distally-directed force of at least 1 N while the tissue anchor is unconstrained.
    Inventive concept 208. The method according to inventive concept 204, further including, after delivering the tissue-coupling element through the wall of the heart:
  • ascertaining whether the tissue-coupling element overlies a coronary blood vessel; and
  • if the tissue-coupling element overlies the coronary blood vessel, rotating the tissue anchor until the tissue-coupling element no longer overlies the coronary blood vessel.
  • Inventive concept 209. The method according to inventive concept 204, further including, after delivering the tissue-coupling element through the wall of the heart:
  • rotating the tissue anchor by rotating the anchor shaft; and
  • bringing the tissue-coupling element into contact with an external surface of the heart by applying tension to the flexible elongate tension member.
  • Inventive concept 210. The method according to inventive concept 209, wherein bringing the tissue-coupling element into contact with the external surface of the heart includes bringing the tissue-coupling element into contact with the external surface of the heart without applying any tension to the anchor shaft.
    Inventive concept 211. The method according to inventive concept 204, wherein a radius of the flexible elongate tension member is less than a radius of the wire.
    Inventive concept 212. The method according to inventive concept 211, wherein the radius of the flexible elongate tension member is less than 50% of the radius of the wire.
    Inventive concept 213. The method according to inventive concept 204, wherein the anchor shaft includes a sealing element.
    Inventive concept 214. The method according to inventive concept 204, wherein the anchor shaft has a central longitudinal axis that is straight when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 215. The method according to inventive concept 204, wherein the anchor shaft and the tissue-coupling element are integral to one another.
    Inventive concept 216. The method according to inventive concept 204, wherein a cross-sectional area of the wire is at least 0.09 mm2.
    Inventive concept 217. The method according to inventive concept 216, wherein the cross-sectional area of the wire is no more than 2.9 mm2.
    Inventive concept 218. The method according to inventive concept 204, wherein the flexible elongate tension member includes Nitinol.
    Inventive concept 219. The method according to inventive concept 204, wherein the open shape is an open loop having more than one turn when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 220. The method according to inventive concept 219, wherein the open loop is shaped as a spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 221. The method according to inventive concept 220, wherein the spiral is shaped as a three-dimensional spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 222. The method according to inventive concept 220, wherein the spiral is shaped as an elliptical spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 223. The method according to inventive concept 219, wherein the open loop is shaped as a three-dimensional open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 224. The method according to inventive concept 223, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the three-dimensional open loop, measured in parallel to a central longitudinal axis of the anchor shaft, is between 1 and 5 mm, and
  • a greatest lateral dimension of the three-dimensional open loop, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 225. The method according to inventive concept 219, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop is shaped so as to define an outermost turn and a second-to-outermost at least partial turn, and
  • the outermost turn at least partially overlaps the second-to-outermost at least partial turn.
  • Inventive concept 226. The method according to inventive concept 219, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop is shaped so as to define one or more curved segments and one or more straight segments.
    Inventive concept 227. The method according to inventive concept 226, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop is shaped so as to define the one or more curved segments and two or more straight segments.
    Inventive concept 228. The method according to inventive concept 219, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop has a greatest lateral dimension, measured perpendicular to a central longitudinal axis of the anchor shaft, and
  • a distance between (a) a radially-outer end of the open loop and (b) a radially-inner-most point of the open loop, measured perpendicular to the central longitudinal axis, is equal to at least 30% of the greatest lateral dimension.
  • Inventive concept 229. The method according to inventive concept 228, wherein a ratio of the greatest longitudinal dimension and the greatest lateral dimension is between 1:2 and 1:18 when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 230. The method according to inventive concept 219, wherein the wire extends from the distal end of the anchor shaft at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 231. The method according to inventive concept 230, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop surrounds a center point, and the wire does not intersect the center point.
    Inventive concept 232. The method according to inventive concept 219, wherein the wire extends from the distal end of the anchor shaft at a radially-inner end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 233. The method according to inventive concept 204, wherein the distal site is located within 3 mm of the distal end of the open shape.
    Inventive concept 234. The method according to inventive concept 233, wherein the distal site on the open shape is at the distal end of the open shape.
    Inventive concept 235. The method according to inventive concept 204, wherein, when the tissue anchor is unconstrained by the deployment tool, (a) a line segment that terminates at (i) the distal site on the open shape and (ii) a proximal end of the tissue-coupling element may have a total length that equals a percentage of (b) a total length of the tissue-coupling element, measured the along tissue-coupling element, the percentage between 25% and 75%.
    Inventive concept 236. The method according to inventive concept 204, wherein the wire is shaped so as to define a channel, and wherein the flexible elongate tension member passes through at least a portion of the channel.
    Inventive concept 237. The method according to inventive concept 236, wherein the flexible elongate tension member passes through the entire channel, and the distal site on the open shape is a distal-end opening of the open shape.
    Inventive concept 238. The method according to inventive concept 237, wherein a distal end portion of the flexible elongate tension member is fixed at or beyond a proximal end of the open shape.
    Inventive concept 239. The method according to inventive concept 236, wherein the channel has a proximal lateral opening within 7 mm of a proximal end of the wire, and wherein the proximal portion of the flexible elongate tension member passes through the proximal lateral opening.
    Inventive concept 240. The method according to inventive concept 239, wherein the proximal portion of the flexible elongate tension member passes through the proximal lateral opening and through a proximal-end opening of the channel.
    Inventive concept 241. The method according to inventive concept 236, wherein the channel has a lateral opening at the site, and wherein the distal portion of the flexible elongate tension member passes through the lateral opening.
    Inventive concept 242. The method according to inventive concept 236,
  • wherein the tissue-coupling element further includes a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire,
  • wherein the distal site is on the tip,
  • wherein the tip is shaped so as to define an extension of the channel, and
  • wherein the flexible elongate tension member passes through a portion of the tip in the extension of the channel, and exits the tip at the distal site.
  • Inventive concept 243. The method according to inventive concept 204,
  • wherein the wire is shaped so as to define first and second major opposing surfaces connected by first and second minor opposing surfaces,
  • wherein the first and the second major opposing surfaces and the first and the second minor opposing surfaces extend along at least 90% of a total length of the wire, and
  • wherein a total surface area of the first minor opposing surface is less than 10% of a total surface area of the major opposing surface.
  • Inventive concept 244. The method according to inventive concept 243, wherein the wire is shaped so as to define an opening within 7 mm of a proximal end of the wire, and wherein the proximal portion of the flexible elongate tension member passes through the opening.
    Inventive concept 245. The method according to inventive concept 243, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 246. The method according to inventive concept 243, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 0.25 and 5 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 247. The method according to inventive concept 243, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 5 and 15 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 248. The method according to inventive concept 204,
  • wherein, extending along at least 90% of a total length of the wire, the wire has a greatest major dimension and a greatest minor dimension perpendicular to the greatest major dimension, and
  • wherein the greatest major dimension equals at least 150% of the greatest minor dimension.
  • Inventive concept 249. The method according to inventive concept 248, wherein the wire is shaped so as to define an opening within 7 mm of a proximal end of the wire, and wherein the proximal portion of the flexible elongate tension member passes through the opening.
    Inventive concept 250. The method according to inventive concept 248, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 251. The method according to inventive concept 248, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 0.25 and 5 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 252. The method according to inventive concept 248, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 5 and 15 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 253. The method according to inventive concept 204, wherein at a plurality of locations along the wire, a cross section of the wire, taken perpendicular to a longitudinal axis of the wire, has a shape that has at least one straight side.
    Inventive concept 254. The method according to inventive concept 253, wherein the at least one straight side has a length of at least 3 mm.
    Inventive concept 255. The method according to inventive concept 204, wherein the wire is shaped so as to define a proximal opening within 7 mm of a proximal end of the wire, and wherein the proximal portion of the flexible elongate tension member passes through the proximal opening.
    Inventive concept 256. The method according to inventive concept 204, wherein the longitudinal segment of the proximal portion of the flexible elongate tension member is coupled in sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 257. The method according to inventive concept 256, wherein the tissue anchor includes one or more annular elements, which are disposed around the at least a portion of the anchor shaft, and couple the flexible elongate tension member in the sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 258. The method according to inventive concept 204, wherein a proximally-facing surface defined by the tissue-coupling element is concave when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 259. The method according to inventive concept 204, wherein a proximally-facing surface defined by the tissue-coupling element is convex when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 260. The method according to inventive concept 204, wherein one or more tethers are fixed to the flexible elongate tension member.
    Inventive concept 261. The method according to inventive concept 204,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the method further includes:
      • implanting a second tissue anchor in the subject, which second tissue anchor is separate and distinct from the first tissue anchor; and
      • facilitating repair of an atrioventricular valve of the subject by applying tension to one or more tethers that couple flexible elongate tension member to the second tissue anchor.
        Inventive concept 262. The method according to inventive concept 261, further including, before applying the tension, coupling the flexible elongate tension member to the second tissue anchor using the one or more tethers.
        Inventive concept 263. The method according to inventive concept 261, wherein the one or more tethers are fixed to (a) the flexible elongate tension member and (b) the second tissue anchor.
        Inventive concept 264. The method according to inventive concept 261, wherein the one or more tethers are (a) fixed to the second tissue anchor and (b) not fixed to the anchor shaft of the first tissue anchor.
        Inventive concept 265. The method according to inventive concept 261, wherein the second tissue anchor includes a helical tissue-coupling element.
        Inventive concept 266. The method according to inventive concept 261, wherein the second tissue anchor includes a stent.
        Inventive concept 267. The method according to inventive concept 204,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the method further includes:
      • implanting a second tissue anchor in the subject, which second tissue anchor (a) separate and distinct from the first tissue anchor, and (b) coupled to the flexible elongate tension member; and
      • facilitating repair of an atrioventricular valve of the subject by applying tension to flexible elongate tension member.
        Inventive concept 268. The method according to inventive concept 267, wherein the flexible elongate tension member is fixed to the second tissue anchor.
        Inventive concept 269. The method according to inventive concept 204, wherein introducing includes introducing the tissue anchor while the tissue-coupling element is constrained by the deployment tool, and a longitudinal portion of the flexible elongate tension member runs alongside a portion of the wire.
        Inventive concept 270. The method according to inventive concept 204, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 271. The method according to inventive concept 270, wherein at least 95% of the area of the projection of the tissue-coupling element on the plane would fall within the first angle.
    Inventive concept 272. The method according to inventive concept 270, wherein at least 80% of the area of the projection of the tissue-coupling element on the plane would fall within a third angle of 150 degrees in the plane having the vertex at the central longitudinal axis.
    Inventive concept 273. The method according to inventive concept 204,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed,
  • wherein the flexible elongate tension member includes a locking stopper, which is axially fixed to the flexible elongate tension member,
  • wherein the locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage, and
  • wherein the method further includes, after delivering the tissue-coupling element through the wall of the heart:
      • at least partially compressing the open shape by applying tension to the flexible elongate tension member; and
      • after the passage prevents proximal movement of the locking stopper past the passage, applying, to the flexible elongate tension member, additional tension that does not further compress the open shape.
        Inventive concept 274. The method according to inventive concept 204, wherein the tissue-coupling element further includes a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire.
        Inventive concept 275. The method according to inventive concept 274, wherein the distal site is on the tip.
        Inventive concept 276. The method according to inventive concept 274, wherein the tip is shaped so as to define a guidewire lumen therethrough.
        Inventive concept 277. The method according to inventive concept 274, wherein the deployment tool includes a deployment shaft shaped so as to define a deployment-shaft lumen, wherein the deployment shaft has a deployment-shaft outer cross-sectional area which equals between 90% and 110% of the greatest tip outer cross-sectional area, and wherein the tip is shaped so as to removably engage a distal end of the deployment shaft.
  • There is also provided, in accordance with an inventive concept 278 of the present invention, a method including:
  • providing a tissue anchor that includes (a) an anchor shaft having a central longitudinal axis, (b) a tissue-coupling element, which (i) extends from a distal end of the anchor shaft, and (ii) includes a wire, and (c) a flexible elongate tension member, which includes a distal portion that is fixed to a site on the wire;
  • introducing, during a transcatheter procedure, the tissue anchor into a cardiac chamber of a heart of a subject, while the tissue-coupling element is constrained by a deployment tool;
  • delivering the tissue-coupling element through a wall of the heart; and
  • at least partially releasing the tissue anchor from the deployment tool such that (a) the tissue-coupling element is unconstrained by the deployment tool, (b) the wire of the tissue-coupling element is shaped as an open shape, (c) if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, the open shape would surround between 170 and 355 degrees of a point in the plane, (d) a longitudinal segment of a proximal portion of the flexible elongate tension member runs alongside at least a portion of the anchor shaft, (e) a crossing portion of the flexible elongate tension member (i) is disposed between the distal and the proximal portions along the flexible elongate tension member, and (ii) crosses at least a portion of the open shape, and (f) the tissue anchor allows relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member.
  • Inventive concept 279. The method according to inventive concept 278,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed,
  • wherein the flexible elongate tension member includes a locking stopper, which is axially fixed to the proximal or the crossing portion of the flexible elongate tension member,
  • wherein the locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage, and
  • wherein the method further includes, after delivering the tissue-coupling element through the wall of the heart:
      • at least partially compressing the open shape by applying tension to the flexible elongate tension member; and
      • after the passage prevents proximal movement of the locking stopper past the passage, applying, to the flexible elongate tension member, additional tension that does not further compress the open shape.
        Inventive concept 280. The method according to inventive concept 278, wherein the open shape is shaped as a portion of a circle or a portion of an ellipse when the tissue anchor is unconstrained by the deployment tool.
        Inventive concept 281. The method according to inventive concept 278, wherein the point falls on a projection onto the plane of a line segment that terminates at (a) the site on the wire and (b) a proximal end of the wire when the tissue anchor is unconstrained by the deployment tool.
        Inventive concept 282. The method according to inventive concept 278, wherein the site on the wire is at a distal end of the wire.
        Inventive concept 283. The method according to inventive concept 282, wherein the wire is shaped so as to define a channel, through which a portion of the flexible elongate tension member passes and exits the wire at the distal end of the wire.
        Inventive concept 284. The method according to inventive concept 278, wherein a radius of the flexible elongate tension member is less than a radius of the wire.
        Inventive concept 285. The method according to inventive concept 284, wherein the radius of the flexible elongate tension member is less than 50% of the radius of the wire.
        Inventive concept 286. The method according to inventive concept 278, wherein, when the tissue anchor is unconstrained by the deployment tool, (a) a line segment that terminates at (i) the site on the wire and (ii) a proximal end of the tissue-coupling element may have a total length that equals a percentage of (b) a total length of the tissue-coupling element, measured the along tissue-coupling element, the percentage between 25% and 75%.
        Inventive concept 287. The method according to inventive concept 278, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the open shape, measured in parallel to a central longitudinal axis of the anchor shaft, is between 0.25 and 5 mm, and
  • a greatest lateral dimension of the open shape, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • There is further provided, in accordance with an inventive concept 288 of the present invention, a method including:
  • providing a tissue anchor that includes (a) an anchor shaft, (b) a tissue-coupling element, which (i) extends from a distal end of the anchor shaft, and (ii) includes a wire, and (c) a flexible elongate tension member;
  • introducing, during a transcatheter procedure, the tissue anchor into a cardiac chamber of a heart of a subject, while the tissue-coupling element is constrained by a deployment tool;
  • delivering the tissue-coupling element through a wall of the heart; and
  • at least partially releasing the tissue anchor from the deployment tool such that (a) the tissue-coupling element is unconstrained by the deployment tool, (b) the wire of the tissue-coupling element is shaped as an open loop having more than one turn, (c) a distal portion of the flexible elongate tension member is fixed to a site on the open loop, (d) a longitudinal segment of a proximal portion of the flexible elongate tension member runs alongside at least a portion of the anchor shaft, (e) a crossing portion of the flexible elongate tension member, disposed between the distal and the proximal portions along the flexible elongate tension member, crosses at least a portion of the open loop, and (f) the tissue anchor allows relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member.
  • Inventive concept 289. The method according to inventive concept 288, further including, after delivering the tissue-coupling element through the wall of the heart, at least partially compressing the open loop by applying tension to the flexible elongate tension member.
    Inventive concept 290. The method according to inventive concept 288, further including, after delivering the tissue-coupling element through the wall of the heart, at least partially compressing the open loop and pulling the tissue-coupling element against an external surface of the heart, by applying tension to the flexible elongate tension member.
    Inventive concept 291. The method according to inventive concept 288,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed,
  • wherein the flexible elongate tension member includes a locking stopper, which is axially fixed to the proximal or the crossing portion of the flexible elongate tension member,
  • wherein the locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage, and
  • wherein the method further includes, after delivering the tissue-coupling element through the wall of the heart:
      • at least partially compressing the open loop by applying tension to the flexible elongate tension member; and
      • after the passage prevents proximal movement of the locking stopper past the passage, applying, to the flexible elongate tension member, additional tension that does not further compress the open loop.
        Inventive concept 292. The method according to inventive concept 291, wherein the locking stopper is axially fixed to the proximal or the crossing portion of the flexible elongate tension member at a distance of between 7 and 22 mm from the site on the open loop.
        Inventive concept 293. The method according to inventive concept 291, wherein, if the tissue-coupling element were straightened in an elongated configuration, the locking stopper would be a distance of between 7 and 12 mm from the passage.
        Inventive concept 294. The method according to inventive concept 288, wherein the open loop is shaped as a spiral when the tissue anchor is unconstrained by the deployment tool.
        Inventive concept 295. The method according to inventive concept 294, wherein the spiral is shaped as a three-dimensional spiral when the tissue anchor is unconstrained by the deployment tool.
        Inventive concept 296. The method according to inventive concept 294, wherein the spiral is shaped as an elliptical spiral when the tissue anchor is unconstrained by the deployment tool.
        Inventive concept 297. The method according to inventive concept 288, wherein the open loop is shaped as a three-dimensional open loop when the tissue anchor is unconstrained by the deployment tool.
        Inventive concept 298. The method according to inventive concept 297, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the three-dimensional open loop, measured in parallel to a central longitudinal axis of the anchor shaft, is between 1 and 5 mm, and
  • a greatest lateral dimension of the three-dimensional open loop, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 299. The method according to inventive concept 288, further including, after delivering the tissue-coupling element through the wall of the heart:
  • ascertaining whether the tissue-coupling element overlies a coronary blood vessel; and
  • if the tissue-coupling element overlies the coronary blood vessel, rotating the tissue anchor until the tissue-coupling element no longer overlies the coronary blood vessel.
  • Inventive concept 300. The method according to inventive concept 288, further including, after delivering the tissue-coupling element through the wall of the heart:
  • rotating the tissue anchor by rotating the anchor shaft; and
  • bringing the tissue-coupling element into contact with an external surface of the heart by applying tension to the flexible elongate tension member.
  • Inventive concept 301. The method according to inventive concept 300, wherein bringing the tissue-coupling element into contact with the external surface of the heart includes bringing the tissue-coupling element into contact with the external surface of the heart without applying any tension to the anchor shaft.
    Inventive concept 302. The method according to inventive concept 288, wherein the site is on an outermost turn of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 303. The method according to inventive concept 288, wherein the site is on a second-to-outermost turn of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 304. The method according to inventive concept 288, wherein a radius of the flexible elongate tension member is less than a radius of the wire.
    Inventive concept 305. The method according to inventive concept 304, wherein the radius of the flexible elongate tension member is less than 50% of the radius of the wire.
    Inventive concept 306. The method according to inventive concept 288, wherein, when the tissue anchor is unconstrained by the deployment tool and the flexible elongate tension member is tensioned straight, if the tissue-coupling element and the flexible elongate tension member were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, an angle between (a) the flexible elongate tension member and (b) a tangent to the open loop at the site would be between 70 and 90 degrees.
    Inventive concept 307. The method according to inventive concept 288, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop is shaped so as to define an outermost turn and a second-to-outermost at least partial turn, and
  • the outermost turn at least partially overlaps the second-to-outermost at least partial turn.
  • Inventive concept 308. The method according to inventive concept 288, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop is shaped so as to define one or more curved segments and one or more straight segments.
    Inventive concept 309. The method according to inventive concept 308, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop is shaped so as to define the one or more curved segments and two or more straight segments.
    Inventive concept 310. The method according to inventive concept 288, wherein the site on the open loop is a first site on the open loop, and wherein, when the tissue anchor is unconstrained by the deployment tool and the flexible elongate tension member is tensioned straight:
  • the open loop surrounds a center point,
  • the wire extends from the distal end of the anchor shaft at a second site on the open loop, and
  • if the tissue-coupling element and the flexible elongate tension member were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, an angle between the first and the second sites, having a vertex at the center point, would be between 130 and 180 degrees.
  • Inventive concept 311. The method according to inventive concept 310, wherein the angle is between 150 and 180 degrees.
    Inventive concept 312. The method according to inventive concept 311, wherein the angle is between 170 and 180 degrees.
    Inventive concept 313. The method according to inventive concept 310, wherein the second site is at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 314. The method according to inventive concept 288, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop has a greatest lateral dimension, measured perpendicular to a central longitudinal axis of the anchor shaft, and
  • a distance between (a) a radially-outer end of the open loop and (b) a radially-inner-most point of the open loop, measured perpendicular to the central longitudinal axis, is equal to at least 30% of the greatest lateral dimension.
  • Inventive concept 315. The method according to inventive concept 314, wherein a ratio of the greatest longitudinal dimension and the greatest lateral dimension is between 1:2 and 1:18 when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 316. The method according to inventive concept 288, wherein the anchor shaft includes a sealing element.
    Inventive concept 317. The method according to inventive concept 288, wherein the anchor shaft has a central longitudinal axis that is straight when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 318. The method according to inventive concept 288, wherein the anchor shaft and the tissue-coupling element are integral to one another.
    Inventive concept 319. The method according to inventive concept 288, wherein a cross-sectional area of the wire is at least 0.09 mm2.
    Inventive concept 320. The method according to inventive concept 319, wherein the cross-sectional area of the wire is no more than 2.9 mm2.
    Inventive concept 321. The method according to inventive concept 288, wherein the flexible elongate tension member includes Nitinol.
    Inventive concept 322. The method according to inventive concept 288, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 323. The method according to inventive concept 322, wherein at least 95% of the area of the projection of the tissue-coupling element on the plane would fall within the first angle.
    Inventive concept 324. The method according to inventive concept 322, wherein at least 80% of the area of the projection of the tissue-coupling element on the plane would fall within a third angle of 150 degrees in the plane having the vertex at the central longitudinal axis.
    Inventive concept 325. The method according to inventive concept 288, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop surrounds a center point, and
  • (a) a site distance between the site and the distal end of the anchor shaft is greater than (b) a center-point distance between the center point and the distal end of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
  • Inventive concept 326. The method according to inventive concept 325, wherein the site distance equals at least 150% of the center-point distance when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 327. The method according to inventive concept 326, wherein the site distance equals at least 175% of the center-point distance when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 328. The method according to inventive concept 288, wherein the longitudinal segment of the proximal portion of the flexible elongate tension member is coupled in sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 329. The method according to inventive concept 328, wherein the tissue anchor includes one or more annular elements, which are disposed around the at least a portion of the anchor shaft, and couple the flexible elongate tension member in the sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 330. The method according to inventive concept 288, wherein the flexible elongate tension member is not fixed to any portion of the open loop beyond 2 mm from the site on the open loop, measured when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 331. The method according to inventive concept 288, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop has a greatest lateral dimension, measured perpendicular to a central longitudinal axis of the anchor shaft, and
  • the flexible elongate tension member is not fixed to any portion of the open loop beyond a distance from the site on the open loop, wherein the distance equals 30% of the greatest lateral dimension.
  • Inventive concept 332. The method according to inventive concept 288, wherein the flexible elongate tension member is fixed to the open loop only at the site on the open loop.
    Inventive concept 333. The method according to inventive concept 288, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop has a greatest lateral dimension, measured perpendicular to a central longitudinal axis of the anchor shaft, and
  • the at least a portion of the open loop crossed by the crossing portion has a length that equals at least 50% of the greatest lateral dimension.
  • Inventive concept 334. The method according to inventive concept 333, wherein the length of the at least a portion of the open loop crossed by the crossing portion equals at least 75% of the greatest lateral dimension when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 335. The method according to inventive concept 334, wherein the length of the at least a portion of the open loop crossed by the crossing portion equals at least 90% of the greatest lateral dimension when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 336. The method according to inventive concept 288, wherein the wire extends from a distal end of the anchor shaft at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 337. The method according to inventive concept 336, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop surrounds a center point, and the wire intersects the center point.
    Inventive concept 338. The method according to inventive concept 336, wherein, when the tissue anchor is unconstrained by the deployment tool, the open loop surrounds a center point, and the wire does not intersect the center point.
    Inventive concept 339. The method according to inventive concept 288, wherein the wire extends from a distal end of the anchor shaft at a radially-inner end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 340. The method according to inventive concept 288, wherein a proximally-facing surface defined by the tissue-coupling element is concave when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 341. The method according to inventive concept 288, wherein a proximally-facing surface defined by the tissue-coupling element is convex when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 342. The method according to inventive concept 288, wherein one or more tethers are fixed to the flexible elongate tension member.
    Inventive concept 343. The method according to inventive concept 288,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the method further includes:
      • implanting a second tissue anchor in the subject, which second tissue anchor is separate and distinct from the first tissue anchor; and
      • facilitating repair of an atrioventricular valve of the subject by applying tension to one or more tethers that couple the flexible elongate tension member to the second tissue anchor.
        Inventive concept 344. The method according to inventive concept 343, further including, before applying the tension, coupling the flexible elongate tension member to the second tissue anchor using the one or more tethers.
        Inventive concept 345. The method according to inventive concept 343, wherein the one or more tethers are fixed to (a) the flexible elongate tension member and (b) the second tissue anchor.
        Inventive concept 346. The method according to inventive concept 343, wherein the one or more tethers are (a) fixed to the second tissue anchor and (b) not fixed to the anchor shaft of the first tissue anchor.
        Inventive concept 347. The method according to inventive concept 343, wherein the second tissue anchor includes a helical tissue-coupling element.
        Inventive concept 348. The method according to inventive concept 343, wherein the second tissue anchor includes a stent.
        Inventive concept 349. The method according to inventive concept 288,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the method further includes:
      • implanting a second tissue anchor in the subject, which second tissue anchor is (a) separate and distinct from the first tissue anchor, and (b) coupled to the flexible elongate tension member; and
      • facilitating repair of an atrioventricular valve of the subject by applying tension to flexible elongate tension member.
        Inventive concept 350. The method according to inventive concept 349, wherein the flexible elongate tension member is fixed to the second tissue anchor.
        Inventive concept 351. The method according to inventive concept 288, wherein introducing includes introducing the tissue anchor while the tissue-coupling element is constrained by the deployment tool, and a longitudinal portion of the flexible elongate tension member runs alongside a portion of the wire.
        Inventive concept 352. The method according to inventive concept 288,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define:
      • a first passage, in which the proximal portion of the flexible elongate tension member is slidably disposed,
      • a second passage, in which a proximal portion of the wire of the tissue-coupling element is fixedly disposed, and
      • a third passage, sized for slidable passage therethrough of a guidewire, and
  • wherein the first, the second, and the third passages have respective, different central longitudinal axes.
  • Inventive concept 353. The method according to inventive concept 352, wherein the third passage has an inner diameter of between 0.25 and 0.75 mm.
    Inventive concept 354. The method according to inventive concept 352, wherein a proximal end of the second passage is closed.
    Inventive concept 355. The method according to inventive concept 288, wherein the wire is shaped so as to define a channel, which has a lateral opening at the site, and wherein the distal portion of the flexible elongate tension member passes through the lateral opening.
    Inventive concept 356. The method according to inventive concept 355, wherein the distal portion of the flexible elongate tension member passes through the lateral opening and extends distally through at least a portion of the channel.
    Inventive concept 357. The method according to inventive concept 356, wherein the distal portion of the flexible elongate tension member extends distally through the at least a portion of the channel to at least within 7 mm of a distal end of the wire.
    Inventive concept 358. The method according to inventive concept 356, wherein the distal portion of the flexible elongate tension member extends distally through the at least a portion of the channel to the distal end of the wire.
    Inventive concept 359. The method according to inventive concept 288,
  • wherein the wire is shaped so as to define first and second major opposing surfaces connected by first and second minor opposing surfaces,
  • wherein the first and the second major opposing surfaces and the first and the second minor opposing surfaces extend along at least 90% of a total length of the wire, and
  • wherein a total surface area of the first minor opposing surface is less than 10% of a total surface area of the major opposing surface.
  • Inventive concept 360. The method according to inventive concept 359, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 361. The method according to inventive concept 288,
  • wherein, extending along at least 90% of a total length of the wire, the wire has a greatest major dimension and a greatest minor dimension perpendicular to the greatest major dimension, and
  • wherein the greatest major dimension equals at least 150% of the greatest minor dimension.
  • Inventive concept 362. The method according to inventive concept 361, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 363. The method according to inventive concept 288, wherein at a plurality of locations along the wire, a cross section of the wire, taken perpendicular to a longitudinal axis of the wire, has a shape that has at least one straight side.
    Inventive concept 364. The method according to inventive concept 363, wherein the at least one straight side has a length of at least 3 mm.
  • There is still further provided, in accordance with an inventive concept 365 of the present invention, a method including:
  • providing a tissue anchor that includes (a) an anchor shaft, (b) a tissue-coupling element, which (i) extends from a distal end of the anchor shaft, (ii) includes a wire and a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire, and (c) a flexible elongate tension member;
  • introducing, during a transcatheter procedure, the tissue anchor into a cardiac chamber of a heart of a subject, while the tissue-coupling element is constrained by a deployment tool;
  • delivering the tissue-coupling element through a wall of the heart; and
  • at least partially releasing the tissue anchor from the deployment tool such that (a) the tissue-coupling element is unconstrained by the deployment tool, (b) the tissue-coupling element is shaped as an open shape, (c) a distal portion of the flexible elongate tension member is fixed to a site on the open shape, (d) a longitudinal segment of a proximal portion of the flexible elongate tension member runs alongside at least a portion of the anchor shaft, (e) a crossing portion of the flexible elongate tension member (i) is disposed between the distal and the proximal portions along the flexible elongate tension member, and (ii) crosses at least a portion of the open shape, and (f) the tissue anchor allows relative axial motion between the at least a portion of the anchor shaft and the longitudinal segment of the proximal portion of the flexible elongate tension member.
  • Inventive concept 366. The method according to inventive concept 365, further including, after delivering the tissue-coupling element through the wall of the heart, at least partially compressing the open shape by applying tension to the flexible elongate tension member.
    Inventive concept 367. The method according to inventive concept 365, further including, after delivering the tissue-coupling element through the wall of the heart, at least partially compressing the open shape and pulling the tissue-coupling element against an external surface of the heart, by applying tension to the flexible elongate tension member.
    Inventive concept 368. The method according to inventive concept 365, wherein the greatest tip outer cross-sectional area equals at least 200% of the average anchoring-element outer cross-sectional area.
    Inventive concept 369. The method according to inventive concept 365, wherein the greatest tip outer cross-sectional area is greater than 1 mm2.
    Inventive concept 370. The method according to inventive concept 365, wherein the tip includes a frustoconical portion.
    Inventive concept 371. The method according to inventive concept 365, wherein the tip is shaped so as to define a guidewire lumen therethrough.
    Inventive concept 372. The method according to inventive concept 371, wherein the tip has a central longitudinal axis, which (a) passes through a distal end-opening of the guidewire lumen, and (b) does not pass through a proximal end-opening of the guidewire lumen.
    Inventive concept 373. The method according to inventive concept 372, wherein a center of the distal end-opening of the guidewire lumen is disposed within 1 mm of the central longitudinal axis of the tip.
    Inventive concept 374. The method according to inventive concept 372, wherein the central longitudinal axis of the tip passes through the distal end of the wire.
    Inventive concept 375. The method according to inventive concept 365, wherein the distal portion of the flexible elongate tension member at least partially runs along the open shape between the site and the tip.
    Inventive concept 376. The method according to inventive concept 375, wherein the distal portion of the flexible elongate tension member, at one or more locations along the distal portion, is fixed to the tip.
    Inventive concept 377. The method according to inventive concept 376, wherein the tip is shaped so as to define a tension-member lumen therethrough, and wherein the distal portion of the flexible elongate tension member passes through at least a portion of the tension-member lumen.
    Inventive concept 378. The method according to inventive concept 365, wherein the deployment tool includes a deployment shaft shaped so as to define a deployment-shaft lumen, wherein the deployment shaft has a deployment-shaft outer cross-sectional area which equals between 90% and 110% of the greatest tip outer cross-sectional area, and wherein the tip is shaped so as to removably engage a distal end of the deployment shaft.
    Inventive concept 379. The method according to inventive concept 378, wherein the tip is shaped so as to define a guidewire lumen therethrough, wherein the deployment shaft is shaped so as to define a guidewire opening through a wall of the deployment shaft, and wherein the guidewire opening reaches the distal end of the deployment shaft.
    Inventive concept 380. The method according to inventive concept 365,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define:
      • a first passage, in which the proximal portion of the flexible elongate tension member is slidably disposed,
      • a second passage, in which a proximal portion of the wire of the tissue-coupling element is fixedly disposed, and
      • a third passage, sized for slidable passage therethrough of a guidewire, and
  • wherein the first, the second, and the third passages have respective, different central longitudinal axes.
  • Inventive concept 381. The method according to inventive concept 380, wherein the third passage has an inner diameter of between 0.25 and 0.75 mm.
    Inventive concept 382. The method according to inventive concept 380, wherein a proximal end of the second passage is closed.
    Inventive concept 383. The method according to inventive concept 365, wherein the open shape is an open loop having more than one turn when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 384. The method according to inventive concept 383, wherein the open loop is shaped as a spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 385. The method according to inventive concept 384, wherein the spiral is shaped as a three-dimensional spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 386. The method according to inventive concept 384, wherein the spiral is shaped as an elliptical spiral when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 387. The method according to inventive concept 383, wherein the open loop is shaped as a three-dimensional open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 388. The method according to inventive concept 387, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • a greatest longitudinal dimension of the three-dimensional open loop, measured in parallel to a central longitudinal axis of the anchor shaft, is between 1 and 5 mm, and
  • a greatest lateral dimension of the three-dimensional open loop, measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Inventive concept 389. The method according to inventive concept 383, wherein the site is on an outermost turn of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 390. The method according to inventive concept 383, wherein, when the tissue anchor is unconstrained by the deployment tool and the flexible elongate tension member is tensioned straight, if the tissue-coupling element and the flexible elongate tension member were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, an angle between (a) the flexible elongate tension member and (b) a tangent to the open loop at the site would be between 70 and 90 degrees.
    Inventive concept 391. The method according to inventive concept 383, wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the open loop is shaped so as to define an outermost turn and a second-to-outermost at least partial turn, and
  • the outermost turn at least partially overlaps the second-to-outermost at least partial turn.
  • Inventive concept 392. The method according to inventive concept 383, wherein the site on the open loop is a first site on the open loop, and wherein, when the tissue anchor is unconstrained by the deployment tool and the flexible elongate tension member is tensioned straight:
  • the open loop surrounds a center point,
  • the wire extends from the distal end of the anchor shaft at a second site on the open loop, and
  • if the tissue-coupling element and the flexible elongate tension member were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, an angle between the first and the second sites, having a vertex at the center point, would be between 130 and 180 degrees.
  • Inventive concept 393. The method according to inventive concept 392, wherein the second site is at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 394. The method according to inventive concept 383, wherein the wire extends from the distal end of the anchor shaft at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 395. The method according to inventive concept 383, wherein the wire extends from the distal end of the anchor shaft at a radially-inner end of the open loop when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 396. The method according to inventive concept 365, wherein a radius of the flexible elongate tension member is less than a radius of the wire.
    Inventive concept 397. The method according to inventive concept 396, wherein the radius of the flexible elongate tension member is less than 50% of the radius of the wire.
    Inventive concept 398. The method according to inventive concept 365, wherein the anchor shaft has a central longitudinal axis that is straight when the tissue anchor is unconstrained by the deployment tool.
    Inventive concept 399. The method according to inventive concept 365, wherein the anchor shaft and the tissue-coupling element are integral to one another.
    Inventive concept 400. The method according to inventive concept 365, wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft, and wherein, when the tissue anchor is unconstrained by the deployment tool:
  • the anchor shaft has a central longitudinal axis,
  • the anchor head is coaxial with the central longitudinal axis, and
  • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • Inventive concept 401. The method according to inventive concept 400, wherein at least 95% of the area of the projection of the tissue-coupling element on the plane would fall within the first angle.
    Inventive concept 402. The method according to inventive concept 400, wherein at least 80% of the area of the projection of the tissue-coupling element on the plane would fall within a third angle of 150 degrees in the plane having the vertex at the central longitudinal axis.
    Inventive concept 403. The method according to inventive concept 365,
  • wherein the tissue anchor includes an anchor head connected to a proximal portion of the anchor shaft,
  • wherein the anchor head is shaped so as to define a passage in which the proximal portion of the flexible elongate tension member is slidably disposed,
  • wherein the flexible elongate tension member includes a locking stopper, which is axially fixed to the proximal or the crossing portion of the flexible elongate tension member,
  • wherein the locking stopper and the passage are sized and shaped such that the size and shape of the passage prevent proximal movement of the locking stopper past the passage, and
  • wherein the method further includes, after delivering the tissue-coupling element through the wall of the heart:
      • at least partially compressing the open shape by applying tension to the flexible elongate tension member; and
      • after the passage prevents proximal movement of the locking stopper past the passage, applying, to the flexible elongate tension member, additional tension that does not further compress the open shape.
        Inventive concept 404. The method according to inventive concept 403, wherein the locking stopper is axially fixed to the proximal or the crossing portion of the flexible elongate tension member at a distance of between 7 and 22 mm from the site on the open shape.
        Inventive concept 405. The method according to inventive concept 403, wherein, if the tissue-coupling element were straightened in an elongated configuration, the locking stopper would be a distance of between 7 and 12 mm from the passage.
        Inventive concept 406. The method according to inventive concept 365, wherein the longitudinal segment of the proximal portion of the flexible elongate tension member is coupled in sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
        Inventive concept 407. The method according to inventive concept 406, wherein the tissue anchor includes one or more annular elements, which are disposed around the at least a portion of the anchor shaft, and couple the flexible elongate tension member in the sliding communication with the at least a portion of the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
        Inventive concept 408. The method according to inventive concept 365, wherein one or more tethers are fixed to the flexible elongate tension member.
        Inventive concept 409. The method according to inventive concept 365,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the method further includes:
      • implanting a second tissue anchor in the subject, which second tissue anchor is separate and distinct from the first tissue anchor; and
      • facilitating repair of an atrioventricular valve of the subject by applying tension to one or more tethers that couple the flexible elongate tension member to the second tissue anchor.
        Inventive concept 410. The method according to inventive concept 409, further including, before applying the tension, coupling the flexible elongate tension member to the second tissue anchor using the one or more tethers.
        Inventive concept 411. The method according to inventive concept 409, wherein the one or more tethers are (a) fixed to the second tissue anchor and (b) not fixed to the anchor shaft of the first tissue anchor.
        Inventive concept 412. The method according to inventive concept 409, wherein the second tissue anchor includes a helical tissue-coupling element.
        Inventive concept 413. The method according to inventive concept 409, wherein the second tissue anchor includes a stent.
        Inventive concept 414. The method according to inventive concept 365,
  • wherein the tissue anchor is a first tissue anchor, and
  • wherein the method further includes:
      • implanting a second tissue anchor in the subject, which second tissue anchor is (a) separate and distinct from the first tissue anchor, and (b) coupled to the flexible elongate tension member; and
      • facilitating repair of an atrioventricular valve of the subject by applying tension to flexible elongate tension member.
        Inventive concept 415. The method according to inventive concept 414, wherein the flexible elongate tension member is fixed to the second tissue anchor.
        Inventive concept 416. The method according to inventive concept 365, wherein introducing includes introducing the tissue anchor while the tissue-coupling element is constrained by the deployment tool, and a longitudinal portion of the flexible elongate tension member runs alongside a portion of the wire.
        Inventive concept 417. The method according to inventive concept 365, wherein the wire is shaped so as to define a channel, which has a lateral opening at the site, and wherein the distal portion of the flexible elongate tension member passes through the lateral opening.
        Inventive concept 418. The method according to inventive concept 417, wherein the distal portion of the flexible elongate tension member passes through the lateral opening and extends distally through at least a portion of the channel.
        Inventive concept 419. The method according to inventive concept 418, wherein the distal portion of the flexible elongate tension member extends distally through the at least a portion of the channel to at least within 7 mm of a distal end of the wire.
        Inventive concept 420. The method according to inventive concept 418, wherein the distal portion of the flexible elongate tension member extends distally through the at least a portion of the channel to the distal end of the wire.
        Inventive concept 421. The apparatus according to any one of inventive concepts 1, 69, 79, and 150, wherein the tissue anchor is shaped so as to define a bend at an interface between the tissue-coupling element and the anchor shaft.
        Inventive concept 422. The apparatus according to inventive concept 421, wherein the bend has an angle of between 45 and 135 degrees.
        Inventive concept 423. The apparatus according to inventive concept 422, wherein the angle is between 60 and 120 degrees.
  • There is additionally provided, in accordance with an application of the present invention, apparatus for delivery in a constrained state within a deployment tool, the apparatus including a tissue anchor, which includes:
  • an anchor shaft;
  • an anchor head connected to a proximal portion of the anchor shaft; and
  • a tissue-coupling element, which extends from a distal end of the anchor shaft,
  • wherein, when the tissue anchor is unconstrained by the deployment tool:
      • the anchor shaft has a central longitudinal axis,
      • the anchor head is coaxial with the central longitudinal axis, and
      • the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (a) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (b) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • For some applications, at least 95% of the area of the projection of the tissue-coupling element on the plane would fall within the first angle.
  • For some applications, at least 80% of the area of the projection of the tissue-coupling element on the plane would fall within a third angle of 150 degrees in the plane having the vertex at the central longitudinal axis.
  • For some applications, an outer portion of the area of the projection of the tissue-coupling element on the plane would fall within all angular positions of a fourth angle of 90 degrees in the plane having the vertex at the central longitudinal axis, which outer portion consists of all points of the area at least 3 mm from the vertex.
  • For some applications, these techniques are practiced in combination with any of the inventive concepts described hereinabove.
  • There is yet additionally provided, in accordance with an application of the present invention, a method including:
  • providing a tissue anchor that includes (a) an anchor shaft, (b) an anchor head connected to a proximal portion of the anchor shaft, and (c) a tissue-coupling element, which extends from a distal end of the anchor shaft;
  • introducing, during a transcatheter procedure, the tissue anchor into a cardiac chamber of a heart of a subject, while the tissue-coupling element is constrained by a deployment tool;
  • delivering the tissue-coupling element through a wall of the heart; and
  • at least partially releasing the tissue anchor from the deployment tool such that (a) the tissue-coupling element is unconstrained by the deployment tool, (b) the anchor head is coaxial with a central longitudinal axis of the anchor shaft, and (c) the tissue-coupling element is shaped such that if the tissue-coupling element were to be projected onto a plane that is perpendicular to the central longitudinal axis, (i) at least 80% of an area of a projection of the tissue-coupling element on the plane would fall within a first angle of 180 degrees in the plane having a vertex at the central longitudinal axis, and (ii) the area would partially overlap, at least 3 mm from the vertex, both rays of a second angle of between 45 and 180 degrees in the plane having the vertex at the central longitudinal axis.
  • For some applications, the method further includes, after delivering the tissue-coupling element through the wall of the heart:
  • ascertaining whether the tissue-coupling element overlies a coronary blood vessel; and
  • if the tissue-coupling element overlies the coronary blood vessel, rotating the tissue anchor until the tissue-coupling element no longer overlies the coronary blood vessel.
  • For some applications, the method further includes, after delivering the tissue-coupling element through the wall of the heart, rotating the tissue anchor and bringing the tissue-coupling element into contact with an external surface of the heart.
  • For some applications:
  • introducing the tissue anchor into the cardiac chamber includes introducing the tissue anchor into an atrium of the heart, and
  • bringing the tissue-coupling element into contact with the external surface of the heart includes bringing the tissue-coupling element into contact with an external surface of a ventricle of the heart.
  • For some applications:
  • introducing the tissue anchor into the atrium includes introducing the tissue anchor into a right atrium, and
  • bringing the tissue-coupling element into contact with the external surface of the ventricle includes bringing the tissue-coupling element into contact with an external surface of a right ventricle.
  • For some applications, at least 95% of the area of the projection of the tissue-coupling element on the plane would fall within the first angle.
  • For some applications, at least 80% of the area of the projection of the tissue-coupling element on the plane would fall within a second angle of 150 degrees in the plane having the vertex at the central longitudinal axis.
  • For some applications, an outer portion of the area of the projection of the tissue-coupling element on the plane would fall within all angular positions of a second angle of 90 degrees in the plane having the vertex at the central longitudinal axis, which outer portion consists of all points of the area at least 3 mm from the vertex.
  • For some applications, these techniques are practiced in combination with any of the inventive concepts described hereinabove.
  • The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a schematic illustration of a tissue anchor before deployment from a deployment tool, in accordance with an application of the present invention;
  • FIGS. 1B-D are schematic illustrations of the tissue anchor of FIG. 1A after deployment from the deployment tool, in accordance with an application of the present invention;
  • FIGS. 2A-B are schematic illustrations of another tissue anchor before deployment from a deployment tool, in accordance with an application of the present invention;
  • FIGS. 3A-C are schematic illustrations of the tissue anchor of FIGS. 2A-B after deployment from the deployment tool, in accordance with an application of the present invention;
  • FIG. 3D is a schematic illustration of an anchor head of the tissue anchor of FIGS. 2A-3C, in accordance with an application of the present invention;
  • FIGS. 4A-B are schematic illustrations of two configurations of a tissue anchor system, in accordance with respective applications of the present invention;
  • FIGS. 5A-B are schematic illustrations of a tissue-coupling element and an anchor shaft of the tissue anchor of FIGS. 2A-3C, in accordance with an application of the present invention;
  • FIGS. 5C-D are schematic illustrations of a tissue-coupling element and an anchor shaft of the tissue anchor of FIGS. 2A-3C, in accordance with respective applications of the present invention;
  • FIGS. 6A-B are schematic illustrations of yet another tissue anchor before deployment from a deployment tool, in accordance with an application of the present invention;
  • FIG. 7 is a schematic illustration of still another tissue anchor after deployment from a deployment tool, in accordance with an application of the present invention;
  • FIG. 8 is a schematic illustration of another tissue anchor after deployment from a deployment tool, in accordance with an application of the present invention;
  • FIGS. 9A-F are schematic illustrations of alternative ways to fix a flexible elongate tension member to a site of an open loop of a tissue anchor, in accordance with respective applications of the present invention;
  • FIGS. 10A-H are schematic illustrations of configurations of tissue anchors, in accordance with respective applications of the present invention;
  • FIG. 11A is a schematic illustration of the tissue anchor of FIG. 10E before deployment from a deployment tool, in accordance with an application of the present invention;
  • FIG. 11B is a schematic illustration of the tissue anchor of FIG. 10F before deployment from a deployment tool, in accordance with an application of the present invention;
  • FIG. 12 is a schematic illustration of another configuration of an open loop of a tissue anchor, in accordance with an application of the present invention;
  • FIGS. 13A-D are schematic illustrations of another tissue anchor having a locking stopper, in accordance with an application of the present invention;
  • FIG. 13E is a schematic illustration of the tissue anchor of FIGS. 13A-D comprising a sealing element, in accordance with an application of the present invention;
  • FIGS. 14A-D are schematic illustrations of a method for deploying the tissue anchor system of FIG. 4B for repairing a tricuspid valve, in accordance with an application of the present invention;
  • FIGS. 15A-C are schematic illustrations of a method for deploying the tissue anchor system of FIG. 4A for repairing the tricuspid valve, in accordance with an application of the present invention; and
  • FIG. 16 is a schematic illustration of several external exit sites, in accordance with respective applications of the present invention.
  • DETAILED DESCRIPTION OF APPLICATIONS
  • Some embodiments of the present invention provide a tissue anchor 20 and a deployment tool 30, which is typically configured to deliver the tissue anchor through a wall of a heart of a subject.
  • FIG. 1A is a schematic illustration of a tissue anchor 200 before deployment from deployment tool 30, and FIGS. 1B-D are schematic illustrations of tissue anchor 200 after deployment from deployment tool 30, in accordance with an application of the present invention. Tissue anchor 200 is one implementation of tissue anchor 20, described above. Tissue anchor 200 comprises (a) an anchor shaft 122, (b) an anchor head 124 connected to a proximal portion 126 of anchor shaft 122, and (c) a tissue-coupling element 128, which extends from a distal end 130 of anchor shaft 122. For some applications, anchor shaft 122 and tissue-coupling element 128 are integral to one another; for example, anchor shaft 122 and tissue-coupling element 128 may comprise a wire.
  • Deployment tool 30 is configured to constrain tissue-coupling element 128 while delivering tissue-coupling element 128 through tissue. For some applications, deployment tool 30 is shaped so as to define a sharp distal piercing tip 32, which is advanced through the wall of the heart of the subject. Typically, during delivery, such as shown in FIG. 1A, deployment tool 30 is configured to hold tissue-coupling element 128 in an elongated, unwound configuration, which may be straight (configuration not shown) or curvy (such as shown in FIG. 1A). For some applications, deployment tool 30 comprises a deployment shaft 34 shaped so as to define a deployment-shaft lumen, such as a hypodermic needle. The deployment-shaft lumen is sized to hold tissue-coupling element 128 constrained therein, and, optionally, to hold other portions of tissue anchor 20 therein, such as anchor shaft 122 and/or anchor head 124. For some applications, deployment tool 30 has a length of between 100 and 180 cm, and/or an inner diameter of between 2 and 6 mm. For some applications, deployment tool 30 comprises a distal-most rigid portion, which typically has a length of 5 to 25 mm, and the remaining proximal portion of the deployment tool is flexible (but not extendable or compressible). For some applications, the proximal portion is shaped so as to define one or more lateral slots 36, which provide flexibility to the proximal portion, while maintaining a backbone that prevents longitudinal compression and extension of the proximal portion. Typically, deployment tool 30 is advanced within a steerable catheter tube, as is known in the art, which may, for example, comprise a braided material. Typically, tissue anchor 20 is provided in sterile packaging, optionally pre-positioned in deployment tool 30.
  • For some applications, tissue-coupling element 128 comprises a wire 150. For some applications, a cross-sectional area of wire 150 is at least 0.09 mm2 (such as at least 0.18 mm2), no more than 3 mm2 (e.g., no more than 2.9 mm2), and/or between 0.09 mm2 (such as 0.18 mm2) and 3 mm2 (e.g., 2.9 mm2). For some applications, wire 150 has a circular cross-section, and a diameter of wire 150 is at least 0.18 mm, no more than 2 mm, and/or between 0.18 and 2 mm. For some applications, a distal end 152 of wire 150 does not define a sharp distal tip; for example, the distal end may be blunt. For some applications, wire 150 comprises metal, such as Nitinol. For some applications, wire 150 comprises one or more radiopaque markers.
  • FIG. 1A shows tissue anchor 200 (including tissue-coupling element 128, anchor shaft 122, and anchor head 124) fully constrained by deployment tool 30. Typically, when tissue-coupling element 128 is constrained by the deployment tool, a longitudinal portion of flexible elongate tension member 202, described hereinbelow, runs alongside a portion of wire 150. For some applications, deployment tool 30 comprises a removable driver 201, which comprises a driver head 203 and at least one shaft 205 that is coupled to the driver head. Driver head 203 is removably coupled to anchor head 124 during penetration of tissue-coupling element 128 through tissue, as described hereinbelow. The at least one shaft 205 is configured to controllably detach the driver head from the anchor head. For example, a deployment needle may run through a channel of the at least one shaft; pulling on the needle detaches the driver head from the anchor head.
  • When tissue anchor 200 is fully constrained by deployment tool 30, tissue-coupling element 128 typically has an outer diameter of at least 0.3 mm, no more than 4 mm, and/or between 0.3 and 4 mm, such as at least 1 mm, no more than 3 mm, and/or between 1 and 3 mm.
  • For some applications, anchor shaft 122 and tissue-coupling element 128 are integral to one another; for example, anchor shaft 122 and tissue-coupling element 128 may both comprise wire 150, as shown.
  • When tissue anchor 200 is unconstrained by deployment tool 30, such as shown in FIGS. 1B-D, wire 150 is shaped as an open loop 154 (e.g., a three-dimensional open loop), such as a spiral 160 (e.g., a three-dimensional spiral) around a center point 162 (labeled in FIG. 1D). For some applications, such as shown in FIGS. 1B-D, wire 150 extends from distal end 130 of anchor shaft 122 at a radially-outer end 164 of open loop 154 (e.g., spiral 160) (labeled in FIGS. 1C and 1D), when tissue anchor 200 is unconstrained by deployment tool 30. For some applications, wire 150 intersects center point 162 when tissue anchor 200 is unconstrained by deployment tool 30 (configuration not shown), while for other applications, wire 150 does not intersect center point 162 when tissue anchor 200 is unconstrained by deployment tool 30 (as shown). For other applications, such as shown in FIG. 7, described hereinbelow, wire 150 extends from distal end 130 of anchor shaft 122 at radially-inner end 264 of an open loop 354 (e.g., a spiral 360).
  • Tissue anchor 200 further comprises a flexible elongate tension member 202, which includes:
      • a distal portion 204 that is fixed to a site 206 on open loop 154 (e.g., spiral 160) (such as by welding, soldering, crimping, and/or knotting, and/or as described hereinbelow with reference to FIGS. 9A-F),
      • a proximal portion 208, which has a longitudinal segment 209 that runs alongside at least a portion 210 of anchor shaft 122 (labeled in FIG. 1C, in which the at least a portion 210 of anchor shaft 122 is the entire length of anchor shaft 122), and
      • a crossing portion 212, which (a) is disposed between distal and proximal portions 204 and 208 along flexible elongate tension member 202, and (b) crosses at least a portion of open loop 154 (e.g., spiral 160) when tissue anchor 200 is unconstrained by deployment tool 30.
  • Although flexible elongate tension member 202 is fixed to wire 150 of tissue-coupling element 128, flexible elongate tension member 202 is typically distinct from wire 150. In other words, flexible elongate tension member 202 and wire 150 are not two longitudinal portions of a single continuous wire, i.e., are not longitudinally contiguous with each other.
  • Tension is applied to tissue-coupling element 128 of tissue anchor 200 via flexible elongate tension member 202. The applied tension is resisted by the outward force of open loop 154 (e.g., spiral 160). The applied tension at least partially compresses and stiffens open loop 154 (e.g., spiral 160). This arrangement of tension distribution may overcome any natural tendency of open loop 154 (e.g., spiral 160) to straighten (i.e., unwind) if tension were to be applied along a central longitudinal axis 134 of anchor shaft 122 via anchor shaft 122, and thus may allow the application of a greater load to open loop 154 (e.g., spiral 160). In addition, this stiffening technique allows open loop 154 (e.g., spiral 160) to be manufactured less stiff than it otherwise would need to be, which facilitates straightening and delivering the tissue anchor, and subsequent stiffening in situ.
  • Typically, before tension is applied to flexible elongate tension member 202, when tissue anchor 200 is unconstrained by deployment tool 30, flexible elongate tension member 202 is not taut across the at least a portion of open loop 154 (e.g., spiral 160). For example, flexible elongate tension member 202 may arc distally, such as can best be seen in FIG. 1C.
  • Typically, tissue anchor 200 is configured to allow relative axial motion between the at least a portion 210 of anchor shaft 122 and longitudinal segment 209 of proximal portion 208 of flexible elongate tension member 202 when tissue anchor 200 is unconstrained by deployment tool 30 (as flexible elongate tension member 202 is tensioned and pulls on tissue-coupling element 128, tissue anchor 200 becomes progressively more constrained by flexible elongate tension member 202; the relative axial motion nevertheless remains possible). In other words, longitudinal segment 209 of proximal portion 208 of flexible elongate tension member 202 is axially moveable with respect to the at least a portion 210 of anchor shaft 122 when tissue anchor 200 is unconstrained by deployment tool 30. Such axial motion allows tension to be applied to flexible elongate tension member 202 without also being applied to anchor shaft 122, and allows open loop 154 (e.g., spiral 160) to be unwound and flexible elongate tension member 202 to be disposed alongside a portion of flexible elongate tension member 202, as shown in FIG. 1A (in which deployment tool 30 constrains both constrain tissue-coupling element 128 and flexible elongate tension member 202). Typically, longitudinal segment 209 of proximal portion 208 of flexible elongate tension member 202 is coupled in sliding communication with the at least a portion 210 of anchor shaft 122, when tissue anchor 200 is unconstrained by deployment tool 30. For some applications, tissue anchor 200 comprises one or more annular elements, which are disposed around the at least a portion of anchor shaft 122, and couple flexible elongate tension member 202 in the sliding communication with the at least a portion 210 of anchor shaft 122, when tissue anchor 200 is unconstrained by deployment tool 30. For example, the annular elements may comprise one or more collars 244, described hereinbelow, loops, or rings.
  • For some applications, flexible elongate tension member 202 is not fixed to any portion of open loop 154 (e.g., spiral 160) beyond 2 mm from site 206 on open loop 154 (e.g., spiral 160), measured when tissue anchor 200 is unconstrained by deployment tool 30. Alternatively or additionally, when tissue anchor 200 is unconstrained by deployment tool 30, flexible elongate tension member 202 is not fixed to any portion of open loop 154 (e.g., spiral 160) beyond a distance from site 206 on open loop 154 (e.g., spiral 160), which distance equals 30% of greatest lateral dimension D3 of open loop 154 (e.g., spiral 160) of tissue-coupling element 128, measured perpendicular to central longitudinal axis 134 (labeled in FIG. 5A). For some applications, flexible elongate tension member 202 is fixed to open loop 154 (e.g., spiral 160) only at site 206 on open loop 154 (e.g., spiral 160). Alternatively, a distal portion of flexible elongate tension member 202 beyond site 206 is fixed to open loop 154 (e.g., spiral 160), such as described hereinbelow with reference to FIGS. 9A-E.
  • Typically, when tissue anchor 200 is unconstrained by deployment tool 30, the at least a portion of open loop 154 (e.g., spiral 160) crossed by crossing portion 212 has a length that equals at least 33% (e.g., at least 50%, at least 75%, or at least 90%) of greatest lateral dimension of open loop 154 (e.g., spiral 160) of tissue-coupling element 128, measured perpendicular to central longitudinal axis 134. (A similar greatest lateral dimension D3 of open loop 354 of tissue anchor 300 is labeled in FIG. 5A.)
  • For some applications, as shown, site 206 is on an outermost turn 214 of open loop 154 (e.g., spiral 160) (labeled in FIG. 1D), when tissue anchor 200 is unconstrained by deployment tool 30. For some other applications, site 206 is on a second-to-outermost turn 216 of open loop 154 (e.g., spiral 160) (labeled in FIG. 1D), when tissue anchor 200 is unconstrained by deployment tool 30 (configuration not shown).
  • Typically, a radius of flexible elongate tension member 202 is less than a radius of wire 150, such as less than 50% of the radius of wire 150. For some applications a cross-sectional area of wire 150 is at least 0.09 mm2 (such as at least 0.18 mm2), no more than 3 mm2 (e.g., no more than 2.9 mm2), and/or between 0.09 mm2 (such as 0.18 mm2) and 3 mm2 (e.g., 2.9 mm2). For some applications, flexible elongate tension member 202 comprises metal, such as a metal alloy, e.g., Nitinol. For some applications, flexible elongate tension member 202 comprises radiopaque sections or is radiopaque, to enable observation of the relative movement when tensioning.
  • For some applications, site 206 on open loop 154 (e.g., spiral 160) is a first site 206 on open loop 154 (e.g., spiral 160), and, when tissue anchor 200 is unconstrained by deployment tool 30 and flexible elongate tension member 202 is tensioned straight, (a) wire 150 extends from distal end 130 of anchor shaft 122 at a second site 218 on open loop 154 (e.g., spiral 160), and (b) if tissue-coupling element 128 and flexible elongate tension member 202 were to be projected onto plane 136 that is perpendicular to central longitudinal axis 134, an angle θ (theta) between the first and the second sites, having a vertex 242 at center point 162, would be between 130 and 180 degrees, such as between 150 and 180 degrees, e.g., between 170 and 180 degrees (labeled in FIG. 1D). For some applications, as shown, second site 218 is at radially-outer end 164 of open loop 154 (e.g., spiral 160).
  • Alternatively or additionally, for some applications, as labeled in FIG. 1D, when tissue anchor 200 is unconstrained by deployment tool 30 and flexible elongate tension member 202 is tensioned straight, if tissue-coupling element 128 and flexible elongate tension member 202 were to be projected onto plane 136 that is perpendicular to central longitudinal axis 134, an angle φ (phi) between (a) flexible elongate tension member 202 and (b) a tangent 250 to open loop 154 (e.g., spiral 160) at site 206 would be between 45 and 90 degrees, such as between 70 and 90 degrees, e.g., 90 degrees.
  • For some application, anchor shaft 122 comprises a sealing element 190. For some applications, sealing element 190 comprises one or more collars 244 disposed around anchor shaft 122, and, typically, a sleeve 246 that couples the collars 244 together. Sleeve 246 defines a lumen having proximal and distal ends. The flexible elongate tension member 202 slidingly passes through the lumen and its ends. (Sleeve 246 is shown in FIG. 1A; for clarity of illustration, sleeve 246 is shown as transparent in FIG. 1B, and is not shown in FIG. 1C.) In this configuration, sealing element 190 is typically sized and shaped to be inserted into the incision through the heart wall, and to provide a blood-tight seal. Sleeve 246, if provided, occludes blood flow to provide the seal. For some applications, sleeve 246 promotes hemostasis. Optionally, filament or fiber is provided within sleeve 246 to promote hemostasis. For example, sleeve 246 may comprise Dacron, and/or may be coated and/or woven to facilitate dotting.
  • For some applications, collars 244 comprise a distal guide collar 244A and a proximal driver collar 244B, which optionally are components of or serve as anchor head 124. For some applications, a proximal end of anchor shaft 122 is fixed within proximal driver collar 244B, as shown in FIG. 1C, or within distal driver collar 244A, as shown in FIG. 3A for tissue anchor 300. For some applications, one or more of collars 244 are radiopaque or comprise a radiopaque marker. For some applications, proximal driver collar 244B is shaped so as to be removably coupleable with an anchor-deployment shaft, such as described regarding a helical tissue anchor in PCT Publication WO 2015/063580, which is incorporated herein by reference.
  • For some applications, a proximally-facing surface defined by tissue-coupling element 128 is convex when tissue anchor 200 is unconstrained by deployment tool 30, such as shown in FIGS. 1B and 1C. For other applications, a proximally-facing surface defined by tissue-coupling element 128 is concave when tissue anchor 200 is unconstrained by deployment tool 30, such as shown in FIG. 5B for tissue anchor 300.
  • For some applications, such as shown in FIGS. 4A-B for tissue anchor 300 (described hereinbelow), one or more tethers 132 are provided, which are configured to be coupled to tissue anchor 200. Typically, the one or more tethers 132 are fixed to flexible elongate tension member 202, typically to proximal portion 208 of the tension member, such as at or near (e.g., within 1 cm of) a proximal end of proximal portion 208. When tension is applied to the one or more tethers, the tension is transmitted to flexible elongate tension member 202, rather than to anchor shaft 122 via anchor head 124. Typically, the one or more tethers are (a) fixed to the second tissue anchor and (b) not fixed to anchor shaft 122 of first tissue anchor 200.
  • For some applications, radially-inner end 264 of open loop 154 (e.g., spiral 160) is bent proximally, such as can be best seen in FIG. 1C. Because of the bend, radially-inner end 264 may help tissue-coupling element 128 resist rotation and uncoiling.
  • For some applications, when tissue anchor 200 is unconstrained by deployment tool 30, such as shown in FIGS. 1B-D, wire 150 (a) is shaped as an open loop 154 having more than one turn, such that a first complete turn of open loop 154 at least partially overlaps (i.e., runs alongside, above, and/or below) a second at-least-partial turn of open loop 154. For some applications, the first complete turn and the second at-least-partial turn radially coincide, i.e., are at a same distance as each other from a center point (configuration not shown). For other applications, as shown in the figures, an outermost turn of open loop 154 at least partially overlaps (i.e., runs alongside, above, and/or below) a second-to-outermost turn of open loop 154 (for example, an outermost turn 214 and a second-to-outermost turn 216 of open loop 154 are labeled in FIG. 1D). (As used in the present application, including in the claims, one turn equals 360 degrees. As used in the present application, including in the claims, “more than one turn” should not be understood as requiring at least two turns; instead, “more than one turn” also includes one turn plus a fraction of a turn, as described below. For example, for applications in which open loop 154 includes an outermost turn and a second-to-outermost turn, the second-to-outermost turn of open loop 154 may be a partial turn, such as shown in FIGS. 3A-C, 4A-B, 5A-D, 7, 8, 9A-F, 10E, 10G, 12, and 13A-E.)
  • For applications in which open loop 154 includes an outermost turn and a second-to-outermost turn, such as shown in FIG. 1D, open loop 154 has radially-outer end 164 and radially-inner end 264, which typically do not touch each other at least when tissue anchor 200 is unconstrained by deployment tool 30. For applications in which the first complete turn and the second at-least-partial turn radially coincide, the two opposite ends of the open loop typically do not touch each other at least when tissue anchor 200 is unconstrained by deployment tool 30. Open loop 154 is defined by an elongate path of wire 150 that winds more than one turn around center point 162 without forming a closed loop. The elongate path may include one or more curved segments and/or one or more straight segments, such as described hereinbelow with reference to FIG. 12. The path may fall in two dimensions, or may fall in three dimensions, in which case the open loop is a three-dimensional open loop, the elongate path of which winds around a center axis while moving parallel to the axis, without forming a closed loop.
  • For some applications, open loop 154 extends from distal end 130 of anchor shaft 122 at radially-outer end 164 of open loop 154. For some applications, wire 150 intersects center point 162 (labeled in FIG. 1D) when tissue anchor 200 is unconstrained by deployment tool 30 (configuration not shown), while for other applications, wire 150 does not intersect center point 162 (labeled in FIG. 1D) when tissue anchor 200 is unconstrained by deployment tool 30 (as shown).
  • For some applications, when tissue anchor 200 is unconstrained by deployment tool 30, such as shown in FIGS. 1B-D, wire 150 of open loop 154 is shaped as a spiral 160 (e.g., a three-dimensional spiral) around center point 162. For some of these applications, wire 150 of spiral 160 extends from distal end 130 of anchor shaft 122 at radially-outer end 164 of spiral 160. For some applications, wire 150 of spiral 160 intersects center point 162 when tissue anchor 200 is unconstrained by deployment tool 30 (configuration not shown), while for other applications, wire 150 of spiral 160 does not intersect center point 162 when tissue anchor 200 is unconstrained by deployment tool 30 (as shown). For some applications, spiral 160 is generally circular when tissue anchor 200 is unconstrained by deployment tool 30 (configuration not shown), while for other applications, spiral 160 is an elliptical spiral when the tissue anchor is unconstrained by deployment tool 30, such as shown in FIGS. 1B-D.
  • As used in the present application, including in the claims, center point 162 is the centroid of projection 139 of tissue-coupling element 128 on plane 136. Typically, such as when tissue-coupling element 128 is shaped as a spiral, tissue-coupling element 128 is non-helical when tissue anchor 200 is unconstrained by deployment tool 30.
  • Reference is made to FIGS. 1A-D. For some applications, tissue anchor 200 is implanted using techniques described hereinbelow with reference to FIGS. 14A-D, 15A-C, and/or 16, optionally in combination with techniques described in one or more of the patents and patent application publications incorporated hereinbelow by reference, mutatis mutandis.
  • Reference is now made to FIGS. 2A-B and 3A-C, which are schematic illustrations of a tissue anchor 300 before (FIGS. 2A-B) and after (FIGS. 3A-C) deployment from deployment tool 30, in accordance with an application of the present invention. Tissue anchor 300 is one implementation of tissue anchor 20, described above. Other than as described below and shown in the figures, tissue anchor 300 is generally similar to tissue anchor 200, described hereinabove with reference to FIGS. 1A-D, and may implement any of the features thereof, mutatis mutandis.
  • For some applications, tissue-coupling element 128 comprises a tip 308, which is fixed to a distal end of wire 150, and has, at a widest longitudinal site 312 along tip 308 (labeled in FIG. 3C), a greatest tip outer cross-sectional area that equals at least 150% (e.g., at least 200%, or at least 300%) of an average wire cross-sectional area of wire 150 (The cross-sectional area of tip 308 is measured perpendicular to a central longitudinal axis 318 of tip 308. Similarly, the cross-sectional area of wire 150 is measured perpendicular to a central longitudinal axis of the wire, and is not a cross-sectional area of open loop 154.) Alternatively or additionally, for some applications, the greatest tip outer cross-sectional area is greater than 1 mm2, e.g., greater than 1.5 mm2, such as greater than 2 mm2. For some applications, tip 308 includes a frustoconical portion 314 (labeled in FIG. 3C).
  • Typically, tip 308 is shaped so as to define a guidewire lumen 316 therethrough. For some applications, central longitudinal axis 318 of tip 308 (a) passes through a distal end-opening 320 of guidewire lumen 316, and (b) does not pass through a proximal end-opening 322 of guidewire lumen 316. For some of these applications, a center 323 of distal end-opening 320 of guidewire lumen 316 is disposed within 1 mm of central longitudinal axis 318 of tip 308, e.g., center 323 falls on central longitudinal axis 318. Alternatively or additionally, for some of these applications, central longitudinal axis 318 of tip 308 passes through the distal end of wire 150.
  • In configurations in which tissue-coupling element 128 comprises tip 308, the tip temporarily serves as an atraumatic distal end of deployment shaft 34 of deployment tool 30 when the tip is removably coupled to a distal end 342 of deployment shaft 34 of deployment tool 30, as shown in FIGS. 2A-B. Thus, in these configurations, deployment tool 30 (including deployment shaft 34) is typically not shaped so as define sharp distal piercing tip 32.
  • For some applications, deployment shaft 34 of deployment tool 30 has a deployment-shaft outer cross-sectional area which equals between 90% and 110% (e.g., 100%) of the greatest tip outer cross-sectional area, and tip 308 is shaped so as to removably engage distal end 342 of deployment shaft 34, such as shown in FIGS. 2A-B, as well as in FIGS. 6A-B, described hereinbelow.
  • Although only the tissue anchors illustrated in FIGS. 2A-3C, 4A-B, 5A-D, 7, 9A-C, 10H, and 15A-C are shown comprising tip 308, the tissue anchors illustrated in FIGS. 1A-D, 9D-F, 10A-D, 10F, 12, 13A-E, 14A-D, and 16 may optionally also comprise tip 308 (such as described below with reference to FIG. 10H regarding FIGS. 10A-D and 10F).
  • Reference is now made to FIG. 3D, which is a schematic illustration of anchor head 124 of tissue anchor 300, in accordance with an application of the present invention. For clarity of illustration, flexible elongate tension member 202, wire 150 of tissue-coupling element 128, and guidewire 310 are not shown in FIG. 3D; these elements are shown inter alia in FIG. 3B. As mentioned above with reference to FIGS. 1A-D, for some applications, anchor head 124 comprises distal guide collar 244A and proximal driver collar 244B, which are optionally connected by a collar shaft 123.
  • For some applications, anchor head 124 (e.g., distal guide collar 244A thereof, as shown) is shaped so as to define:
      • a first passage 330, in which proximal portion 208 of flexible elongate tension member 202 is slidably disposed,
      • a second passage 332, in which a proximal portion of wire 150 of tissue-coupling element 128 is fixedly disposed, and
      • a third passage 334, sized for slidable passage therethrough of guidewire 310.
        First, second, and third passages 330, 332, and 334 have respective, different central longitudinal axes. The passages keep flexible elongate tension member 202, the proximal portion of wire 150, and guidewire 310 aligned with but separate from one another. For some applications, a proximal end 336 of second passage 332 is closed. For some applications, third passage 334 has an inner diameter of between 0.25 and 0.75 mm.
  • For some applications, distal guide collar 244A of anchor head 124 is shaped so as to define first, second, and third passages 330, 332, and 334, and proximal driver collar 244B of anchor head 124 to shaped so as to define:
      • a fourth passage 338, (a) in which proximal portion 208 of flexible elongate tension member 202 is slidably disposed, and (b) which is optionally coaxial with first passage 330 (as shown), and/or
      • a fifth passage 339, (a) which is sized for slidable passage therethrough of guidewire 310, and (b) which is optionally coaxially with third passage 334 (as shown).
  • For some applications, when tissue anchor 300 (and open loop 154 (e.g., spiral 160) thereof) is unconstrained by deployment tool 30, open loop 154 (e.g., spiral 160) has a first outer dimension, measured in a direction parallel to flexible elongate tension member 202. After tension is applied to flexible elongate tension member 202, flexible elongate tension member 202 becomes more narrow in the direction of flexible elongate tension member 202, such that open loop 154 (e.g., spiral 160) has a second outer dimension, measured in a direction parallel to flexible elongate tension member 202, which is less than the first outer dimension, e.g., no more than 90% of the first out dimension, such as no more than 80% of the first out dimension, e.g., no more than 70% of the first out dimension, no more than 50% of the first out dimension, or no more than 20% of the first out dimension. For some applications, the force applied to flexible elongate tension member 202 to achieve this reduction is between 2 and 50 N, such as between 5 and 20 N, e.g., 5 N, 7 N, 10 N, 20 N, or 30 N. The amount of force is dependent on the radius of wire 150, and may increase as a power of the radius, such as a third or fourth power of the radius. For some applications, a smallest radius of wire 150 is chosen that is able to withstand between 5 and 20 N of force.
  • Reference is now made to FIGS. 4A-B, which are schematic illustrations of two configurations of a tissue anchor system 248, in accordance with respective applications of the present invention. In these applications, tissue anchor 300 is a first tissue anchor 182A of tissue anchor system 248, which further comprises (a) a second tissue anchor 182B, which is separate and distinct first tissue anchor 182A, and (b) the one or more tethers 132, which are configured to couple (i) flexible elongate tension member 202 of first tissue anchor 182A to (ii) second tissue anchor 182B. For some applications, one of the one or more tethers 132 is fixed to (a) flexible elongate tension member 202 of first tissue anchor 182A and (b) second tissue anchor 182B.
  • For some applications, such as shown in FIG. 4A, second tissue anchor 182B comprises a helical tissue-coupling element 184. For example, second tissue anchor 182B may implement techniques described in PCT Publication WO 2015/193728 (e.g., with reference to FIG. 8 thereof), PCT Publication WO 2014/108903, and/or the patents and patent application publications incorporated hereinbelow by reference. For other applications, such as shown in FIG. 4B, second tissue anchor 182B comprises a stent 186. For example, second tissue anchor 182B may implement techniques described in one or more of the following applications, which are incorporated herein by reference: US Patent Application Publication 2011/0184510, US Patent Application Publication 2012/0035712, US Patent Application Publication 2013/0018459, US Patent Application Publication 2013/0046380, PCT Publication WO 2014/141239, and/or the patents and patent application publications incorporated hereinbelow by reference.
  • Reference is made to FIGS. 1A-D, 3A, and 4A-B. For some applications, anchor shaft 122 comprises sealing element 190, which is configured to form a blood-tight seal between a portion of anchor shaft 122 inside the heart chamber and wall 194 of the heart. For some applications, sealing element 190 is annular, and snugly surrounds anchor shaft 122.
  • Reference is now made to FIGS. 5A-B, which are schematic illustrations of tissue-coupling element 128 and anchor shaft 122, in accordance with an application of the present invention. FIGS. 5A-B provide two views of a configuration tissue-coupling element 128 and anchor shaft 122, when tissue anchor 300 is unconstrained by deployment tool 30. The parameters of open loop 354 of tissue anchor 300 described with reference to FIGS. 5A-B may also apply to open loop 154 of tissue anchor 200, described hereinabove with reference to FIGS. 1A-D.
  • Reference is made to FIGS. 3A-C and 5A-D. When tissue anchor 300 is unconstrained by deployment tool 30, such as shown in FIGS. 3A-C and 5A-D:
      • anchor shaft 122 has central longitudinal axis 134,
      • anchor head 124 is coaxial with central longitudinal axis 134, and
      • tissue-coupling element 128 is shaped such that if tissue-coupling element 128 were to be projected onto a plane 136 that is perpendicular to central longitudinal axis 134:
        • at least 80% (e.g., at least 90%, such as at least 95%) of an area 138 of a projection 139 of tissue-coupling element 128 on plane 136 would fall within a first angle α (alpha) of 180 degrees in plane 136 having a vertex 140 at central longitudinal axis 134, as labeled in FIG. 2B, and
        • area 138 would partially overlap, at a distance D1 of at least 3 mm from vertex 140, both rays 142A and 142B of a second angle β (beta) of between 45 and 180 degrees in plane 136 having vertex 140 at central longitudinal axis 134 (the partial overlap is illustrated by the heavier portions of the rays).
  • As used in the present application, including in the claims, a “central longitudinal axis” of an elongate structure is the set of all centroids of transverse cross-sectional sections of the structure along the structure. Thus the cross-sectional sections are locally perpendicular to the central longitudinal axis, which runs along the structure. (If the structure is circular in cross-section, the centroids correspond with the centers of the circular cross-sectional sections.)
  • Tissue-coupling element 128 is configured to have a predetermined shape when unconstrained by deployment tool 30. For example, the tissue-coupling element may comprise a shape-memory material, such as a shape-memory alloy, e.g., Nitinol. Thus, tissue-coupling element 128 automatically transitions to the predetermined shape when released from being constrained by deployment tool 30 to being unconstrained by deployment tool 30.
  • For some applications, central longitudinal axis 134 is straight when tissue anchor 300 is unconstrained by deployment tool 30, such as shown in FIGS. 3A-C and 5A-D.
  • For some applications, such as shown in FIGS. 3A-C and 5A-B, a proximally-facing surface defined by tissue-coupling element 128 (i.e., the surface defined by tissue-coupling element 128 that is configured to touch the external surface of the heart) is concave when tissue anchor 300 is unconstrained by deployment tool 30 (in other words, tissue-coupling element 128 is concave when viewed from proximal portion 126 of anchor shaft 122). Such a concave shape may approximate the natural convex shape of an external surface of the wall of the heart.
  • For other applications, the proximally-facing surface defined by tissue-coupling element 128 is generally flat, when tissue anchor 300 is unconstrained by deployment tool 30 (configuration not shown). Optionally, upon coming into full contact with the external surface of the heart, the proximally-facing surface defined by the tissue-coupling element may assume a concave shape conforming to the convex shape of the external surface of the heart.
  • For some applications, when tissue anchor 300 is unconstrained by deployment tool 30:
      • a greatest longitudinal dimension D2 of tissue-coupling element 128, measured parallel to central longitudinal axis 134, is between 1 and 6 mm (such as between 2 and 5 mm) (labeled in FIG. 5B), and
      • a greatest lateral dimension D3 of tissue-coupling element 128, measured perpendicular to central longitudinal axis 134, is between 4 and 25 mm (such as between 5 and 20 mm) (labeled in FIG. 5A).
  • Typically, a ratio of the greatest longitudinal dimension D2 and greatest lateral dimension D3 is between 1:2 and 1:18, such as between 1:5 and 1:10, e.g., 1:7 when tissue anchor 300 is unconstrained by deployment tool 30.
  • For some applications, tissue-coupling element 128 has a length of at least 5 mm (e.g., at least 10 mm), no more than 100 mm (e.g., no more than 60 mm), and/or between 5 and 100 mm (e.g., between 10 and 60 mm) when constrained into a straight configuration.
  • For some applications, when tissue anchor 300 is unconstrained by deployment tool 30, such as shown in FIGS. 3A-C and 5A-D, tissue-coupling element 128 (including wire 150 and tip 308) (a) is shaped as open loop 354 having more than one turn, such that a first complete turn of open loop 354 at least partially overlaps (i.e., runs alongside, above, and/or below) a second at-least-partial turn of open loop 354. For some applications, the first complete turn and the second at-least-partial turn radially coincide, i.e., are at a same distance as each other from a center point (configuration not shown). For other applications, as shown in the figures, an outermost turn of open loop 354 at least partially overlaps (i.e., runs alongside, above, and/or below) a second-to-outermost turn of open loop 354. For some applications, open loop 354 is a three-dimensional open loop. For some applications, open loop 354 is a spiral 360 (e.g., a three-dimensional spiral).
  • For some applications, open loop 354 extends from distal end 130 of anchor shaft 122 at radially-outer end 164 of open loop 354. For some applications, wire 150 intersects center point 162 (labeled in FIG. 3C) when tissue anchor 300 is unconstrained by deployment tool 30 (configuration not shown), while for other applications, wire 150 does not intersect center point 162 (labeled in FIG. 3C) when tissue anchor 300 is unconstrained by deployment tool 30 (as shown).
  • For some applications, such as shown in FIGS. 3A-C and 5A-D (as well as FIGS. 4A-B, 7, 9A-C, and 15A-C), when tissue anchor 300 is unconstrained by deployment tool 30, open loop 354 has more than one turn and less than two turns. For example, as shown in FIGS. 3A-C and 5A-D, open loop 354 may have more than one turn and less than 1.5 turns, such as more than one turn, e.g., more than 1.01 turns (363.6 degrees), such as more than 1.02 turns (367.2 degrees), and/or less than 1.25 turns (450 degrees).
  • For some applications, when tissue anchor 300 is unconstrained by deployment tool 30, such as shown in FIGS. 3A-C and 5A-D, tissue-coupling element 128 (including wire 150 and tip 308 if provided) of open loop 354 is shaped as spiral 160 (e.g., a three-dimensional spiral) around center point 162. For some of these applications, wire 150 of spiral 160 extends from distal end 130 of anchor shaft 122 at radially-outer end 164 of spiral 160. For some applications, wire 150 of spiral 160 intersects center point 162 when tissue anchor 300 is unconstrained by deployment tool 30 (configuration not shown), while for other applications, wire 150 of spiral 160 does not intersect center point 162 when tissue anchor 300 is unconstrained by deployment tool 30 (as shown). For some applications, spiral 160 is an elliptical spiral when the tissue anchor is unconstrained by deployment tool 30, such as shown in FIGS. 3A-C and 5A-D (as well as in FIGS. 4A-B, 7, 9A-C, and 15A-C).
  • For some applications, such as shown in FIGS. 3A-C and 5A-D (as well as FIGS. 4A-B, 7, 9A-C, and 15A-C), when the tissue anchor is unconstrained by deployment tool 30, spiral 160 has more than one turn and less than two turns. For example, as shown in FIGS. 3A-C and 5A-D, spiral 160 may have more than one turn and less than 1.5 turns, such as more than one turn and less than 1.25 turns.
  • For some applications, when tissue anchor 300 is unconstrained by deployment tool 30, the open loop (e.g., the spiral) has greatest lateral dimension D3 (labeled in FIG. 5A), measured perpendicular to central longitudinal axis 134, and a distance between (a) radially-outer end 164 of open loop 354 (e.g., spiral 160) and (b) a radially-inner-most point 166 of open loop 354 (e.g., spiral 160), measured perpendicular to central longitudinal axis 134, is equal to at least 30% of the greatest lateral dimension D3. Alternatively or additionally, for some applications, a distance between radially-inner-most point 166 and a closest point thereto on an outermost turn of open loop 354, measured perpendicular to central longitudinal axis 134, is equal to at least 30% of the greatest lateral dimension D3.
  • Reference is made to FIGS. 5C-D, which are schematic illustrations of tissue-coupling element 128 and anchor shaft 122, in accordance with respective applications of the present invention. The parameters of open loop 354 of tissue anchor 300 described with reference to FIGS. 5C-D may also apply to open loop 154 of tissue anchor 200, described hereinabove with reference to FIGS. 1A-D. For some applications, as shown in FIG. 5C, at least 80%, such as at least 90%, e.g., at least 95%, of area 138 of projection 139 of tissue-coupling element 128 on plane 136 would fall within a third angle γ (gamma) of 150 degrees in plane 136 having vertex 140 at central longitudinal axis 134, if tissue-coupling element 128 were to be projected onto plane 136.
  • For some applications, as shown in FIG. 5D, an outer portion 168 of area 138 of projection 139 of tissue-coupling element 128 on plane 136 consists of all points of area 138 at least a distance D from vertex 140; for example, the distance D may be 2 mm, such as 3 mm, e.g., 4 mm. Outer portion 168 would fall within all angular positions of a fourth angle δ (delta) of 90 degrees in plane 136 having vertex 140 at central longitudinal axis 134, which outer portion 168, if tissue-coupling element 128 were to be projected onto plane 136. In other words, at all angular positions of fourth angle δ (delta), there is at least one point of outer portion 168. (Outer portion 168 may additionally fall within angular positions outside of fourth angle δ (delta), such as shown in FIG. 5D.)
  • Reference is now made to FIGS. 6A-B, which are schematic illustrations of a tissue anchor 400 before deployment from deployment tool 30, in accordance with an application of the present invention. Tissue anchor 400 is one implementation of tissue anchor 20, described above. Other than as described below and shown in the figures, tissue anchor 400 is generally similar to tissue anchor 300, described hereinabove with reference to FIGS. 2A-B, 3A-D, 4A-B, and 5A-D, and may implement any of the features thereof, mutatis mutandis.
  • In the configuration shown in FIGS. 6A-B, guidewire 310, rather than passing through deployment shaft 34 of deployment tool 30 alongside wire 150 of tissue-coupling element 128 (as shown in FIGS. 2A-B), exits deployment shaft 34 near distal end 342 of deployment shaft 34, typically through a guidewire opening 344 (e.g., slot) that is defined by the wall of deployment shaft 34 and extends to distal end 342 of deployment shaft 34. Optionally, deployment tool 30 further comprises a guide tube 346, which is fixed to an external surface of deployment tool 30; guidewire 310 passes through guide tube 346. In addition, in the configuration shown in FIGS. 6A-B, anchor head 124 typically is not shaped so as to define third passage 334 (described hereinabove with reference to FIG. 3D), because guidewire 310 does not pass through anchor head 124.
  • Reference is now made to FIG. 7, which is a schematic illustration of a tissue anchor 430, in accordance with an application of the present invention. Tissue anchor 430 is one implementation of tissue anchor 20, described above. Other than as described below, tissue anchor 430 is generally similar to tissue anchor 300, described hereinabove with reference to FIGS. 2A-B, 3A-D, 4A-B, and 5A-D, and may implement any of the features thereof, mutatis mutandis. In addition, tissue anchor 430 may implement any of the features of tissue anchor 200, described hereinabove with reference to FIGS. 1A-D, mutatis mutandis, and/or tissue anchors 340, 350, 430, 370, 400, 420, 470, and/or 490, mutatis mutandis.
  • Tissue-coupling element 128 of tissue anchor 430 comprises wire 150, which is shaped as an open loop 256, e.g., a spiral 260. Wire 150 extends from distal end 130 of anchor shaft 122 at a radially-inner end 264 of open loop 256 (e.g., spiral 260), when tissue anchor 220 is unconstrained by deployment tool 30. This is unlike the typical configurations of open loop 154 (e.g., spiral 160) and open loop 354 (e.g., spiral 360), described hereinabove, in which wire 150 extends from distal end 130 of anchor shaft 122 at radially-outer end 164 of the open loop (e.g., the spiral). In the present configurations, when tissue anchor 430 is unconstrained by deployment tool 30, radially-inner end 264 of open loop 256 (e.g., spiral 260) is typically disposed within 15 mm of center point 162, such as coinciding with center point 162.
  • Typically, tissue anchor 430 comprises exactly one flexible elongate tension member 202, which includes:
      • distal portion 204 that is fixed to site 206 on open loop 256 (e.g., spiral 260),
      • longitudinal segment 209 of proximal portion 208 that runs alongside the at least a portion 210 of anchor shaft 122 (labeled, for example, in FIG. 3B), and
      • crossing portion 212, which (a) is disposed between distal and proximal portions 204 and 208 (labeled, for example, in FIG. 3B) along flexible elongate tension member 202, and (ii) crosses at least a portion of open loop 256 (e.g., spiral 260) when tissue anchor 430 is unconstrained by deployment tool 30.
  • For some applications, as shown, site 206 is on outermost turn 214 of open loop 256 (e.g., spiral 260), when tissue anchor 430 is unconstrained by deployment tool 30. Flexible elongate tension member 202 may implement any of the features described hereinabove with reference to FIGS. 1A-5D, mutatis mutandis.
  • Reference is now made to FIG. 8, which is a schematic illustration of a tissue anchor 340 after deployment from deployment tool 30, in accordance with an application of the present invention. Tissue anchor 340 is one implementation of tissue anchor 20, described above. Other than as described below and shown in the figures, tissue anchor 340 is generally similar to tissue anchor 300, described hereinabove with reference to FIGS. 2A-B, 3A-D, 4A-B, and 5A-D, and may implement any of the features thereof, mutatis mutandis. Tissue anchor 340, unlike tissue anchor 300, does not comprise tip 308; therefore, tissue anchor 340 is typically delivered using deployment shaft 34 having sharp distal piercing tip 32, as described hereinabove with reference to FIG. 1A.
  • Reference is made to FIGS. 9A-F, which are schematic illustrations of alternative ways to fix flexible elongate tension member 202 to site 206 of open loop 154 or open loop 354, in accordance with respective applications of the present invention. These techniques may be used in combination with any of the configurations of tissue anchor 20 described herein.
  • In the configuration shown in FIG. 9A, distal portion 204 of flexible elongate tension member 202 is fixed to site 206 on open loop 354 by crimping a crimping element 288 around wire 150. In this configuration, a distal portion of flexible elongate tension member 202 beyond site 206 is fixed (e.g., by welding or soldering) to open loop 354, such as near radially-inner end 264 of open loop 354. Distal portion 204 of flexible elongate tension member 202 at least partially runs along open loop 354 between site 206 (on open loop 354) and tip 308. The portion of flexible elongate tension member 202 between site 206 and radially-inner end 264 may be attached to wire 150, or may be held near wire 150, such as by a sleeve, as described with reference to FIG. 9E. It is noted that site 206 is the site on open loop 354 at which flexible elongate tension member 202 makes functional contact with the loop for applying tension across the loop, rather than other sites along wire 150 to which flexible elongate tension member 202 may also be attached.
  • Although the techniques of FIG. 9A are illustrated for open loop 354 of tissue anchor 300, these techniques may also be practiced with the other tissue anchors described herein, including with open loop 154 of tissue anchor 200, described hereinabove with reference to FIGS. 1A-D.
  • The configuration shown in FIG. 9B is generally similar to the configuration shown in FIG. 9A, except that in the configuration shown in FIG. 9B, distal portion 204 of elongate tension member 202, at one or more locations along distal portion 204, is fixed to tip 308. For some applications, tip 308 is shaped so as to define a tension-member lumen 348 therethrough, and distal portion 204 of flexible elongate tension member 202 passes through at least a portion of tension-member lumen 348. For some applications, flexible elongate tension member 202 is fixed to tip 308 by a bead 356 soldered to a distal end of flexible elongate tension member 202.
  • The configuration shown in FIG. 9C is generally similar to the configuration shown in FIG. 9B, except that in the configuration shown in FIG. 9C, wire 150 is shaped so as to define a channel (i.e., wire 150 is tubular), and the channel is shaped so as to define a lateral opening 396 at site 206. Distal portion 204 of flexible elongate tension member 202 enters the channel through lateral opening 396 at site 206, passes through the channel, and exits wire 150 at distal end 294 of wire 150.
  • FIG. 9D is a schematic illustration of a tissue anchor 350, in accordance with an application of the present invention. Tissue anchor 350 is one implementation of tissue anchor 20, described above. Tissue anchor 350 is generally similar to the configuration of tissue anchor 300 shown in FIG. 9C, except as follows. Like the configuration shown in FIG. 9C, wire 150 is shaped so as to define a channel which has lateral opening 396 at site 206. Distal portion 204 of flexible elongate tension member 202 enters the channel through lateral opening 396 at site 206, passes through the channel, and exits wire 150 at distal end 294 of wire 150. For some applications, flexible elongate tension member 202 is fixed to distal end 294 of wire by bead 356 soldered to a distal end of flexible elongate tension member 202.
  • The configuration shown in FIG. 9E may be used in combination with the configuration shown in FIG. 9A, 9B, 9C, or 9D, or separately. In the configuration shown in FIG. 9E, open loop 154 is covered with a sleeve 280, which may comprise a woven material, comprising, for example, polyester. A distal portion of flexible elongate tension member 202 beyond site 206 is fixed (e.g., by welding or soldering) to open loop 154, such as near radially-inner end 264 of open loop 154 (this area of open loop 154 may facilitate attachment because this area is straighter than other portions of the open loop). Flexible elongate tension member 202 penetrates and exits sleeve 280 at site 206, such as by passing between the fibers of sleeve 280, or through an opening made in sleeve 280, which opening is optionally reinforced. Distal portion 204 of flexible elongate tension member 202 is fixed to site 206 on open loop 154 indirectly by being restrained by sleeve 280. Sleeve 280 may in addition improve tissue growth on the tissue anchor. Optionally, a more proximal portion of flexible elongate tension member 202, after crossing open loop 154, re-enters sleeve 280 through a lateral wall of the sleeve, and exits the proximal end of the sleeve.
  • FIG. 9F is a schematic illustration of a tissue anchor 370, in accordance with an application of the present invention. Tissue anchor 370 is one implementation of tissue anchor 20, described above. Tissue anchor 370 is similar in some respect to tissue anchor 340, described hereinabove with reference to FIG. 8, and may implement any features thereof, mutatis mutandis. Tissue anchor 370 optionally does not comprise anchor head 124, as shown; alternatively, tissue anchor 370 does comprise anchor head.
  • For some applications, wire 150 of tissue anchor 370 is shaped so as to define first and second major opposing surfaces 372A and 372B connected by first and second minor opposing surfaces 374A and 374B. First and second major opposing surfaces 372A and 372B and first and second minor opposing surfaces 374A and 374B extend along at least 90% of a total length of wire 150. A total surface area of first minor opposing surface 374A is less than 20%, e.g., less than 10%, such as less than 5%, of a total surface area of major opposing surface 372A.
  • Alternatively or additionally, for some applications, extending along at least 90% of a total length of wire 150, wire 150 has a greatest major dimension DMAJ and a greatest minor dimension DMIN perpendicular to the greatest major dimension DMAJ. The greatest major dimension DMAJ equals at least 150% (e.g., at least 200%, such as at least 300%) of the greatest minor dimension DMIN.
  • Alternatively or additionally, for some applications, at a plurality of locations along wire 150, a cross section of wire 150, taken perpendicular to a longitudinal axis of wire 150, has a shape that has at least one straight side 376, such as at least two straight sides 376, at least three straight sides 376, or four straight sides 376 (as shown). For some applications, the at least one straight side 376 has a length of at least 3 mm. (It is noted that the longitudinal axis of wire 150 typically includes one or more curved portions, such as shown in FIG. 9F.)
  • Reference is still made to FIG. 9F. For some applications, when the tissue anchor 370 is unconstrained by deployment tool 30: (a) a greatest longitudinal dimension of an open shape 291 (e.g., open loop 154), measured in parallel to a central longitudinal axis of anchor shaft 122, is between 0.25 and 5 mm, e.g., between 1 and 5 mm, and (b) a greatest lateral dimension of open shape 291 (e.g., open loop 154), measured perpendicular to the central longitudinal axis, is between 4 and 20 mm.
  • Reference is now made to FIGS. 10A-H, which are schematic illustrations of respective configurations of tissue anchor 20, in accordance with respective applications of the present invention. Tissue anchor 20 may have any of the characteristics described herein, mutatis mutandis. In these configurations of tissue anchor 20, tissue-coupling element 128 (e.g., wire 150 thereof, as shown in FIGS. 10A-G, or wire 150 and tip 308 thereof together, as shown in FIG. 10H) is shaped as open shape 291, such as open loop 154, when tissue anchor 20 is unconstrained by deployment tool 30. Flexible elongate tension member 202 extends from a distal site 380 on open shape 291 (in other words, site 206 is distal site 380), distal site 380 located within 7 mm (e.g., within 3 mm) of distal end 294 of open shape 291, such as at distal end 294, as shown in FIGS. 10A, 10B, 10C, and 10D). Alternatively or additionally, distal site 380 is located within a distance of distal end 294 of open shape 291, which distance equals 5% of a total length of wire 150, and/or equals 10% of greatest lateral dimension D3 of tissue-coupling element 128, measured perpendicular to central longitudinal axis 134 (labeled inter alia in FIG. 5A).
  • As described hereinabove, proximal portion 208 of flexible elongate tension member 202 has longitudinal segment 209 that runs alongside at least portion 210 of anchor shaft 122 when tissue anchor 20 is unconstrained by deployment tool 30 (these elements are labeled in FIGS. 1C and 3B, described hereinabove). As described hereinabove, tissue anchor 20 is configured to allow relative axial motion between the at least a portion 210 of anchor shaft 122 and longitudinal segment 209 of proximal portion 208 of flexible elongate tension member 202 when tissue anchor 20 is unconstrained by deployment tool 30.
  • For some applications, application to flexible elongate tension member 202 of a distally-directed force of at least 1 N while tissue anchor 20 is unconstrained draws the distal end of open shape 291 toward distal end 130 of anchor shaft 122.
  • FIG. 10A is a schematic illustration of a tissue anchor 290, in accordance with an application of the present invention. Tissue anchor 290 is one implementation of tissue anchor 20, described above. Except as described below, tissue anchor 290 is generally similar to tissue anchor 340, described hereinabove with reference to FIG. 8, and tissue anchor 400, described hereinbelow with reference to FIGS. 13A-E. Wire 150 of tissue anchor 290 is not shaped as open loop 154 when tissue anchor 290 is unconstrained by deployment tool 30. Instead, wire 150 is shaped as open shape 291, such as a portion of a circle or a portion of an ellipse. Typically, if, when tissue anchor 290 is unconstrained by deployment tool 30, tissue-coupling element 128 were to be projected onto plane 136 that is perpendicular to central longitudinal axis 134 of anchor shaft 122, open shape 291 would surround at least 170 degrees, no more than 355 degrees, and/or between 170 and 355 degrees of a point 292 in plane 136, such as at least 180 degrees (e.g., at least 190 degrees), no more than 345 degrees, and/or between 180 degrees (e.g., 190 degrees) and 345 degrees. For some applications, such as in which open shape 291 surrounds between 170 and 190 degrees of point 292, site 206 is at distal end 294 of wire 150. For some of these applications, wire 150 is shaped so as to define a channel (i.e., wire 150 is tubular). A portion of flexible elongate tension member 202 passes through the channel and exits the channel of wire 150 at distal end 294 of wire 150. For any of the applications described above, point 292 optionally may fall on a projection onto plane 136 of a line segment that terminates at (a) site 206 on wire 150 and (b) a proximal end 382 of tissue-coupling element 128 when tissue anchor 290 is unconstrained by deployment tool 30. For any of the applications described above, when tissue anchor 290 is unconstrained by deployment tool 30, (a) a line segment that terminates at (i) site 206 (i.e., distal site 380) on open shape 291 and (ii) proximal end 382 of tissue-coupling element 128 may have a total length that equals a percentage of (b) a total length of tissue-coupling element 128, measured along tissue-coupling element 128, the percentage at least 25%, (e.g., at least 40%, such as at least 50%), no more than 75% (e.g., no more than 70%, such as no more than 60%), and/or between 25% and 75% (e.g., between 40% and 70%, such as between 50% and 60%). Typically, at least a portion of tissue-coupling element 128 is curved, such as the entire tissue-coupling element 128.
  • For some applications, such as shown in FIGS. 10A-E and 10H, wire 150 is shaped so as to define a channel (i.e., wire 150 is tubular). In these applications, flexible elongate tension member 202 typically passes through at least a portion of the channel. For some applications, such as shown in FIGS. 10A-D and 10H, flexible elongate tension member 202 passes through the entire channel, and distal site 380 on open shape 291 is a distal-end opening of open shape 291. For some applications, a distal end portion of flexible elongate tension member 202 is fixed at or beyond proximal end 382 of open shape 291 (e.g., fixed to anchor head 124 beyond proximal end 382 of open shape 291).
  • For some applications, such as shown in FIG. 10B, when tissue anchor 20 is unconstrained by deployment tool 30, (a) a line segment that terminates at (i) site 206 on wire 150 and (ii) a proximal end 382 of tissue-coupling element 128 may have a total length that equals a percentage of (b) a total length of tissue-coupling element 128, measured along tissue-coupling element 128, the percentage at least 25%, (e.g., at least 40%, such as at least 50%), no more than 75% (e.g., no more than 70%, such as no more than 60%), and/or between 25% and 75% (e.g., between 40% and 70%, such as between 50% and 60%). Typically, at least a portion of tissue-coupling element 128 is curved, such as the entire tissue-coupling element 128.
  • For some of these applications, as shown in FIGS. 10C-D, a tissue anchor 420 is provided, which is one implementation of tissue anchor 20. Upon application of distally-directed tension to flexible elongate tension member 202, distal end 294 of wire 150 is drawn into contact with anchor head 124, such as with collar 244 of the anchor head, which prevents excessive, unnecessary strain on open loop 154. This arrangement is similar to, and may serve as an alternative to, locking stopper 270, described hereinbelow with reference to FIGS. 13D-E.
  • For some of these applications, such as shown in FIG. 10E, the channel has a proximal lateral opening 390 within 7 mm of a proximal end 392 of wire 150, and proximal portion 208 of flexible elongate tension member 202 passes through proximal lateral opening 390. For some applications, proximal portion 208 of flexible elongate tension member 202 passes through proximal lateral opening 390 and through a proximal-end opening 394 of the channel.
  • For some applications, such as shown in FIG. 10E, the channel has lateral opening 396 at site 206, and distal portion 204 of flexible elongate tension member 202 passes through lateral opening 396.
  • For some applications, such as shown in FIG. 10F, a tissue anchor 470 is provided, which is one implementation of tissue anchor 20. Wire 150 typically has one or more of the shapes and/or dimensions described hereinabove with reference to FIG. 9F.
  • For some applications, such as shown in FIG. 10F, wire 150 is shaped so as to define a proximal opening 398 within 7 mm (e.g., within 3 mm) of proximal end 392 of wire 150, and proximal portion 208 of flexible elongate tension member 202 passes through proximal opening 398.
  • For some applications, as shown in FIG. 10G, a tissue anchor 490 is provided, which is one implementation of tissue anchor 20. Open loop 154 generally extends distally from anchor shaft 122. For some applications, wire 150 has one or more of the shapes and/or dimensions described hereinabove with reference to FIG. 9F, except that, unlike the dimensions given for FIG. 9F, typically, when tissue anchor 490 is unconstrained by deployment tool 30: (a) a greatest longitudinal dimension of open shape 291 (e.g., open loop 154), measured in parallel to central longitudinal axis 134 of anchor shaft 122, is between 5 and 15 mm, and (b) a greatest lateral dimension of open shape 291 (e.g., open loop 154), measured perpendicular to central longitudinal axis 134, is between 4 and 20 mm.
  • Reference is made to FIG. 10H (for clarity of illustration only tip 308 is shown in cross-section). For some applications, the tissue anchors illustrated in FIGS. 10A-D and 10F comprise tip 308. For example, FIG. 10H shows a configuration of tissue anchor 290 of FIG. 10B in which the tissue anchor comprises tip 308. For some applications, distal site 380 is on tip 308. For some applications, in this configuration tip 308 is shaped so as define an extension of the channel (the channel is defined by wire 150). Flexible elongate tension member 202 passes through a portion of tip 308 in this extension of the wire channel, and exits tip 308 (and tissue-coupling element 128) at distal site 380.
  • Reference is now made to FIG. 11A, which is a schematic illustration of tissue anchor 450, described hereinabove with reference to FIG. 10E, before deployment from deployment tool 30, in accordance with an application of the present invention. In this configuration, deployment tool 30 does not comprise a lumen in which the tissue anchor is constrained during deployment, but instead comprises a rod 494 that is inserted into the channel of tissue anchor 450 and holds the tissue anchor generally straight for delivery. For some applications, rod 494 is shaped so as to define a guidewire lumen 496, for delivery of deployment tool 30 over a guidewire.
  • Reference is now made to FIG. 11B, which is a schematic illustration of tissue anchor 470, described hereinabove with reference to FIG. 10F, before deployment from deployment tool 30, in accordance with an application of the present invention. The flatness of tissue anchor 470 may leave space in deployment shaft 34 for passage of a guidewire alongside tissue anchor 470.
  • Reference is now made to FIG. 12, which is a schematic illustration of another configuration of open loop 154, in accordance with an application of the present invention. This configuration may be used in combination tissue anchors 20, 200, 300, 340, 350, 430, 370, 400, 420, 470, and 490. In this configuration, when the tissue anchor is unconstrained by deployment tool 30, open loop 154 is shaped so as to define one or more curved portions 296 (e.g., two or more curved portions 296) and one or more straight portions 298 (e.g., two or more straight portions 298). Straight portions 298 generally maximize the surface contact with the external surface of the heart and thus provide good anchoring. For some applications, open loop 154 is shaped as a common, conventional paper clip (an oblong shape with straight sides, with approximately 1.5 turns).
  • Reference is now made to FIGS. 13A-D, which are schematic illustrations of a tissue anchor 400, in accordance with an application of the present invention. Tissue anchor 400 is one implementation of tissue anchor 20, described above. Other than as described below, tissue anchor 400 is generally similar to tissue anchor 200, described hereinabove with reference to FIGS. 1A-D, and may implement any of the features thereof, mutatis mutandis. Alternatively or additionally, tissue anchor 400 may implement any of the features of tissue anchor 300, described hereinabove with reference to FIGS. 2A-3D and/or any of the other configurations of tissue anchor 20 described herein, including tissue anchors 200, 340, 350, 430, 370, 420, 470, and 490.
  • When tissue anchor 400 is unconstrained by deployment tool 30, such as shown in FIGS. 13A-D, wire 150 is shaped as open loop 154 (e.g., a three-dimensional open loop) around center point 162 (labeled in FIGS. 1D and 3C), and, optionally, as spiral 160 (e.g., a three-dimensional spiral) around center point 162 (labeled in FIGS. 1D and 3C). For some applications, such as shown in FIGS. 13A-D, wire 150 extends from distal end 130 of anchor shaft 122 at radially-outer end 164 of open loop 154 (and, optionally, spiral 160) (labeled in FIG. 13A), when tissue anchor 400 is unconstrained by deployment tool 30. For some applications, open loop 154 (and, optionally, spiral 160) has the dimensions described hereinabove with reference to FIGS. 5A-B and/or 5C-D. For some applications, tissue-coupling element 128 has one or more of the characteristics described hereinabove with reference to FIGS. 5C-D. For some applications, the proximally-facing surface defined by tissue-coupling element 128 is generally flat, when tissue anchor 400 is unconstrained by deployment tool 30 (configuration not shown). Optionally, upon coming into full contact with the external surface of the heart, the proximally-facing surface defined by the tissue-coupling element may assume a concave shape conforming to the convex shape of the external surface of the heart.
  • In the configuration shown in FIGS. 13A-D, tissue anchor 400 further comprises flexible elongate tension member 202, which includes:
      • distal portion 204 that is fixed to site 206 on open loop 154 (such as by welding, soldering, crimping, and/or knotting, and/or as described hereinabove with reference to FIGS. 9A-F),
      • proximal portion 208, which has longitudinal segment 209 that runs alongside at least portion 210 of anchor shaft 122 (labeled in FIG. 13B, in which the at least a portion 210 of anchor shaft 122 is the entire length of anchor shaft 122), and
      • crossing portion 212, which (a) is disposed between distal and proximal portions 204 and 208 along flexible elongate tension member 202, and (ii) crosses at least a portion of open loop 154 when tissue anchor 400 is unconstrained by deployment tool 30.
  • Although flexible elongate tension member 202 is fixed to wire 150 of tissue-coupling element 128, flexible elongate tension member 202 is typically distinct from wire 150. In other words, flexible elongate tension member 202 and wire 150 are not two longitudinal portions of a single continuous wire, i.e., are not longitudinally contiguous with each other.
  • Tension is applied to tissue-coupling element 128 of tissue anchor 400 via flexible elongate tension member 202. The applied tension is resisted by the outward force of open loop 154. The applied tension at least partially compresses and stiffens open loop 154. This arrangement of tension distribution may overcome any natural tendency of open loop 154 to straighten (i.e., unwind) if tension were to be applied along central longitudinal axis 134 via anchor shaft 122, and thus may allow the application of a greater load to open loop 154.
  • Typically, before tension is applied to flexible elongate tension member 202, when tissue anchor 400 is unconstrained by deployment tool 30, flexible elongate tension member 202 is not taut across the at least a portion of open loop 154. For example, flexible elongate tension member 202 may arc distally, such as can best be seen in FIG. 13A.
  • Typically, tissue anchor 400 is configured to allow relative axial motion between the at least a portion 210 of anchor shaft 122 and longitudinal segment 209 of proximal portion 208 of flexible elongate tension member 202 when tissue anchor 400 is unconstrained by deployment tool 30. Such axial motion allows tension to be applied to flexible elongate tension member 202 without also being applied to anchor shaft 122, and allows open loop 154 to be unwound and flexible elongate tension member 202 to be disposed alongside a portion of flexible elongate tension member 202, as shown in FIG. 13A. Typically, longitudinal segment 209 of proximal portion 208 of flexible elongate tension member 202 is coupled in sliding communication with the at least a portion 210 of anchor shaft 122, when tissue anchor 400 is unconstrained by deployment tool 30. For some applications, tissue anchor 400 comprises one or more annular elements, which are disposed around the at least a portion of anchor shaft 122, and couple flexible elongate tension member 202 in the sliding communication with the at least a portion 210 of anchor shaft 122, when tissue anchor 400 is unconstrained by deployment tool 30. For example, the annular elements may comprise one or more collars, loops, or rings. Anchor shaft 122 (e.g., the collars) is shaped such that flexible elongate tension member 202 runs generally parallel to central longitudinal axis 134 of anchor shaft 122.
  • For some applications, as shown, site 206 is on an outermost turn of open loop 154, when tissue anchor 400 is unconstrained by deployment tool 30. For some other applications, site 206 is on a second-to-outermost turn of open loop 154, when tissue anchor 400 is unconstrained by deployment tool 30 (configuration not shown).
  • Typically, a radius of flexible elongate tension member 202 is less than a radius of wire 150, such as less than 50% of the radius of wire 150. Flexible elongate tension member 202 and/or wire 150 may have any of the characteristics described hereinabove with reference to FIGS. 3C, 5A-D and/or 5C-D, including dimensions and relative arrangement with respect to each other.
  • For some applications, one or more tethers 132 are provided, which are configured to be coupled to tissue anchor 400. Typically, the one or more tethers 132 are fixed to flexible elongate tension member 202, typically to proximal portion 208 of the tension member, such as at or near (e.g., within 1 cm of) a proximal end of proximal portion 208. When tension is applied to the one or more tethers, the tension is transmitted to flexible elongate tension member 202, rather than to anchor shaft 122 via anchor head 124.
  • For some applications, anchor head 124 is shaped so as to define a passage 272 in which proximal portion 208 of flexible elongate tension member 202 is slidably disposed. Flexible elongate tension member 202 comprises a locking stopper 270, which is axially fixed to proximal portion 208 or crossing portion 212 of flexible elongate tension member 202. Locking stopper 270 and passage 272 are sized and shaped such that the size and shape of passage 272 prevent proximal movement of locking stopper 270 past passage 272. Optionally, locking stopper 270 engages passage 272 (as shown). For some applications, passage 272 is a channel through a portion of anchor head 124 (such as through one or more collars of anchor head 124) (as shown), while for other applications, passage 272 is a groove (e.g., a U-shaped groove) (configuration not shown). For some applications, locking stopper 270 is shaped so as to define a base 274 and a flange 276. The flange is too large to pass through passage 272, while base 274 may or may not be too large to enter the passage. For some applications, locking stopper 270 is manufactured as a separate element that is fixed to flexible elongate tension member 202, such as by crimping, welding, or soldering. For other applications, locking stopper 270 is integral to flexible elongate tension member 202.
  • For some applications, passage 272 extends to a distal end of anchor head 124 (as shown), while for other applications, passage 272 is disposed more proximally in anchor head 124, such as near a proximal end of anchor head 124 (configuration not shown). Typically, locking stopper 270 is axially fixed to proximal portion 208 or crossing portion 212 of flexible elongate tension member 202 at a distance of at least 7 mm, no more than 22 mm, and/or between 7 and 22 mm from site 206 on the open loop, measured along flexible elongate tension member 202 (i.e., measured along the curvature of flexible elongate tension member 202 if it is curved, such as shown in FIGS. 13A-B). Alternatively or additionally, for some applications, if tissue-coupling element 128 were straightened in an elongated configuration, for example by being disposed in deployment tool 30 such as shown in FIG. 1A mutatis mutandis, locking stopper 270 would be a distance of at least 7 mm, no more than 12 mm, and/or between 7 and 12 mm (e.g., 10 mm) from passage 272. Alternatively or additionally, for some applications, when tissue anchor 400 is unconstrained by deployment tool 30 (and flexible elongate tension member 202 is curved, such as shown in FIGS. 13A-B), locking stopper 270 is disposed at a distance of at least 7 mm, no more than 12 mm, and/or between 7 and 12 mm (e.g., 10 mm) from passage 272. For some applications, when sufficient tension is applied to flexible elongate tension member 202 straighten flexible elongate tension member 202 but not compress open loop 154, locking stopper 270 moves between 5 and 8 mm toward passage 272, such that locking stopper 270 is disposed at a distance of at least 2 mm, no more than 5 mm, and/or between 2 and 5 mm (e.g., 10 mm) from passage 272.
  • As shown in FIG. 13C-D, tension is applied to tissue-coupling element 128 of tissue anchor 200 via flexible elongate tension member 202. The applied tension is resisted by the outward force of open loop 154. The applied tension at least partially compresses and stiffens open loop 154. This arrangement of tension distribution may overcome any natural tendency of open loop 154 to straighten (i.e., unwind) if tension were to be applied along central longitudinal axis 134 via anchor shaft 122, and thus may allow the application of a greater load to open loop 154. The tension applied to tissue-coupling element 128 thus locks open loop 154 into a desired shape.
  • Locking stopper 270 limits the total load that can be applied to open loop 154 by flexible elongate tension member 202, thereby reducing excessive, unnecessary strain on open loop 154. For example, the first 1.5 to 5 N of force applied to flexible elongate tension member 202 may sufficiently deform open loop 154 and engage locking stopper 270. Additional load (tension) that is applied by flexible elongate tension member 202 pulls on the entire tissue anchor 400, and does not further increase the load applied across open loop 154 to site 206, and thus does not further compress the open loop. As described hereinbelow with reference to FIGS. 14D and 15A-C, such tension may be applied to pull tissue anchor 400 closer to another tissue anchor, in order to facilitate repair of an atrioventricular valve of the subject, such as tricuspid valve 504.
  • These techniques thus allow the use of relatively flexible tissue-coupling element, in order to not generate too much outward force inside a delivery tube, which might make axial movement of the tissue-coupling element in the delivery tube difficult or impossible. The tissue-coupling element is tensioned upon delivery, thereby changing its shape and providing a strong tissue-coupling element that cannot unwind easily, and thus remains coupled to the tissue. In addition, minimizing the load on attachment site 206 provides a mechanical advantage that increases the durability of the device under higher loads.
  • As mentioned above, open loop 154 may have more than one turn and less than 1.5 turns, such as more than one turn, e.g., more than 1.01 turns (363.6 degrees), such as more than 1.02 turns (367.2 degrees), and/or less than 1.25 turns (450 degrees) (one turn equals 360 degrees). Providing open loop 154 with more than one turn, rather than exactly one turn or less than one turn, prevents crossing portion 212 from sliding down off of open loop 154 and onto anchor shaft 122 when tension is applied to crossing portion 212. Such sliding might result in crossing portion 212 cutting into tissue of the heart.
  • Reference is made to FIG. 13E, which is a schematic illustration of tissue anchor 400 comprising a sealing element 402, in accordance with an application of the present invention. Sealing element 402 is similar in some respects to sealing element 190, described hereinabove with reference to FIGS. 1A-D and 4A-B. Sealing element 402 is configured to form a blood-tight seal between a portion of anchor head 124 inside the heart chamber and wall 194 of the heart. For some applications, sealing element 402 comprises a compressible sponge. For some applications, an outer diameter of sealing element 402, when expanded, equals at least 1.5 times, e.g., at least 2 times, an inner diameter of deployment shaft 34 of deployment tool 30, described hereinabove with reference to FIG. 1A. For some applications, sealing element 402 is disposed on the narrower portion of anchor head 124 between two collars.
  • Reference is made to FIGS. 1B-C, 3A-B, 4A-B, 5A-D, 7, 8, 9A-F, 10A-H, and 13A-E. For some applications, tissue anchor 20 is shaped so as to define a bend 480 at an interface between tissue-coupling element 128 and anchor shaft 122. Typically, bend 480 has an angle ε (epsilon) of between 45 and 135 degrees, e.g., between 60 and 120 degrees, such as between 85 and 105 degrees, e.g., 90 degrees, as labeled in FIGS. 1C and 3B.
  • Reference is now made to FIGS. 14A-D, which are schematic illustrations of a method for deploying tissue anchor system 248, described hereinabove with reference to FIGS. 4A-B, for repairing tricuspid valve 504, in accordance with an application of the present invention. In the particular method shown in these figures, first and second tissue anchors 182A and 182B of tissue anchor system 248 comprise first tissue anchor 400, described hereinabove with reference to FIGS. 13A-E, and stent 186, described hereinabove with reference to FIG. 4B. The method may also be used to deploy other tissue anchors described herein, mutatis mutandis, including tissue anchor 300. Tissue anchor system 248 further comprises deployment tool 30, for deploying first tissue anchor 182A, and, typically, a second anchor delivery tool for deploying second tissue anchor 182B.
  • As shown in FIG. 14A, first anchor deployment tool 30 is advanced, during a transcatheter procedure (typically endovascularly, such as percutaneously). Also as shown in FIG. 14A, for applications in which deployment tool 30 is shaped so as to define sharp distal piercing tip 32, such as described hereinabove with reference to FIG. 1A, first anchor deployment tool 30 is advanced through the wall of the heart by advancing sharp distal piercing tip 32 of the tool through first implantation site 530. Successful passage through the wall is typically confirmed using imaging.
  • For applications in which tissue anchor 20 comprises tip 308, typically one of the configurations of deployment tool 30 described with reference to FIG. 2A-B or 6A-B is instead used; in these configurations, deployment tool 30 (including deployment shaft 34) is not shaped so as define sharp distal piercing tip 32. Typically, guidewire 310 is first introduced through the wall of the heart using conventional transcatheter guidewire advancement techniques, and deployment tool 30, with tissue anchor 20 disposed therein, is deployed through the wall over the guidewire.
  • First implantation site 530 is shown as within 1 cm of the site on the annulus that circumferentially corresponds to circumferential middle 521 of anterior leaflet 586; alternative first implantation sites 530 are set forth hereinbelow in Table 1. For some applications, first implantation site 530 is within 10 mm, such as within 5 mm, of RCA 590.
  • As shown in FIG. 14B, first tissue anchor 182A is partially released from first anchor deployment tool 30 such that tissue-coupling element 128 is unconstrained by first anchor deployment tool 30. The surgeon ascertains, typically using imaging, whether tissue-coupling element 128 overlies a coronary blood vessel, such as RCA 590. In the procedure shown in FIG. 14B, tissue-coupling element 128 does overlie a coronary blood vessel (RCA 590). For applications in which tissue anchor 20 comprises tip 308, once proper deployment of tissue-coupling element 128 is confirmed, guidewire 310 is withdrawn. (Guidewire 310 is shown in FIGS. 3A-C for clarity of illustration; during the implantation procedure, the guidewire is typically withdrawn before the tissue anchor reaches the configuration shown in these figures.)
  • For some applications, such as shown in FIGS. 14A-D, first anchor deployment tool 30, and first tissue anchor 182A, exit the heart at external exit site 550 on right atrium 500. Typically, in these applications, first tissue anchor 182A passes through an atrial portion of the annulus, or an edge of the annulus and the origin of the trabeculae carneae. For other applications, such as described hereinbelow with reference to FIG. 16, first anchor deployment tool 30, and first tissue anchor 182A, exit the heart at external exit site 550 on right ventricle 552. Typically, in these applications, first tissue anchor 182A passes under RCA 590 in the annulus and exits on the ventricular wall.
  • If tissue-coupling element 128 overlies a coronary blood vessel (e.g., RCA 590), the surgeon rotates first tissue anchor 182A (clockwise and/or counterclockwise, about central longitudinal axis 134) until tissue-coupling element 128 no longer overlies the coronary blood vessel, as shown in FIG. 14C. The rotation is typically performed by rotating anchor shaft 122. The surgeon brings tissue-coupling element 128 into contact with an external surface 534 of the heart, by proximally retracting first tissue anchor 182A.
  • Providing the tissue anchor (e.g., tissue anchor 400) with an elliptical shape (or paper clip shape) reduces the risk of contact with a sensitive anatomic structure, such as a blood vessel, e.g., the RCA.
  • After first tissue anchor 182A has been implanted at first implantation site 530, driver 201 is decoupled from the anchor head and deployment tool 30 is removed from the subject's body, typically leaving catheter 506 in situ.
  • As shown in FIG. 14D, second tissue anchor 182B is implanted in the subject at second implantation site 540. For example, as shown, second tissue anchor 182B may comprise stent 186, and second implantation site 540 may be inferior vena cava 508; an alternative second implantation site 540 is set forth hereinbelow in Table 1. Tension is applied to the one or more tethers 132 that couple the first tissue anchor 182A (e.g., flexible elongate tension member 202 thereof) to second tissue anchor 182B. Typically, the tension is applied without applying tension to anchor shaft 122. Application of such tension facilitates repair of an atrioventricular valve of the subject, such as tricuspid valve 504.
  • For some applications, second tissue anchor 182B is implanted in the subject, and first tissue anchor 182A is coupled to second tissue anchor 182B by the one or more tethers 132 using the techniques described for connecting first and second tissue-engaging elements 60 a and 60 b in US Patent Application Publication 2014/0114390 with reference to FIGS. 34A-E thereof; the '390 publication is incorporated herein by reference. For some applications, one of the one or more tethers 132 is fixed to one of (a) first tissue anchor 182A and (b) second tissue anchor 182B. For some applications, first and second tissue anchors 182A and 182B are implanted using techniques described in US Patent Application Publication 2012/0035712 with reference to FIGS. 7A-D and/or FIGS. 11A-B thereof; the '715 publication is incorporated herein by reference.
  • The following Table 1 sets forth exemplary combinations of (a) anatomical markers for first implantation site 530, (b) second implantation site 540, and (c) external exit sites 550. These sites are listed by way of example and not limitation; the surgeon typically selects the exact sites based on the subject's individual needs and anatomy. Any appropriate location on the heart wall may be used. First implantation site 530 is located within 1 cm of the site on the annulus that circumferentially corresponds to the anatomical marker (i.e., is at the same angular location or “o'clock” as the respective anatomical marker). The direction of the 1 cm from the site on the annulus may be either circumferentially (i.e., clockwise or counterclockwise) around the annulus, up the wall of the right atrium above the annulus, or a combination of circumferentially around the annulus and up the wall of the atrium.
  • Typically, the surgeon uses the anatomical markers to find the exact location first implantation site 530, which is within 1 cm of the anatomical markers, as described above. For example, the commissures are easily detectable using imaging, and thus represent good anatomical markers. However, the commissures are not appropriate for implantation (because they are too delicate), so, in this example, the tissue anchors are implanted near the annulus, such as up the wall of the atrium, within 1 cm from the commissure.
  • TABLE 1
    First implantation site Second implantation External exit site
    530 anatomical marker site 540 550
    Circumferential middle Inferior vena cava Right atrium 500 (site
    521 of anterior leaflet 586 508 550A in FIG. 16)
    An anteroposterior Inferior vena cava Right atrium 500 (site
    commissure
    512 508 550B in FIG. 16)
    Circumferential middle Inferior vena cava Right ventricle 552
    521 of anterior leaflet 586 508 (site 550C in FIG. 16)
    Anteroposterior Inferior vena cava Right ventricle 552
    commissure 512 508 (site550D in FIG. 16)
    A circumferential middle Superior vena cava Right ventricle 552
    of a posterior leaflet 510 (site 550C in FIG. 16)
    Anteroposterior Superior vena cava Right ventricle 552
    commissure 512 510 (site 550D in FIG. 16)
    Circumferential middle A coronary sinus Right atrium 500 (site
    521 of anterior leaflet 586 550A in FIG. 16)
  • Reference is now made to FIGS. 15A-C, which are schematic illustrations of another method for deploying tissue anchor system 248 for repairing tricuspid valve 504, in accordance with an application of the present invention. In the particular method shown in these figures, first tissue anchor 182A of tissue anchor system 248 comprises first tissue anchor 300, and second tissue anchor 182B of tissue anchor system 180 comprises helical tissue-coupling element 184, described hereinabove with reference to FIG. 4A. The method may also be used to deploy other tissue anchors described herein, including tissue anchor 200 or 400 of tissue anchor system 248 as the first tissue anchor, mutatis mutandis. Tissue anchor system 180 or tissue anchor system 248 further comprises deployment tool 30, for deploying first tissue anchor 182A, and, typically, a second anchor delivery tool 570 for deploying second tissue anchor 182B. For some applications, second anchor delivery tool 570 comprises a torque-delivery tool, such as described in PCT Publication WO 2015/193728, which is incorporated herein by reference. Tissue anchor system 248 allows first and second tissue anchors 182A and 182B to be delivered separately and connected afterwards in situ. This simplifies the procedure for the operator, and allows an approach from two or more different blood vessels such as transfemoral, transjugular, transradial or transapical approaches, which may provide simpler access to the anchoring point.
  • First tissue anchor 182A is implanted as described hereinabove with reference to FIGS. 13A-D, as appropriate. As mentioned above, first implantation site 530 is shown as circumferential middle 521 of anterior leaflet 586; alternative first implantation sites 530 are set forth hereinbelow in Table 2. As mentioned with reference to FIG. 13C, after first tissue anchor 182A has been implanted at first implantation site 530, deployment tool 30 is removed from the subject's body, typically leaving catheter 506 in situ.
  • As shown in FIG. 15A, second tissue anchor 182B is implanted in the subject at second implantation site 540. For example, second tissue anchor 182B may comprise helical tissue-coupling element 184, described hereinabove with reference to FIG. 4A, and second implantation site 540 may be within 1 cm of a site on the annulus that circumferentially corresponds to a septoposterior commissure 517; alternative second implantation sites 540 are set forth hereinbelow in Table 2. For some applications, the one or more tethers 132 comprise a single tether 132. For some applications, tether 132 defines a plurality of securement protrusions 560 spaced at intervals along tether 132, which protrusions serve as the friction-enhancing features. For some applications, as shown, protrusions 560 comprise respective cylinders on tether 132.
  • For some applications, outside the subject's body, the surgeon threads a free end of tether 132 through a lateral opening 582 of an outer tether-securing element 580 of second tissue anchor 182B, and then through a lumen of a delivery tube 614. Tether 132 thus connects first and second tissue anchors 182A and 182B.
  • For some applications, as shown in FIG. 15A, second tissue anchor 182B is implanted at second implantation site 540 using a torque-delivery cable 728 of the torque-delivery tool, as described in above-mentioned PCT Publication WO 2015/193728. Second tissue anchor 182B and torque-delivery cable 728 are introduced over tether 132 and through delivery tube 614, which itself is advanced through catheter 506. A tether-locking mechanism of second tissue anchor 182B is introduced in an unlocked state in which sliding of tether 132 through a lateral opening of second tissue anchor 182B is not inhibited. Second tissue anchor 182B is implanted at second implantation site 540 by rotating torque-delivery cable 728 (including a torque-delivery head).
  • The size of the tricuspid valve orifice is reduced by tensioning tether 132, so as to reduce regurgitation. Such tensioning may be performed by proximally pulling on the free end of tether 132, such that a portion of tether 132 is pulled through lateral opening 582 of second tissue anchor 182B. This tension can be applied remotely, i.e., via catheter 506. Application of such tension facilitates repair of an atrioventricular valve of the subject, such as tricuspid valve 504.
  • As shown in FIG. 15B, once the tension has been applied, torque-delivery cable 728 (including the torque-delivery head) is decoupled from second tissue anchor 182B, such as by removing a locking wire. As a result, a spring expands and presses tether 132 against an outer tether-securing element 780, both of which are described in above-mentioned PCT Publication WO 2015/193728. This pressing transitions the tether-locking mechanism to a locked state, in which state the sliding of tether 132 through the second tissue anchor 182B is inhibited. Such locking maintains the distance and tension between second tissue anchor 182B and first tissue anchor 182B.
  • As shown in FIG. 15C, after tether 132 has been tensioned, an excess portion of tether 132 remains free in the right atrium. It is generally undesirable to leave this excess portion free to move around in the atrium. For some applications, the excess portion of tether 132 is cut and removed from the atrium, using a cutting tool, such as thoracoscopic scissors, as known in the art. Further alternatively, for some applications, the excess portion is secured in a desired disposition in the vasculature of the right atrium, such as in inferior vena cava 508, superior vena cava 510, or a coronary sinus.
  • The following Table 2 sets forth exemplary combinations of (a) anatomical markers for first implantation site 530, (b) anatomical markers for second implantation site 540, and (c) external exit sites 550. These sites are listed by way of example and not limitation; the surgeon typically selects the exact sites based on the subject's individual needs and anatomy. Each of first and second implantation sites 530 and 540 is located within 1 cm of the site on the annulus that circumferentially corresponds to the respective anatomical marker (i.e., is at the same angular location or “o'clock” as the respective anatomical marker). The direction of the 1 cm from the site on the annulus may be either circumferentially (i.e., clockwise or counterclockwise) around the annulus, up the wall of the right atrium above the annulus, or a combination of circumferentially around the annulus and up the wall of the atrium. For example, as shown in FIG. 15C, septoposterior commissure 517 is near, but not on, the annulus, and second tissue anchor 182B is shown implanted at second implantation site 540, which is at the site on the annulus that circumferentially corresponds to this commissure. Second implantation site 540 could also be up to 1 cm clockwise or counterclockwise around the annulus from this site on the annulus, up to 1 cm up the wall of the atrium, or a combination of these two directions.
  • Typically, the surgeon uses the anatomical markers to find the exact locations of first and second implantation sites 530 and 540, which are within 1 cm of the anatomical markers, as described above. For example, the commissures are easily detectable using imaging, and thus represent good anatomical markers. However, the commissures are not appropriate for implantation (because they are too delicate), so, in this example, second tissue anchor 182B is implanted on the annulus or up the wall of the atrium, within 1 cm from the commissure.
  • TABLE 2
    Second implantation
    First implantation site site 540 anatomical External exit site
    530 anatomical marker marker 550
    Circumferential middle Septoposterior Right atrium 500
    521 of anterior leaflet 586 commissure 517
    Anteroposterior Septoposterior Right atrium 500
    commissure 512 commissure 517
    Circumferential middle Septoposterior Right ventricle 552
    521 of anterior leaflet 586 commissure 517
    Anteroposterior Septoposterior Right ventricle 552
    commissure 512 commissure 517
    Anteroposterior a coronary sinus Right ventricle 552
    commissure 512 ostium 554 (labeled
    in FIG. 15C)
  • Reference is now made to FIG. 16, which is a schematic illustration of several external exit sites 550, in accordance with respective applications of the present invention. External exit sites 550 are typically within 10 mm, such as 5 mm, of RCA 590 or branches from the RCA such as the posterior descending artery (PDA) or veins of the right ventricle. External exit sites 550A and 550C are on right atrium 500, and external exit sites 550B and 550D are on right ventricle 552.
  • For some applications, both first and second tissue anchors 182A and 182B comprise respective tissue anchors 20 (tissue anchors 200, 300, 340, 350, 430, 370, 400, 420, 470, or 490, or a combination of two different ones of these tissue anchors). For some applications, first tissue anchor 182A is implanted at an implantation site located with 1 cm of the site on the annulus that circumferentially corresponds to an anatomical marker between circumferential middle 521 of anterior leaflet 586 and anteroposterior commissure 512, inclusive. Alternatively or additionally, for some applications, second tissue anchor 182B is implanted at an implantation site located with 1 cm of the site on the annulus that circumferentially corresponds to an anatomical marker between a circumferential middle of a posterior leaflet and septoposterior commissure 517, inclusive.
  • Further alternatively or additionally, for some applications, second tissue anchor 182B is implanted at an implantation site located above the triangle of Koch, through the septal muscle into the left atrium above the level of the mitral valve. The off-centeredness of tissue anchor 20 allows the tissue-coupling element to be rotated during implantation so as to avoid contact with the mitral valve if the anchor enters the left atrium lower than expected. For some of these applications, first tissue anchor 182A comprises a stent, such as described hereinabove, which may be connected to second tissue anchor 182B by one or more tethers, at least one of which passes through a pulley, such as described in PCT Publication WO 2015/063580, which is incorporated herein by reference. Alternatively, the tissue anchors are implanted and coupled to one another under tension using the techniques described hereinabove with reference to FIG. 15B, mutatis mutandis.
  • Reference is made to FIGS. 1A-16. For some applications, apparatus is provided for delivery in a constrained state within deployment tool 30, the apparatus comprising tissue anchor 20, which comprises (a) anchor shaft 122, and (b) tissue-coupling element 128, which comprises wire 150. When tissue anchor 20 is unconstrained by deployment tool 30:
      • anchor shaft 122 has central longitudinal axis 134,
      • for applications in which tissue-coupling element 128 does not comprise tip 308, wire 150 of tissue-coupling element 128 is shaped as open loop 154 having more than one turn (optionally, around a center point 162), and (b) for applications in which tissue-coupling element 128 comprises tip 308, tissue-coupling element 128 is shaped as open loop 354 having more than one turn (optionally, around center point 162), and
      • wire 150 extends from distal end 130 of anchor shaft 122 at a radially-outer end 164 of open loop 154 or 354, as the case may be.
  • These applications are optionally practiced in combination with any of inventive concepts 2-68, described hereinabove in the Summary of the Application section, mutatis mutandis.
  • For some applications, a method is provided that comprises (a) providing tissue anchor 20 having the characteristics described immediately above; (b) introducing, during a transcatheter procedure, tissue anchor 20 into a cardiac chamber of a heart of a subject, while tissue-coupling element 128 is constrained by deployment tool 30; (c) delivering tissue-coupling element 128 through a wall of the heart; and (d) at least partially releasing tissue anchor 20 from deployment tool 30.
  • The method is optionally practiced in combination with any of inventive concepts 205-277, described hereinabove in the Summary of the Application section, mutatis mutandis.
  • Although the techniques described herein have been described as being used to remodel the tricuspid valve, these techniques may also be used to remodel the mitral valve, mutatis mutandis. In addition, the tissue anchors described herein may be implanted on the surface of any wall of the heart or other organ where tension is to be applied, and rotationally repositioned to avoid obstructions of anatomic structures such as blood vessels or conduction systems, or pre-existing implants.
  • As used in the present application, including in the claims, when a range of values is specified using the word “between,” the range includes the endpoint values.
  • The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein:
      • U.S. Pat. No. 8,475,525 to Maisano et al.;
      • U.S. Pat. No. 8,961,596 to Maisano et al.;
      • U.S. Pat. No. 8,961,594 to Maisano et al.;
      • International Application PCT/IL2011/000064, filed Jan. 20, 2011, which published as PCT Publication WO 2011/089601, and U.S. application Ser. No. 13/574,088 in the national stage thereof, which published as US Patent Application Publication 2013/0046380;
      • U.S. application Ser. No. 13/553,081, filed Jul. 19, 2012, which published as US Patent Application Publication 2013/0018459;
      • International Application PCT/IL2012/000282, filed Jul. 19, 2012, which published as PCT Publication WO 2013/011502;
      • U.S. Provisional Application 61/750,427, filed Jan. 9, 2013;
      • U.S. Provisional Application 61/783,224, filed Mar. 14, 2013;
      • International Application PCT/IL2013/050470, filed May 30, 2013, which published as PCT Publication WO 2013/179295;
      • U.S. Provisional Application 61/897,491, filed Oct. 30, 2013;
      • U.S. Provisional Application 61/897,509, filed Oct. 30, 2013;
      • U.S. application Ser. No. 14/143,355, filed Dec. 30, 2013, which published as US Patent Application Publication 2014/0114390;
      • International Application PCT/IL2014/050027, filed Jan. 9, 2014, which published as PCT Publication WO 2014/108903;
      • International Application PCT/IL2014/050233, filed Mar. 9, 2014, which published as PCT Publication WO 2014/141239;
      • U.S. Provisional Application 62/014,397, filed Jun. 19, 2014;
      • International Application PCT/IB2014/002351, filed Oct. 28, 2014, which published as PCT Publication WO 2015/063580;
      • U.S. application Ser. No. 14/525,668, filed Oct. 28, 2014, which published as US Patent Application Publication 2015/0119936;
      • U.S. Provisional Application 62/086,269, filed Dec. 2, 2014;
      • U.S. Provisional Application 62/131,636, filed Mar. 11, 2015;
      • U.S. Provisional Application 62/167,660, filed May 28, 2015; and
      • International Application PCT/IB2015/001196, filed Jun. 14, 2015, which published as PCT Publication WO 2015/193728.
  • Patents and patent application publications incorporated by reference in the present patent application are to be considered an integral part of the application except that to the extent any terms are defined in these incorporated patents and patent application publications in a manner that conflicts with the definitions made explicitly or implicitly in the present specification, only the definitions in the present specification should be considered. In particular, the definition of “spiral” provided in U.S. Provisional Application 62/086,269, filed Dec. 2, 2014, and U.S. Provisional Application 62/167,660, filed May 28, 2015 should not be considered.
  • It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims (23)

1-34. (canceled)
35. Apparatus comprising an implantable tissue anchor for delivery in a constrained state within a deployment tool, the implantable tissue anchor comprising:
an anchor shaft; and
a tissue-coupling element, which (a) extends from a distal end of the anchor shaft, (b) comprises a wire and a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire, and (c) is shaped as an open shape that is generally orthogonal to the anchor shaft when the tissue anchor is unconstrained by the deployment tool.
36. The apparatus according to claim 35, wherein the greatest tip outer cross-sectional area equals at least 200% of the average anchoring-element outer cross-sectional area.
37. The apparatus according to claim 35, wherein the greatest tip outer cross-sectional area is greater than 1 mm2.
38. The apparatus according to claim 35, wherein the tip comprises a frustoconical portion.
39. The apparatus according to claim 35, wherein the anchor shaft has a central longitudinal axis that is straight when the tissue anchor is unconstrained by the deployment tool.
40. The apparatus according to claim 35, wherein the anchor shaft and the tissue-coupling element are integral to one another.
41. The apparatus according to claim 35, wherein the open shape is an open loop having more than one turn when the tissue anchor is unconstrained by the deployment tool.
42. The apparatus according to claim 41, wherein the open loop is shaped as a spiral when the tissue anchor is unconstrained by the deployment tool.
43. The apparatus according to claim 42, wherein the spiral is shaped as an elliptical spiral when the tissue anchor is unconstrained by the deployment tool.
44. The apparatus according to claim 41, wherein the wire extends from the distal end of the anchor shaft at a radially-outer end of the open loop when the tissue anchor is unconstrained by the deployment tool.
45. The apparatus according to claim 35, wherein when the tissue anchor is unconstrained by the deployment tool, if the tissue-coupling element were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, the open shape would surround between 170 and 355 degrees of a point in the plane, wherein the point falls on a projection onto the plane of a line segment that terminates at (a) a site at the distal end of the wire and (b) a proximal end of the tissue-coupling element.
46. The apparatus according to claim 35, wherein the wire comprises a shape-memory alloy that causes the wire to automatically transition to the open shape when released from being constrained by the deployment tool to being unconstrained by the deployment tool.
47. The apparatus according to claim 35, wherein the tissue anchor is a first tissue anchor, and wherein the apparatus further comprises:
a second tissue anchor, which is separate and distinct from the first tissue anchor; and
one or more tethers that couple the first tissue anchor to the second tissue anchor.
48. A method comprising:
introducing, during a transcatheter procedure, an implantable tissue anchor into a cardiac chamber of a heart of a subject, while a tissue-coupling element of the tissue anchor is constrained by a deployment tool, the tissue-coupling element (i) extending from a distal end of an anchor shaft of the tissue anchor, and (ii) including a wire and a tip, which is fixed to a distal end of the wire, and has, at a widest longitudinal site along the tip, a greatest tip outer cross-sectional area that equals at least 150% of an average wire cross-sectional area of the wire;
delivering the tissue-coupling element through a wall of the heart; and
at least partially releasing the tissue anchor from the deployment tool such that the tissue-coupling element is unconstrained by the deployment tool, and the tissue-coupling element is shaped as an open shape that is generally orthogonal to the anchor shaft.
49. The method according to claim 48, wherein the greatest tip outer cross-sectional area equals at least 200% of the average anchoring-element outer cross-sectional area.
50. The method according to claim 48, wherein the greatest tip outer cross-sectional area is greater than 1 mm2.
51. The method according to claim 48, wherein the open shape is an open loop having more than one turn when the tissue anchor is unconstrained by the deployment tool.
52. The method according to claim 48, wherein the anchor shaft has a central longitudinal axis that is straight when the tissue anchor is unconstrained by the deployment tool.
53. The method according to claim 48, wherein the anchor shaft and the tissue-coupling element are integral to one another.
54. The apparatus according to claim 48, wherein when the tissue anchor is unconstrained by the deployment tool, if the tissue-coupling element were to be projected onto a plane that is perpendicular to a central longitudinal axis of the anchor shaft, the open shape would surround between 170 and 355 degrees of a point in the plane, wherein the point falls on a projection onto the plane of a line segment that terminates at (a) a site at the distal end of the wire and (b) a proximal end of the tissue-coupling element.
55. The method according to claim 48, wherein the wire includes a shape-memory alloy that causes the wire to automatically transition to the open shape when released from being constrained by the deployment tool to being unconstrained by the deployment tool.
56. The method according to claim 48, wherein the tissue anchor is a first tissue anchor, and wherein the method further comprises:
implanting a second tissue anchor in the subject, which second tissue anchor is separate and distinct from the first tissue anchor; and
facilitating repair of an atrioventricular valve of the subject by applying tension to one or more tethers that couple the first tissue anchor to the second tissue anchor.
US16/729,780 2014-12-02 2019-12-30 Tissue Anchors Pending US20200129170A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/729,780 US20200129170A1 (en) 2014-12-02 2019-12-30 Tissue Anchors

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462086269P 2014-12-02 2014-12-02
US201562167660P 2015-05-28 2015-05-28
US15/165,768 US11389152B2 (en) 2014-12-02 2016-05-26 Off-center tissue anchors with tension members
US16/729,780 US20200129170A1 (en) 2014-12-02 2019-12-30 Tissue Anchors

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/165,768 Continuation US11389152B2 (en) 2014-12-02 2016-05-26 Off-center tissue anchors with tension members

Publications (1)

Publication Number Publication Date
US20200129170A1 true US20200129170A1 (en) 2020-04-30

Family

ID=55135451

Family Applications (11)

Application Number Title Priority Date Filing Date
US15/104,467 Active US9907547B2 (en) 2014-12-02 2015-12-02 Off-center tissue anchors
US15/165,768 Active 2037-02-08 US11389152B2 (en) 2014-12-02 2016-05-26 Off-center tissue anchors with tension members
US15/619,881 Active 2036-06-10 US10463358B2 (en) 2014-12-02 2017-06-12 Off-center tissue anchors
US16/166,534 Active 2036-09-22 US11006946B2 (en) 2014-12-02 2018-10-22 Tissue anchors with hemostasis seal
US16/198,639 Active US10441267B2 (en) 2014-12-02 2018-11-21 Tissue anchors with hemostasis seal
US16/573,328 Active US10588618B2 (en) 2014-12-02 2019-09-17 Tissue anchors with hemostasis seal
US16/724,796 Active 2036-08-31 US11337686B2 (en) 2014-12-02 2019-12-23 Off-center tissue anchors
US16/729,780 Pending US20200129170A1 (en) 2014-12-02 2019-12-30 Tissue Anchors
US16/811,070 Active 2036-05-27 US11484303B2 (en) 2014-12-02 2020-03-06 Off-center tissue anchors
US16/872,254 Active 2036-05-16 US11497485B2 (en) 2014-12-02 2020-05-11 Off-center tissue anchors
US18/045,952 Pending US20230210515A1 (en) 2014-12-02 2022-10-12 Off-Center Tissue Anchors

Family Applications Before (7)

Application Number Title Priority Date Filing Date
US15/104,467 Active US9907547B2 (en) 2014-12-02 2015-12-02 Off-center tissue anchors
US15/165,768 Active 2037-02-08 US11389152B2 (en) 2014-12-02 2016-05-26 Off-center tissue anchors with tension members
US15/619,881 Active 2036-06-10 US10463358B2 (en) 2014-12-02 2017-06-12 Off-center tissue anchors
US16/166,534 Active 2036-09-22 US11006946B2 (en) 2014-12-02 2018-10-22 Tissue anchors with hemostasis seal
US16/198,639 Active US10441267B2 (en) 2014-12-02 2018-11-21 Tissue anchors with hemostasis seal
US16/573,328 Active US10588618B2 (en) 2014-12-02 2019-09-17 Tissue anchors with hemostasis seal
US16/724,796 Active 2036-08-31 US11337686B2 (en) 2014-12-02 2019-12-23 Off-center tissue anchors

Family Applications After (3)

Application Number Title Priority Date Filing Date
US16/811,070 Active 2036-05-27 US11484303B2 (en) 2014-12-02 2020-03-06 Off-center tissue anchors
US16/872,254 Active 2036-05-16 US11497485B2 (en) 2014-12-02 2020-05-11 Off-center tissue anchors
US18/045,952 Pending US20230210515A1 (en) 2014-12-02 2022-10-12 Off-Center Tissue Anchors

Country Status (5)

Country Link
US (11) US9907547B2 (en)
EP (2) EP3284412A1 (en)
JP (2) JP6717820B2 (en)
CN (1) CN106999178B (en)
WO (1) WO2016087934A1 (en)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006097931A2 (en) 2005-03-17 2006-09-21 Valtech Cardio, Ltd. Mitral valve treatment techniques
US8951285B2 (en) 2005-07-05 2015-02-10 Mitralign, Inc. Tissue anchor, anchoring system and methods of using the same
WO2010004546A1 (en) 2008-06-16 2010-01-14 Valtech Cardio, Ltd. Annuloplasty devices and methods of delivery therefor
US9883943B2 (en) 2006-12-05 2018-02-06 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US11259924B2 (en) 2006-12-05 2022-03-01 Valtech Cardio Ltd. Implantation of repair devices in the heart
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
US8382829B1 (en) 2008-03-10 2013-02-26 Mitralign, Inc. Method to reduce mitral regurgitation by cinching the commissure of the mitral valve
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US9011530B2 (en) 2008-12-22 2015-04-21 Valtech Cardio, Ltd. Partially-adjustable annuloplasty structure
US8241351B2 (en) 2008-12-22 2012-08-14 Valtech Cardio, Ltd. Adjustable partial annuloplasty ring and mechanism therefor
US8926696B2 (en) 2008-12-22 2015-01-06 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US8545553B2 (en) 2009-05-04 2013-10-01 Valtech Cardio, Ltd. Over-wire rotation tool
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US8353956B2 (en) 2009-02-17 2013-01-15 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
US9968452B2 (en) 2009-05-04 2018-05-15 Valtech Cardio, Ltd. Annuloplasty ring delivery cathethers
US10098737B2 (en) 2009-10-29 2018-10-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US9180007B2 (en) 2009-10-29 2015-11-10 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
EP2506777B1 (en) 2009-12-02 2020-11-25 Valtech Cardio, Ltd. Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof
US9307980B2 (en) 2010-01-22 2016-04-12 4Tech Inc. Tricuspid valve repair using tension
US10058323B2 (en) 2010-01-22 2018-08-28 4 Tech Inc. Tricuspid valve repair using tension
US8475525B2 (en) 2010-01-22 2013-07-02 4Tech Inc. Tricuspid valve repair using tension
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9918840B2 (en) 2011-06-23 2018-03-20 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US10792152B2 (en) 2011-06-23 2020-10-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US8858623B2 (en) 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
US9724192B2 (en) 2011-11-08 2017-08-08 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US8961594B2 (en) 2012-05-31 2015-02-24 4Tech Inc. Heart valve repair system
EP2900150B1 (en) 2012-09-29 2018-04-18 Mitralign, Inc. Plication lock delivery system
US9949828B2 (en) 2012-10-23 2018-04-24 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US10376266B2 (en) 2012-10-23 2019-08-13 Valtech Cardio, Ltd. Percutaneous tissue anchor techniques
WO2014087402A1 (en) 2012-12-06 2014-06-12 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
EP2943132B1 (en) 2013-01-09 2018-03-28 4Tech Inc. Soft tissue anchors
WO2014134183A1 (en) 2013-02-26 2014-09-04 Mitralign, Inc. Devices and methods for percutaneous tricuspid valve repair
EP2967931B8 (en) 2013-03-14 2017-04-12 4Tech Inc. Stent with tether interface
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
CN105283214B (en) 2013-03-15 2018-10-16 北京泰德制药股份有限公司 Translate conduit, system and its application method
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US10299793B2 (en) 2013-10-23 2019-05-28 Valtech Cardio, Ltd. Anchor magazine
WO2015063580A2 (en) 2013-10-30 2015-05-07 4Tech Inc. Multiple anchoring-point tension system
US10022114B2 (en) 2013-10-30 2018-07-17 4Tech Inc. Percutaneous tether locking
US10052095B2 (en) 2013-10-30 2018-08-21 4Tech Inc. Multiple anchoring-point tension system
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
WO2015193728A2 (en) 2014-06-19 2015-12-23 4Tech Inc. Cardiac tissue cinching
US10383729B2 (en) 2014-09-29 2019-08-20 The Provost, Fellows Foundation Scholars, and The Other Members of the Board, of the College of The Holy and Undivided Trinity of Queen Elizabeth Near Dublin (TCD) Heart valve treatment device and method
EP4331503A2 (en) 2014-10-14 2024-03-06 Edwards Lifesciences Innovation (Israel) Ltd. Leaflet-restraining techniques
EP3284412A1 (en) 2014-12-02 2018-02-21 4Tech Inc. Off-center tissue anchors
US20160256269A1 (en) 2015-03-05 2016-09-08 Mitralign, Inc. Devices for treating paravalvular leakage and methods use thereof
CR20170480A (en) * 2015-04-30 2018-02-21 Valtech Cardio Ltd Annuloplasty technologies
DE102015107242B4 (en) * 2015-05-08 2022-11-03 Highlife Sas System for implanting an implant around a peripheral tissue structure in a heart and method for placing and delivering an implant on a guidewire of such a system
US10463492B2 (en) * 2015-11-17 2019-11-05 Edwards Lifesciences Corporation Systems and devices for setting an anchor
WO2017117370A2 (en) 2015-12-30 2017-07-06 Mitralign, Inc. System and method for reducing tricuspid regurgitation
US10751182B2 (en) 2015-12-30 2020-08-25 Edwards Lifesciences Corporation System and method for reshaping right heart
US11833034B2 (en) 2016-01-13 2023-12-05 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
WO2017125170A1 (en) * 2016-01-22 2017-07-27 Medtentia International Ltd Oy Annuloplasty implant
CN108882981B (en) 2016-01-29 2021-08-10 内奥瓦斯克迪亚拉公司 Prosthetic valve for preventing outflow obstruction
US20200146854A1 (en) 2016-05-16 2020-05-14 Elixir Medical Corporation Methods and devices for heart valve repair
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
GB201611910D0 (en) 2016-07-08 2016-08-24 Valtech Cardio Ltd Adjustable annuloplasty device with alternating peaks and troughs
WO2018035378A1 (en) 2016-08-18 2018-02-22 4Tech Inc. Tissue anchors with flexible tips for insertion into the pericardial cavity
AU2017335994B2 (en) * 2016-09-30 2019-11-21 Boston Scientific Scimed, Inc. Tissue retraction device
EP3541462A4 (en) 2016-11-21 2020-06-17 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
US10925731B2 (en) 2016-12-30 2021-02-23 Pipeline Medical Technologies, Inc. Method and apparatus for transvascular implantation of neo chordae tendinae
US11083580B2 (en) 2016-12-30 2021-08-10 Pipeline Medical Technologies, Inc. Method of securing a leaflet anchor to a mitral valve leaflet
US9877833B1 (en) 2016-12-30 2018-01-30 Pipeline Medical Technologies, Inc. Method and apparatus for transvascular implantation of neo chordae tendinae
CN111493925A (en) * 2017-02-08 2020-08-07 4科技有限公司 Implanted dynamometer
EP3579761A2 (en) 2017-02-08 2019-12-18 4Tech Inc. Post-implantation tensioning in cardiac implants
US10441266B2 (en) 2017-03-01 2019-10-15 4Tech Inc. Post-implantation tension adjustment in cardiac implants
EP3592289B1 (en) 2017-03-09 2021-07-07 Medtronic Vascular Inc. Tension management devices for stented prosthesis delivery device
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
US20180353297A1 (en) * 2017-06-08 2018-12-13 4Tech Inc. Tissue Anchor with Tether Stop
WO2019013994A1 (en) * 2017-07-10 2019-01-17 4Tech Inc. Tissue anchors with load-bearing features
EP3672530A4 (en) 2017-08-25 2021-04-14 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
WO2019074815A1 (en) 2017-10-10 2019-04-18 4Tech Inc. Force-distributing anchor system
WO2019083894A1 (en) * 2017-10-24 2019-05-02 University Of Maryland, Baltimore Method and apparatus for cardiac procedures
EP3661428B1 (en) * 2017-10-31 2021-07-21 4Tech Inc. Tissue anchors with hemostasis features
US10835221B2 (en) * 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
US11135062B2 (en) 2017-11-20 2021-10-05 Valtech Cardio Ltd. Cinching of dilated heart muscle
EP3743015A1 (en) 2018-01-24 2020-12-02 Valtech Cardio, Ltd. Contraction of an annuloplasty structure
WO2019145941A1 (en) 2018-01-26 2019-08-01 Valtech Cardio, Ltd. Techniques for facilitating heart valve tethering and chord replacement
CA3089782A1 (en) 2018-02-09 2019-08-15 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A heart valve therapeutic device
US20200360001A1 (en) * 2018-02-09 2020-11-19 4Tech Inc. Frustoconical Hemostatic Sealing Elements
WO2019195860A2 (en) 2018-04-04 2019-10-10 Vdyne, Llc Devices and methods for anchoring transcatheter heart valve
CR20210020A (en) 2018-07-12 2021-07-21 Valtech Cardio Ltd Annuloplasty systems and locking tools therefor
EP3720363A1 (en) 2018-08-07 2020-10-14 4 Tech Inc. Post-implantation tensioning in cardiac implants
CN109009490B (en) * 2018-09-13 2023-11-24 中国医科大学附属盛京医院 Flexible recoverable puncture anchor and fixer thereof
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
US10321995B1 (en) 2018-09-20 2019-06-18 Vdyne, Llc Orthogonally delivered transcatheter heart valve replacement
JP2022504241A (en) 2018-10-05 2022-01-13 シファメド・ホールディングス・エルエルシー Artificial heart valve device, system, and method
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
JP7260930B2 (en) 2018-11-08 2023-04-19 ニオバスク ティアラ インコーポレイテッド Ventricular deployment of a transcatheter mitral valve prosthesis
US11864751B2 (en) 2018-12-05 2024-01-09 Boston Scientific Scimed, Inc. Endoscopic tissue approximation system and methods
CA3123034A1 (en) 2018-12-12 2020-06-18 Pipeline Medical Technologies, Inc. Method and apparatus for mitral valve chord repair
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
US10653522B1 (en) 2018-12-20 2020-05-19 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valve prosthesis
AU2019408052A1 (en) * 2018-12-21 2021-07-08 National University Of Ireland, Galway A medical anchor device
CN113226193A (en) * 2018-12-24 2021-08-06 4科技有限公司 Self-locking tissue anchor
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
WO2020181154A2 (en) 2019-03-05 2020-09-10 Vdyne, Inc. Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US10631983B1 (en) 2019-03-14 2020-04-28 Vdyne, Inc. Distal subannular anchoring tab for side-delivered transcatheter valve prosthesis
US10758346B1 (en) 2019-03-14 2020-09-01 Vdyne, Inc. A2 clip for side-delivered transcatheter mitral valve prosthesis
EP3941391A4 (en) 2019-03-19 2022-11-23 Shifamed Holdings, LLC Prosthetic cardiac valve devices, systems, and methods
EP3946163A4 (en) 2019-04-01 2022-12-21 Neovasc Tiara Inc. Controllably deployable prosthetic valve
CN113924065A (en) 2019-04-10 2022-01-11 内奥瓦斯克迪亚拉公司 Prosthetic valve with natural blood flow
JP2022530764A (en) 2019-05-04 2022-07-01 ブイダイン,インコーポレイテッド Tightening device and method for deploying a laterally delivered artificial heart valve with a native annulus.
EP3972673A4 (en) 2019-05-20 2023-06-07 Neovasc Tiara Inc. Introducer with hemostasis mechanism
WO2020257643A1 (en) 2019-06-20 2020-12-24 Neovasc Tiara Inc. Low profile prosthetic mitral valve
EP3996630A1 (en) * 2019-07-11 2022-05-18 Medtentia International Ltd Oy Annuloplasty device
WO2021024183A1 (en) 2019-08-05 2021-02-11 Croivalve Ltd. Apparatus and methods for treating a defective cardiac valve
CN114929116A (en) * 2019-08-08 2022-08-19 透壁系统有限责任公司 Tissue crossing system and anchor for use therewith
EP4017442A4 (en) 2019-08-20 2023-07-26 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
CN114630665A (en) 2019-08-26 2022-06-14 维迪内股份有限公司 Laterally deliverable transcatheter prosthetic valve and methods of delivery and anchoring thereof
KR20220122966A (en) 2019-10-29 2022-09-05 에드워즈 라이프사이언시스 이노베이션 (이스라엘) 리미티드 Annuloplasty and Tissue Anchor Techniques
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery
IT202000012562A1 (en) 2020-05-27 2021-11-27 Milano Politecnico DEVICE AND ASSEMBLY FOR REPAIRING A HEART VALVE

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040220596A1 (en) * 2003-02-04 2004-11-04 Frazier Andrew G.C. Patent foramen ovale closure system
US20050273135A1 (en) * 2004-05-07 2005-12-08 Nmt Medical, Inc. Catching mechanisms for tubular septal occluder
US6986784B1 (en) * 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US20060212047A1 (en) * 2001-09-06 2006-09-21 Ryan Abbott Systems and Methods for Treating Septal Defects
US20070010851A1 (en) * 2003-07-14 2007-01-11 Chanduszko Andrzej J Tubular patent foramen ovale (PFO) closure device with catch system
US20070055333A1 (en) * 2005-09-06 2007-03-08 Sean Forde Removable intracardiac RF device
US20070073337A1 (en) * 2001-09-06 2007-03-29 Ryan Abbott Clip-Based Systems And Methods For Treating Septal Defects
US20070250081A1 (en) * 2006-03-31 2007-10-25 Nmt Medical, Inc. Adjustable length patent foramen ovale (PFO) occluder and catch system
US20100312259A1 (en) * 2001-04-24 2010-12-09 Houser Russell A Tissue closure devices, device and systems for delivery, kits and methods therefor
US20110152886A1 (en) * 2007-02-26 2011-06-23 Olympus Medical Systems Corp. Applicator and tissue fastening method through natural orifice
US20120179086A1 (en) * 2009-09-11 2012-07-12 Peter Shank Anchors with open heads
US8641704B2 (en) * 2007-05-11 2014-02-04 Medtronic Ablation Frontiers Llc Ablation therapy system and method for treating continuous atrial fibrillation
US20140379074A1 (en) * 2012-01-31 2014-12-25 Mitral Valve Technologies Sa Mitral valve docking devices, systems and methods

Family Cites Families (655)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4007743A (en) 1975-10-20 1977-02-15 American Hospital Supply Corporation Opening mechanism for umbrella-like intravascular shunt defect closure device
US4214349A (en) 1978-11-30 1980-07-29 Midland-Ross Corporation Tie wrap
GB2084468B (en) 1980-09-25 1984-06-06 South African Inventions Surgical implant
IT1144379B (en) 1981-07-14 1986-10-29 Sorin Biomedica Spa CARDIAC VALVE PROSTHESIS
US4444207A (en) 1981-10-19 1984-04-24 Cordis Corporation Method of anchoring a temporary cardiac pacing lead
US4405313A (en) 1982-01-29 1983-09-20 Sisley James R Figure-eight, dual-lumen catheter and method of using
US4493329A (en) 1982-08-19 1985-01-15 Lynn Crawford Implantable electrode having different stiffening and curvature maintaining characteristics along its length
DE3230858C2 (en) 1982-08-19 1985-01-24 Ahmadi, Ali, Dr. med., 7809 Denzlingen Ring prosthesis
US4532926A (en) 1983-06-20 1985-08-06 Ethicon, Inc. Two-piece tissue fastener with ratchet leg staple and sealable latching receiver
US4548202A (en) 1983-06-20 1985-10-22 Ethicon, Inc. Mesh tissue fasteners
US4741336A (en) 1984-07-16 1988-05-03 Ethicon, Inc. Shaped staples and slotted receivers (case VII)
US4625727A (en) 1985-01-24 1986-12-02 Leiboff Arnold R Anastomosis device with excisable frame
US4712549A (en) 1985-07-01 1987-12-15 Edward Weck & Co. Automatic hemostatic clip applier
US4853986A (en) 1986-01-02 1989-08-08 The Awareness Marketing Corporation Water level control
US4808157A (en) 1987-07-13 1989-02-28 Neuro Delivery Technology, Inc. Multi-lumen epidural-spinal needle
US4884567A (en) 1987-12-03 1989-12-05 Dimed Inc. Method for transvenous implantation of objects into the pericardial space of patients
FI85223C (en) 1988-11-10 1992-03-25 Biocon Oy BIODEGRADERANDE SURGICAL IMPLANT OCH MEDEL.
US5336233A (en) 1989-01-26 1994-08-09 Chen Fusen H Anastomotic device
SE467459B (en) 1990-09-25 1992-07-20 Allset Marine Lashing Ab WIRELESS BEFORE HEARING CHARGES TO CONTAINERS
US5108420A (en) 1991-02-01 1992-04-28 Temple University Aperture occlusion device
CA2078530A1 (en) 1991-09-23 1993-03-24 Jay Erlebacher Percutaneous arterial puncture seal device and insertion tool therefore
US5330521A (en) 1992-06-29 1994-07-19 Cohen Donald M Low resistance implantable electrical leads
ES2049653B1 (en) 1992-10-05 1994-12-16 Velazquez Francisco Farrer CORRECTIVE DEVICE FOR FEMALE URINARY INCONTINENCE.
US5374286A (en) 1993-03-31 1994-12-20 Medtronic, Inc. Torque indicator for fixed screw leads
US6776754B1 (en) 2000-10-04 2004-08-17 Wilk Patent Development Corporation Method for closing off lower portion of heart ventricle
US5450860A (en) 1993-08-31 1995-09-19 W. L. Gore & Associates, Inc. Device for tissue repair and method for employing same
US5730127A (en) * 1993-12-03 1998-03-24 Avitall; Boaz Mapping and ablation catheter system
US5843120A (en) 1994-03-17 1998-12-01 Medinol Ltd. Flexible-expandable stent
US5885278A (en) * 1994-10-07 1999-03-23 E.P. Technologies, Inc. Structures for deploying movable electrode elements
AU3783195A (en) 1994-11-15 1996-05-23 Advanced Cardiovascular Systems Inc. Intraluminal stent for attaching a graft
US5904697A (en) 1995-02-24 1999-05-18 Heartport, Inc. Devices and methods for performing a vascular anastomosis
US6743198B1 (en) 1995-03-20 2004-06-01 Conticare Medical, Inc. Self-cleansing bladder drainage device
US5662683A (en) 1995-08-22 1997-09-02 Ortho Helix Limited Open helical organic tissue anchor and method of facilitating healing
US5823955A (en) * 1995-11-20 1998-10-20 Medtronic Cardiorhythm Atrioventricular valve tissue ablation catheter and method
ATE218052T1 (en) 1995-11-27 2002-06-15 Schneider Europ Gmbh STENT FOR USE IN A PHYSICAL PASSAGE
US5957953A (en) 1996-02-16 1999-09-28 Smith & Nephew, Inc. Expandable suture anchor
US5776178A (en) 1996-02-21 1998-07-07 Medtronic, Inc. Medical electrical lead with surface treatment for enhanced fixation
US6402780B2 (en) 1996-02-23 2002-06-11 Cardiovascular Technologies, L.L.C. Means and method of replacing a heart valve in a minimally invasive manner
US5755760A (en) * 1996-03-11 1998-05-26 Medtronic, Inc. Deflectable catheter
US5853422A (en) 1996-03-22 1998-12-29 Scimed Life Systems, Inc. Apparatus and method for closing a septal defect
US6702846B2 (en) 1996-04-09 2004-03-09 Endocare, Inc. Urological stent therapy system and method
WO1997041778A1 (en) 1996-05-08 1997-11-13 Salviac Limited An occluder device
US5702343A (en) 1996-10-02 1997-12-30 Acorn Medical, Inc. Cardiac reinforcement device
US5948000A (en) 1996-10-03 1999-09-07 United States Surgical Corporation System for suture anchor placement
US6045497A (en) 1997-01-02 2000-04-04 Myocor, Inc. Heart wall tension reduction apparatus and method
US5961440A (en) 1997-01-02 1999-10-05 Myocor, Inc. Heart wall tension reduction apparatus and method
US6050936A (en) 1997-01-02 2000-04-18 Myocor, Inc. Heart wall tension reduction apparatus
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US6406420B1 (en) 1997-01-02 2002-06-18 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US6077214A (en) 1998-07-29 2000-06-20 Myocor, Inc. Stress reduction apparatus and method
US5928281A (en) 1997-03-27 1999-07-27 Baxter International Inc. Tissue heart valves
US6251109B1 (en) 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6042606A (en) 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
US6027523A (en) 1997-10-06 2000-02-22 Arthrex, Inc. Suture anchor with attached disk
US6231516B1 (en) 1997-10-14 2001-05-15 Vacusense, Inc. Endoluminal implant with therapeutic and diagnostic capability
US6332893B1 (en) 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method
US6193734B1 (en) 1998-01-23 2001-02-27 Heartport, Inc. System for performing vascular anastomoses
US6533807B2 (en) 1998-02-05 2003-03-18 Medtronic, Inc. Radially-expandable stent and delivery system
ES2343228T3 (en) * 1998-02-10 2010-07-26 Ethicon Endo-Surgery, Inc. OCLUSION, ANCHORAGE, TENSIONING OR STEERING EQUIPMENT BY FLOW.
US20050021085A1 (en) 1998-05-11 2005-01-27 Surgical Connections, Inc. Surgical stabilizer devices and methods
CA2333121C (en) 1998-05-21 2006-07-25 Christopher J. Walshe A tissue anchor system
US7063711B1 (en) 1998-05-29 2006-06-20 By-Pass, Inc. Vascular surgery
US6010113A (en) 1998-06-15 2000-01-04 Honeywell, Inc. Damper with fanning blades
US6260552B1 (en) 1998-07-29 2001-07-17 Myocor, Inc. Transventricular implant tools and devices
US6129713A (en) 1998-08-11 2000-10-10 Embol-X, Inc. Slidable cannula and method of use
US6206913B1 (en) 1998-08-12 2001-03-27 Vascular Innovations, Inc. Method and system for attaching a graft to a blood vessel
US6345068B1 (en) 1998-09-16 2002-02-05 Infineon Technologies Ag Hierarchical delay lock loop code tracking system with multipath correction
US7128073B1 (en) 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
US20010049554A1 (en) 1998-11-18 2001-12-06 Carlos E. Ruiz Endovascular prosthesis and method of making
WO2000042949A2 (en) 1999-01-22 2000-07-27 Gore Enterprise Holdings, Inc. A biliary stent-graft
US7842048B2 (en) 2006-08-18 2010-11-30 Abbott Laboratories Articulating suture device and method
US8137364B2 (en) 2003-09-11 2012-03-20 Abbott Laboratories Articulating suturing device and method
US6298272B1 (en) 1999-03-29 2001-10-02 Cardiac Pacemakers, Inc. High impedance electrode tip with internal drug delivery capability
US6695768B1 (en) 1999-03-30 2004-02-24 Robert A. Levine Adjustable periventricular ring/ring like device/method for control of ischemic mitral regurgitation and congestive heart disease
US6325797B1 (en) * 1999-04-05 2001-12-04 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
ATE484241T1 (en) 1999-04-09 2010-10-15 Evalve Inc METHOD AND DEVICE FOR HEART VALVE REPAIR
US6752813B2 (en) 1999-04-09 2004-06-22 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US7563267B2 (en) 1999-04-09 2009-07-21 Evalve, Inc. Fixation device and methods for engaging tissue
WO2006116558A2 (en) 1999-04-09 2006-11-02 Evalve, Inc. Device and methods for endoscopic annuloplasty
US6183512B1 (en) 1999-04-16 2001-02-06 Edwards Lifesciences Corporation Flexible annuloplasty system
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
US20050222665A1 (en) 1999-04-23 2005-10-06 Ernest Aranyi Endovascular fastener applicator
DE60044531D1 (en) 1999-06-25 2010-07-22 Vahid Saadat TISSUE TREATMENT DEVICE
US6626899B2 (en) 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
SE514718C2 (en) 1999-06-29 2001-04-09 Jan Otto Solem Apparatus for treating defective closure of the mitral valve apparatus
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US6997951B2 (en) 1999-06-30 2006-02-14 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US6592609B1 (en) 1999-08-09 2003-07-15 Bonutti 2003 Trust-A Method and apparatus for securing tissue
WO2001010306A1 (en) 1999-08-09 2001-02-15 Salviac Limited An occluder with anchor
US8388672B2 (en) 1999-08-09 2013-03-05 Cardiokinetix, Inc. System for improving cardiac function by sealing a partitioning membrane within a ventricle
US6338738B1 (en) 1999-08-31 2002-01-15 Edwards Lifesciences Corp. Device and method for stabilizing cardiac tissue
ES2283316T3 (en) 1999-09-13 2007-11-01 Rex Medical, Lp VASCULAR CLOSURE
US6231561B1 (en) 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US20030069570A1 (en) * 1999-10-02 2003-04-10 Witzel Thomas H. Methods for repairing mitral valve annulus percutaneously
US7615076B2 (en) 1999-10-20 2009-11-10 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US6626930B1 (en) 1999-10-21 2003-09-30 Edwards Lifesciences Corporation Minimally invasive mitral valve repair method and apparatus
AUPQ366099A0 (en) 1999-10-26 1999-11-18 Queensland University Of Technology Ortho paedic screw
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US7169187B2 (en) 1999-12-22 2007-01-30 Ethicon, Inc. Biodegradable stent
US6494908B1 (en) 1999-12-22 2002-12-17 Ethicon, Inc. Removable stent for body lumens
US6989028B2 (en) 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US7507252B2 (en) 2000-01-31 2009-03-24 Edwards Lifesciences Ag Adjustable transluminal annuloplasty system
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US6461336B1 (en) 2000-02-08 2002-10-08 LARRé JORGE CASADO Cardiological medical equipment
DE10010074B4 (en) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for fastening and anchoring heart valve prostheses
US7993368B2 (en) 2003-03-13 2011-08-09 C.R. Bard, Inc. Suture clips, delivery devices and methods
US6537198B1 (en) 2000-03-21 2003-03-25 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US6551344B2 (en) 2000-04-26 2003-04-22 Ev3 Inc. Septal defect occluder
US7083628B2 (en) 2002-09-03 2006-08-01 Edwards Lifesciences Corporation Single catheter mitral valve repair device and method for use
US7347870B1 (en) 2000-05-25 2008-03-25 Bioring Sa Device for shrinking or reinforcing the heart valvular orifices
US7632303B1 (en) 2000-06-07 2009-12-15 Advanced Cardiovascular Systems, Inc. Variable stiffness medical devices
US6575976B2 (en) 2000-06-12 2003-06-10 Arthrex, Inc. Expandable tissue anchor
US7077861B2 (en) 2000-07-06 2006-07-18 Medtentia Ab Annuloplasty instrument
US6613078B1 (en) 2000-08-02 2003-09-02 Hector Daniel Barone Multi-component endoluminal graft assembly, use thereof and method of implanting
SE0002878D0 (en) 2000-08-11 2000-08-11 Kimblad Ola Device and method of treatment of atrioventricular regurgitation
US7510572B2 (en) 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
US20060106278A1 (en) 2004-05-14 2006-05-18 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of an adjustable bridge implant system
US7527646B2 (en) 2000-09-20 2009-05-05 Ample Medical, Inc. Devices, systems, and methods for retaining a native heart valve leaflet
WO2004030568A2 (en) 2002-10-01 2004-04-15 Ample Medical, Inc. Device and method for repairing a native heart valve leaflet
US6893459B1 (en) 2000-09-20 2005-05-17 Ample Medical, Inc. Heart valve annulus device and method of using same
US20080091264A1 (en) 2002-11-26 2008-04-17 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
US8784482B2 (en) 2000-09-20 2014-07-22 Mvrx, Inc. Method of reshaping a heart valve annulus using an intravascular device
US8956407B2 (en) 2000-09-20 2015-02-17 Mvrx, Inc. Methods for reshaping a heart valve annulus using a tensioning implant
US6602288B1 (en) 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US6616684B1 (en) 2000-10-06 2003-09-09 Myocor, Inc. Endovascular splinting devices and methods
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US6508828B1 (en) 2000-11-03 2003-01-21 Radi Medical Systems Ab Sealing device and wound closure device
US7041097B1 (en) 2000-12-21 2006-05-09 Cardiac Pacemakers, Inc. System and method for accessing the coronary sinus
US6929660B1 (en) 2000-12-22 2005-08-16 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6503259B2 (en) 2000-12-27 2003-01-07 Ethicon, Inc. Expandable anastomotic device
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
US20020107531A1 (en) 2001-02-06 2002-08-08 Schreck Stefan G. Method and system for tissue repair using dual catheters
EP1365702A2 (en) 2001-03-08 2003-12-03 Atritech, Inc. Atrial filter implants
FR2822370B1 (en) 2001-03-23 2004-03-05 Perouse Lab TUBULAR ENDOPROSTHESIS COMPRISING A DEFORMABLE RING AND REQUIRED OF INTERVENTION FOR ITS IMPLANTATION
US6622730B2 (en) 2001-03-30 2003-09-23 Myocor, Inc. Device for marking and aligning positions on the heart
US6619291B2 (en) 2001-04-24 2003-09-16 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty
US20090143808A1 (en) 2001-04-24 2009-06-04 Houser Russell A Guided Tissue Cutting Device, Method of Use and Kits Therefor
US8202315B2 (en) 2001-04-24 2012-06-19 Mitralign, Inc. Catheter-based annuloplasty using ventricularly positioned catheter
IL143007A0 (en) 2001-05-07 2002-04-21 Rafael Medical Technologies In Retrievable intravascular support structures
ITMI20011012A1 (en) 2001-05-17 2002-11-17 Ottavio Alfieri ANNULAR PROSTHESIS FOR MITRAL VALVE
US6641597B2 (en) 2001-05-25 2003-11-04 Arthrex, Inc. Interference fit knotless suture anchor fixation
US20040153135A1 (en) 2001-06-21 2004-08-05 Karl Haase Methods and apparatus for crossing a heart valve
FR2826863B1 (en) 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
US7547321B2 (en) 2001-07-26 2009-06-16 Alveolus Inc. Removable stent and method of using the same
US7288105B2 (en) 2001-08-01 2007-10-30 Ev3 Endovascular, Inc. Tissue opening occluder
US6997944B2 (en) 2001-08-13 2006-02-14 Advanced Cardiovascular Systems, Inc. Apparatus and method for decreasing stent gap size
WO2003020179A1 (en) 2001-08-31 2003-03-13 Mitral Interventions Apparatus for valve repair
US7338506B2 (en) 2001-09-05 2008-03-04 Caro Nicholas C Scleral clip and procedures for using same
EP1434542A2 (en) 2001-10-01 2004-07-07 Ample Medical, Inc. Methods and devices for heart valve treatments
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
US7144363B2 (en) * 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
US6949122B2 (en) 2001-11-01 2005-09-27 Cardiac Dimensions, Inc. Focused compression mitral valve device and method
US8231639B2 (en) 2001-11-28 2012-07-31 Aptus Endosystems, Inc. Systems and methods for attaching a prosthesis within a body lumen or hollow organ
US20050177180A1 (en) 2001-11-28 2005-08-11 Aptus Endosystems, Inc. Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ
US20030176914A1 (en) 2003-01-21 2003-09-18 Rabkin Dmitry J. Multi-segment modular stent and methods for manufacturing stents
US6793673B2 (en) 2002-12-26 2004-09-21 Cardiac Dimensions, Inc. System and method to effect mitral valve annulus of a heart
US7179282B2 (en) 2001-12-05 2007-02-20 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US6908478B2 (en) 2001-12-05 2005-06-21 Cardiac Dimensions, Inc. Anchor and pull mitral valve device and method
US6976995B2 (en) 2002-01-30 2005-12-20 Cardiac Dimensions, Inc. Fixed length anchor and pull mitral valve device and method
US6746457B2 (en) 2001-12-07 2004-06-08 Abbott Laboratories Snared suture trimmer
US6978176B2 (en) 2001-12-08 2005-12-20 Lattouf Omar M Treatment for patient with congestive heart failure
EP1465555B1 (en) 2001-12-21 2015-05-06 QuickRing Medical Technologies Ltd. Implantation system for annuloplasty rings
WO2003055417A1 (en) 2001-12-28 2003-07-10 Edwards Lifesciences Ag Delayed memory device
SE524709C2 (en) 2002-01-11 2004-09-21 Edwards Lifesciences Ag Device for delayed reshaping of a heart vessel and a heart valve
US6764510B2 (en) 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
US6960229B2 (en) 2002-01-30 2005-11-01 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US7311705B2 (en) * 2002-02-05 2007-12-25 Medtronic, Inc. Catheter apparatus for treatment of heart arrhythmia
US6926714B1 (en) * 2002-02-05 2005-08-09 Jasbir S. Sra Method for pulmonary vein isolation and catheter ablation of other structures in the left atrium in atrial fibrillation
US7048754B2 (en) 2002-03-01 2006-05-23 Evalve, Inc. Suture fasteners and methods of use
US6797001B2 (en) 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair
US20090112052A1 (en) * 2002-03-25 2009-04-30 Ams Research Corporation Implant Inserted Without Bone Anchors For Treatment of Urge Incontinence
US7094244B2 (en) 2002-03-26 2006-08-22 Edwards Lifesciences Corporation Sequential heart valve leaflet repair device and method of use
CA2950492C (en) 2002-05-08 2018-12-04 Cardiac Dimensions Pty. Ltd. Device and method for modifying the shape of a body organ
US7351256B2 (en) 2002-05-10 2008-04-01 Cordis Corporation Frame based unidirectional flow prosthetic implant
CA2485285A1 (en) 2002-05-10 2003-11-20 Cordis Corporation Method of making a medical device having a thin wall tubular membrane over a structural frame
US20040117004A1 (en) 2002-05-16 2004-06-17 Osborne Thomas A. Stent and method of forming a stent with integral barbs
AU2003247526A1 (en) 2002-06-12 2003-12-31 Mitral Interventions, Inc. Method and apparatus for tissue connection
US7753924B2 (en) 2003-09-04 2010-07-13 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
AU2003245507A1 (en) 2002-06-13 2003-12-31 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US7241257B1 (en) 2002-06-28 2007-07-10 Abbott Cardiovascular Systems, Inc. Devices and methods to perform minimally invasive surgeries
IL150855A (en) 2002-07-22 2007-06-03 Leonid Monassevitch Intratubular anastomosis apparatus
US20040044364A1 (en) 2002-08-29 2004-03-04 Devries Robert Tissue fasteners and related deployment systems and methods
US8758372B2 (en) 2002-08-29 2014-06-24 St. Jude Medical, Cardiology Division, Inc. Implantable devices for controlling the size and shape of an anatomical structure or lumen
CO5500017A1 (en) 2002-09-23 2005-03-31 3F Therapeutics Inc MITRAL PROTESTIC VALVE
EP1562522B1 (en) 2002-10-01 2008-12-31 Ample Medical, Inc. Devices and systems for reshaping a heart valve annulus
US7087064B1 (en) 2002-10-15 2006-08-08 Advanced Cardiovascular Systems, Inc. Apparatuses and methods for heart valve repair
US8979923B2 (en) 2002-10-21 2015-03-17 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
EP1555949A4 (en) 2002-10-21 2009-07-01 Mitralign Inc Method and apparatus for performing catheter-based annuloplasty using local plications
US6733536B1 (en) 2002-10-22 2004-05-11 Scimed Life Systems Male urethral stent device
US8010207B2 (en) 2002-10-31 2011-08-30 Medtronic, Inc. Implantable medical lead designs
US7112219B2 (en) 2002-11-12 2006-09-26 Myocor, Inc. Devices and methods for heart valve treatment
US7247134B2 (en) 2002-11-12 2007-07-24 Myocor, Inc. Devices and methods for heart valve treatment
US7331972B1 (en) 2002-11-15 2008-02-19 Abbott Cardiovascular Systems Inc. Heart valve chord cutter
AU2003290979A1 (en) 2002-11-15 2004-06-15 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Method and device for catheter-based repair of cardiac valves
US7335213B1 (en) 2002-11-15 2008-02-26 Abbott Cardiovascular Systems Inc. Apparatus and methods for heart valve repair
US7485143B2 (en) 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
US7404824B1 (en) 2002-11-15 2008-07-29 Advanced Cardiovascular Systems, Inc. Valve aptation assist device
US7175625B2 (en) 2002-11-25 2007-02-13 Triage Medical Soft tissue anchor and method of using same
US7108710B2 (en) 2002-11-26 2006-09-19 Abbott Laboratories Multi-element biased suture clip
US7608114B2 (en) 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
US7837729B2 (en) 2002-12-05 2010-11-23 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty delivery system
US7037290B2 (en) 2002-12-16 2006-05-02 Medtronic, Inc. Multi-lumen steerable catheter
US20040158314A1 (en) 2002-12-24 2004-08-12 Novostent Corporation Ribbon-type vascular prosthesis having stress-relieving articulation and methods of use
US7316710B1 (en) 2002-12-30 2008-01-08 Advanced Cardiovascular Systems, Inc. Flexible stent
US7160309B2 (en) 2002-12-31 2007-01-09 Laveille Kao Voss Systems for anchoring a medical device in a body lumen
US20040254600A1 (en) 2003-02-26 2004-12-16 David Zarbatany Methods and devices for endovascular mitral valve correction from the left coronary sinus
WO2004075789A2 (en) 2003-02-26 2004-09-10 Cook Incorporated PROTHESIS ADAPTED FOR PLACEDd UNDER EXTERNAL IMAGING
US7381210B2 (en) 2003-03-14 2008-06-03 Edwards Lifesciences Corporation Mitral valve repair system and method for use
EP1608297A2 (en) 2003-03-18 2005-12-28 St. Jude Medical, Inc. Body tissue remodeling apparatus
US7357818B2 (en) 2003-03-26 2008-04-15 Boston Scientific Scimed, Inc. Self-retaining stent
US20050107871A1 (en) 2003-03-30 2005-05-19 Fidel Realyvasquez Apparatus and methods for valve repair
US20050131523A1 (en) 2003-04-02 2005-06-16 Mehran Bashiri Detachable and retrievable stent assembly
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US7530995B2 (en) 2003-04-17 2009-05-12 3F Therapeutics, Inc. Device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US7159593B2 (en) 2003-04-17 2007-01-09 3F Therapeutics, Inc. Methods for reduction of pressure effects of cardiac tricuspid valve regurgitation
US8221492B2 (en) 2003-04-24 2012-07-17 Cook Medical Technologies Artificial valve prosthesis with improved flow dynamics
US8267981B2 (en) 2003-06-10 2012-09-18 Depuy Mitek, Inc. Suture anchor with improved drive head
WO2004112652A2 (en) 2003-06-20 2004-12-29 Medtronic Vascular, Inc. Device, system, and method for contracting tissue in a mammalian body
WO2004112585A2 (en) 2003-06-20 2004-12-29 Medtronic Vascular, Inc. Valve annulus reduction system
US7316706B2 (en) 2003-06-20 2008-01-08 Medtronic Vascular, Inc. Tensioning device, system, and method for treating mitral valve regurgitation
WO2005004966A1 (en) 2003-07-02 2005-01-20 Cook Critical Care Incorporated Central venous catheter
US8052751B2 (en) 2003-07-02 2011-11-08 Flexcor, Inc. Annuloplasty rings for repairing cardiac valves
US7201772B2 (en) 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
WO2005018507A2 (en) 2003-07-18 2005-03-03 Ev3 Santa Rosa, Inc. Remotely activated mitral annuloplasty system and methods
US20050016560A1 (en) 2003-07-21 2005-01-27 Dee Voughlohn Unique hair-styling system and method
US8211087B2 (en) 2003-07-31 2012-07-03 Cook Medical Technologies Llc Distal wire stop
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US7371244B2 (en) 2003-08-25 2008-05-13 Ethicon, Inc. Deployment apparatus for suture anchoring device
US20050049692A1 (en) 2003-09-02 2005-03-03 Numamoto Michael J. Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US8100923B2 (en) 2003-09-15 2012-01-24 Abbott Laboratories Suture locking device and methods
US20050059997A1 (en) 2003-09-17 2005-03-17 Bauman Ann M. Circular stapler buttress
US7462188B2 (en) 2003-09-26 2008-12-09 Abbott Laboratories Device and method for suturing intracardiac defects
US7435248B2 (en) * 2003-09-26 2008-10-14 Boston Scientific Scimed, Inc. Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel
US20060259137A1 (en) 2003-10-06 2006-11-16 Jason Artof Minimally invasive valve replacement system
US20050075730A1 (en) 2003-10-06 2005-04-07 Myers Keith E. Minimally invasive valve replacement system
EP1682215B1 (en) 2003-10-24 2008-12-24 Cardiac Pacemakers, Inc. Myocardial lead attachment system
US20050090827A1 (en) 2003-10-28 2005-04-28 Tewodros Gedebou Comprehensive tissue attachment system
US7655040B2 (en) 2003-11-12 2010-02-02 Medtronic Vascular, Inc. Cardiac valve annulus reduction system
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US20050177228A1 (en) 2003-12-16 2005-08-11 Solem Jan O. Device for changing the shape of the mitral annulus
WO2005058206A1 (en) 2003-12-16 2005-06-30 Edwards Lifesciences Ag Device for changing the shape of the mitral annulus
US20050273138A1 (en) 2003-12-19 2005-12-08 Guided Delivery Systems, Inc. Devices and methods for anchoring tissue
US9526616B2 (en) 2003-12-19 2016-12-27 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US7258697B1 (en) 2003-12-22 2007-08-21 Advanced Cardiovascular Systems, Inc. Stent with anchors to prevent vulnerable plaque rupture during deployment
US8864822B2 (en) 2003-12-23 2014-10-21 Mitralign, Inc. Devices and methods for introducing elements into tissue
US7431726B2 (en) 2003-12-23 2008-10-07 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
EP2526895B1 (en) 2003-12-23 2014-01-29 Sadra Medical, Inc. Repositionable heart valve
US7824443B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Medical implant delivery and deployment tool
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US20050137686A1 (en) 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Externally expandable heart valve anchor and method
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7449024B2 (en) 2003-12-23 2008-11-11 Abbott Laboratories Suturing device with split arm and method of suturing tissue
US7390332B2 (en) 2004-02-24 2008-06-24 Depuy Mitek, Inc. Methods and devices for repairing tissue
US20070208389A1 (en) 2004-02-25 2007-09-06 Amundson David C Coronary Sinus Locater Method and Apparatus for Biventricular Pacing
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
SE0400546D0 (en) 2004-03-05 2004-03-05 Dan Lundgren Tubular bone anchoring element
US20050203606A1 (en) 2004-03-09 2005-09-15 Vancamp Daniel H. Stent system for preventing restenosis
EP2308425B2 (en) 2004-03-11 2023-10-18 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous Heart Valve Prosthesis
WO2005087139A1 (en) 2004-03-15 2005-09-22 Baker Medical Research Institute Treating valve failure
NL1025830C2 (en) 2004-03-26 2005-02-22 Eric Berreklouw Prosthesis e.g. heart valve secured in place by ring with shape memory material anchor, includes anchor temperature control system
US20050228388A1 (en) 2004-03-30 2005-10-13 Darrel Brodke Double lead bone screw
US7993397B2 (en) 2004-04-05 2011-08-09 Edwards Lifesciences Ag Remotely adjustable coronary sinus implant
WO2005099374A2 (en) 2004-04-05 2005-10-27 Genesee Biomedical, Inc. Method and apparatus for the surgical treatment of congestive heart failure
US7374573B2 (en) 2004-05-03 2008-05-20 Shlomo Gabbay System and method for improving ventricular function
US7534259B2 (en) 2004-05-05 2009-05-19 Direct Flow Medical, Inc. Nonstented heart valves with formed in situ support
WO2005110280A2 (en) 2004-05-07 2005-11-24 Valentx, Inc. Devices and methods for attaching an endolumenal gastrointestinal implant
US20050251208A1 (en) 2004-05-07 2005-11-10 Usgi Medical Inc. Linear anchors for anchoring to tissue
US7390329B2 (en) 2004-05-07 2008-06-24 Usgi Medical, Inc. Methods for grasping and cinching tissue anchors
US20060122692A1 (en) 2004-05-10 2006-06-08 Ran Gilad Stent valve and method of using same
US20050256532A1 (en) 2004-05-12 2005-11-17 Asha Nayak Cardiovascular defect patch device and method
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US7276078B2 (en) 2004-06-30 2007-10-02 Edwards Lifesciences Pvt Paravalvular leak detection, sealing, and prevention
US7597703B2 (en) 2004-09-07 2009-10-06 Medtronic Vascular, Inc. Mechanically expandable occluder
AU2005284739B2 (en) 2004-09-14 2011-02-24 Edwards Lifesciences Ag Device and method for treatment of heart valve regurgitation
US20090118776A1 (en) 2004-09-24 2009-05-07 Biomec, Inc. Tissue anchors
US8052592B2 (en) 2005-09-27 2011-11-08 Evalve, Inc. Methods and devices for tissue grasping and assessment
JP5393980B2 (en) 2004-09-28 2014-01-22 サージカル ソリューションズ リミテッド ライアビリティ カンパニー Suture anchor
US20070083168A1 (en) 2004-09-30 2007-04-12 Whiting James S Transmembrane access systems and methods
US7749250B2 (en) * 2006-02-03 2010-07-06 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US7857830B2 (en) * 2006-02-03 2010-12-28 Biomet Sports Medicine, Llc Soft tissue repair and conduit device
US20060189993A1 (en) * 2004-11-09 2006-08-24 Arthrotek, Inc. Soft tissue conduit device
US20060106420A1 (en) 2004-11-12 2006-05-18 Medtronic Vascular, Inc. Patch for treating a septal defect
US7720550B2 (en) 2004-12-03 2010-05-18 Medtronic, Inc. High impedance active fixation electrode of an electrical medical lead
US7211110B2 (en) 2004-12-09 2007-05-01 Edwards Lifesciences Corporation Diagnostic kit to assist with heart valve annulus adjustment
WO2009053952A2 (en) 2007-10-26 2009-04-30 Mednua Limited A medical device for use in treatment of a valve
DE602005015358D1 (en) 2004-12-15 2009-08-20 Cook Ireland Ltd X-RAY DENSITY MANIPULATION DEVICES
IE20050841A1 (en) 2004-12-15 2006-10-04 Mednua Ltd A medical device suitable for use in treatment of a valve
US8105352B2 (en) 2004-12-16 2012-01-31 Radi Medical Systems Ab Medical sealing device
CA2597066C (en) 2005-02-07 2014-04-15 Evalve, Inc. Methods, systems and devices for cardiac valve repair
EP2410948B1 (en) 2005-02-07 2016-07-20 Abbott Vascular Devices for cardiac valve repair
EP2353494B1 (en) 2005-02-08 2014-07-30 Koninklijke Philips N.V. System for percutaneous glossoplasty
US9089323B2 (en) 2005-02-22 2015-07-28 P Tech, Llc Device and method for securing body tissue
US7931671B2 (en) 2005-03-11 2011-04-26 Radi Medical Systems Ab Medical sealing device
WO2006097931A2 (en) 2005-03-17 2006-09-21 Valtech Cardio, Ltd. Mitral valve treatment techniques
WO2007080595A2 (en) 2006-01-12 2007-07-19 Metacure N.V. Electrode assemblies, tools, and methods for gastric wall implantation
CA2601818A1 (en) 2005-03-25 2006-10-05 Ample Medical, Inc. Device, systems, and methods for reshaping a heart valve annulus
EP1861045B1 (en) 2005-03-25 2015-03-04 St. Jude Medical, Cardiology Division, Inc. Apparatus for controlling the internal circumference of an anatomic orifice or lumen
US8864823B2 (en) 2005-03-25 2014-10-21 StJude Medical, Cardiology Division, Inc. Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen
US7947207B2 (en) 2005-04-12 2011-05-24 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US20060259135A1 (en) 2005-04-20 2006-11-16 The Cleveland Clinic Foundation Apparatus and method for replacing a cardiac valve
SE531468C2 (en) 2005-04-21 2009-04-14 Edwards Lifesciences Ag An apparatus for controlling blood flow
US8333777B2 (en) 2005-04-22 2012-12-18 Benvenue Medical, Inc. Catheter-based tissue remodeling devices and methods
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US7500989B2 (en) 2005-06-03 2009-03-10 Edwards Lifesciences Corp. Devices and methods for percutaneous repair of the mitral valve via the coronary sinus
US7766816B2 (en) 2005-06-09 2010-08-03 Chf Technologies, Inc. Method and apparatus for closing off a portion of a heart ventricle
CA2612679A1 (en) * 2005-06-20 2007-01-04 Richardo D. Roman Ablation catheter
US8685083B2 (en) 2005-06-27 2014-04-01 Edwards Lifesciences Corporation Apparatus, system, and method for treatment of posterior leaflet prolapse
US8252005B2 (en) 2005-06-30 2012-08-28 Edwards Lifesciences Corporation System, apparatus, and method for fastening tissue
US8313497B2 (en) 2005-07-01 2012-11-20 Abbott Laboratories Clip applier and methods of use
US8951285B2 (en) 2005-07-05 2015-02-10 Mitralign, Inc. Tissue anchor, anchoring system and methods of using the same
EP1919397B1 (en) 2005-07-13 2013-01-02 Medtronic, Inc. Two-piece percutaneous prosthetic heart valves
DE102006017873A1 (en) 2005-07-14 2007-01-25 Qualimed Innovative Medizinprodukte Gmbh Temporary stent
EP1903991B1 (en) 2005-07-15 2009-09-09 The Cleveland Clinic Foundation Apparatus for remodelling a cardiac valve annulus
US7927371B2 (en) * 2005-07-15 2011-04-19 The Cleveland Clinic Foundation Apparatus and method for reducing cardiac valve regurgitation
US7875056B2 (en) 2005-07-22 2011-01-25 Anpa Medical, Inc. Wedge operated retainer device and methods
US20070027533A1 (en) * 2005-07-28 2007-02-01 Medtronic Vascular, Inc. Cardiac valve annulus restraining device
US7883517B2 (en) 2005-08-08 2011-02-08 Abbott Laboratories Vascular suturing device
EP1933756B1 (en) 2005-08-19 2016-07-20 CHF Technologies Inc. Steerable lesion excluding heart implants for congestive heart failure
US20070060895A1 (en) 2005-08-24 2007-03-15 Sibbitt Wilmer L Jr Vascular closure methods and apparatuses
US9492277B2 (en) 2005-08-30 2016-11-15 Mayo Foundation For Medical Education And Research Soft body tissue remodeling methods and apparatus
US20070078297A1 (en) 2005-08-31 2007-04-05 Medtronic Vascular, Inc. Device for Treating Mitral Valve Regurgitation
US7846179B2 (en) 2005-09-01 2010-12-07 Ovalis, Inc. Suture-based systems and methods for treating septal defects
US8968379B2 (en) 2005-09-02 2015-03-03 Medtronic Vascular, Inc. Stent delivery system with multiple evenly spaced pullwires
WO2007030415A2 (en) 2005-09-07 2007-03-15 The Foundry, Inc. Apparatus and method for disrupting subcutaneous structures
CA2660892A1 (en) 2005-09-09 2007-03-15 Edwards Lifesciences Corporation Device and method for reshaping mitral valve annulus
WO2007033360A2 (en) * 2005-09-14 2007-03-22 Micardia Corporation Left atrial balloon catheter
US20070073391A1 (en) 2005-09-28 2007-03-29 Henry Bourang System and method for delivering a mitral valve repair device
US20080190989A1 (en) 2005-10-03 2008-08-14 Crews Samuel T Endoscopic plication device and method
US8852270B2 (en) 2007-11-15 2014-10-07 Cardiosolutions, Inc. Implant delivery system and method
US8449606B2 (en) 2005-10-26 2013-05-28 Cardiosolutions, Inc. Balloon mitral spacer
US9259317B2 (en) 2008-06-13 2016-02-16 Cardiosolutions, Inc. System and method for implanting a heart implant
US7785366B2 (en) 2005-10-26 2010-08-31 Maurer Christopher W Mitral spacer
US8778017B2 (en) 2005-10-26 2014-07-15 Cardiosolutions, Inc. Safety for mitral valve implant
US8216302B2 (en) 2005-10-26 2012-07-10 Cardiosolutions, Inc. Implant delivery and deployment system and method
US8092525B2 (en) 2005-10-26 2012-01-10 Cardiosolutions, Inc. Heart valve implant
WO2007053592A2 (en) 2005-10-31 2007-05-10 Cook Incorporated Composite stent graft
WO2007056583A1 (en) 2005-11-09 2007-05-18 Aspire Medical, Inc. Glossoplasty using tissue anchor glossopexy with volumetric tongue reduction
WO2007058857A2 (en) 2005-11-10 2007-05-24 Arshad Quadri Balloon-expandable, self-expanding, vascular prosthesis connecting stent
EP1954198A1 (en) 2005-11-15 2008-08-13 Aoi Medical, Inc. Arterial closure button
WO2007062054A2 (en) 2005-11-21 2007-05-31 The Brigham And Women's Hospital, Inc. Percutaneous cardiac valve repair with adjustable artificial chordae
FR2894131B1 (en) 2005-12-02 2008-12-05 Perouse Soc Par Actions Simpli DEVICE FOR TREATING A BLOOD VESSEL, AND ASSOCIATED TREATMENT NECESSARY.
US8197441B2 (en) 2005-12-06 2012-06-12 Abbott Cardiovascular Systems Inc. Catheter mounted automatic vessel occlusion and fluid dispersion devices
WO2007100408A2 (en) 2005-12-15 2007-09-07 Georgia Tech Research Corporation Papillary muscle position control devices, systems & methods
WO2007078772A1 (en) 2005-12-15 2007-07-12 The Cleveland Clinic Foundation Apparatus and method for treating a regurgitant valve
WO2007072399A1 (en) 2005-12-19 2007-06-28 Robert William Mayo Frater Annuloplasty prosthesis
DE602006015356D1 (en) 2005-12-22 2010-08-19 Symetis Sa STENT VALVES AS FLAPS AND RELEVANT PROCEDURES AND OPERATING SYSTEMS
US20070168013A1 (en) 2006-01-19 2007-07-19 Myles Douglas Vascular graft and deployment system
US7628797B2 (en) 2006-01-31 2009-12-08 Edwards Lifesciences Corporation System, apparatus, and method for fastening tissue
US8562647B2 (en) * 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for securing soft tissue to bone
US7967820B2 (en) 2006-02-07 2011-06-28 P Tech, Llc. Methods and devices for trauma welding
US7637946B2 (en) 2006-02-09 2009-12-29 Edwards Lifesciences Corporation Coiled implant for mitral valve repair
EP2583640B1 (en) 2006-02-16 2022-06-22 Venus MedTech (HangZhou), Inc. Minimally invasive replacement heart valve
US20070203391A1 (en) 2006-02-24 2007-08-30 Medtronic Vascular, Inc. System for Treating Mitral Valve Regurgitation
US8801777B2 (en) 2007-04-18 2014-08-12 David Elmaleh Intravascular device with netting system
ITMI20060410A1 (en) 2006-03-07 2007-09-08 Ethicon Endo Surgery Inc ANASTOMOTIC DEVICE
US7431692B2 (en) 2006-03-09 2008-10-07 Edwards Lifesciences Corporation Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ
US20070219558A1 (en) 2006-03-15 2007-09-20 Allen Deutsch Method and apparatus for arthroscopic surgery using suture anchors
US7815652B2 (en) 2006-03-21 2010-10-19 Ethicon Endo-Surgery, Inc. Surgical fastener and instrument
WO2007115110A2 (en) 2006-03-29 2007-10-11 The Catheter Exchange, Inc. Method and device for cavity obliteration
EP2502569A3 (en) 2006-03-31 2013-04-17 Nanyang Technological University A tissue retractor kit
EP2010102B1 (en) * 2006-04-12 2019-06-12 Medtronic Vascular, Inc. Annuloplasty device having a helical anchor
US7442207B2 (en) 2006-04-21 2008-10-28 Medtronic Vascular, Inc. Device, system, and method for treating cardiac valve regurgitation
WO2007130881A2 (en) 2006-04-29 2007-11-15 Arbor Surgical Technologies, Inc. Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them
WO2007136532A2 (en) 2006-05-03 2007-11-29 St. Jude Medical, Inc. Soft body tissue remodeling methods and apparatus
EP2029053B1 (en) 2006-05-15 2011-02-23 Edwards Lifesciences AG A system for altering the geometry of the heart
US8932348B2 (en) 2006-05-18 2015-01-13 Edwards Lifesciences Corporation Device and method for improving heart valve function
WO2007139677A2 (en) 2006-05-25 2007-12-06 Interventional And Surgical Innovations, Llc Device for regulating blood flow
US8092517B2 (en) 2006-05-25 2012-01-10 Deep Vein Medical, Inc. Device for regulating blood flow
US7811316B2 (en) 2006-05-25 2010-10-12 Deep Vein Medical, Inc. Device for regulating blood flow
US8109993B2 (en) 2006-05-25 2012-02-07 Deep Vein Medical, Inc. Device for regulating blood flow
US20070276437A1 (en) 2006-05-25 2007-11-29 Mitralign, Inc. Lockers for surgical tensioning members and methods of using the same to secure surgical tensioning members
WO2007140470A2 (en) 2006-06-01 2007-12-06 Edwards Lifesciences Corporation Prosthetic insert for improving heart valve function
US7934506B2 (en) 2006-06-21 2011-05-03 Koninklijke Philips Electronics N.V. System and method for temporary tongue suspension
NZ573919A (en) 2006-06-30 2012-08-31 Cvdevices Llc A system for engaging heart tisue utilising a vacuum for percutaneous intravascular access to cardiac tissue
US20080077231A1 (en) 2006-07-06 2008-03-27 Prescient Medical, Inc. Expandable vascular endoluminal prostheses
US8870916B2 (en) 2006-07-07 2014-10-28 USGI Medical, Inc Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use
US7527185B2 (en) 2006-07-12 2009-05-05 Niti Surgical Solutions Ltd. Compression anastomosis ring assembly and applicator for use therewith
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US8252036B2 (en) 2006-07-31 2012-08-28 Syntheon Cardiology, Llc Sealable endovascular implants and methods for their use
US20080097595A1 (en) 2006-08-22 2008-04-24 Shlomo Gabbay Intraventricular cardiac prosthesis
US20080065156A1 (en) 2006-09-08 2008-03-13 Hauser David L Expandable clip for tissue repair
US8870914B2 (en) 2006-09-12 2014-10-28 Cook Medical Technologies Llc Medical device and a method for sealing a puncture or an opening
US9211115B2 (en) 2006-09-28 2015-12-15 Bioventrix, Inc. Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states
US8029556B2 (en) 2006-10-04 2011-10-04 Edwards Lifesciences Corporation Method and apparatus for reshaping a ventricle
US7771467B2 (en) 2006-11-03 2010-08-10 The Cleveland Clinic Foundation Apparatus for repairing the function of a native aortic valve
US20080125400A1 (en) 2006-11-27 2008-05-29 Christopher Speirs Use of phosphoenolpyruvate derivatives
WO2010004546A1 (en) 2008-06-16 2010-01-14 Valtech Cardio, Ltd. Annuloplasty devices and methods of delivery therefor
AU2007330338A1 (en) 2006-12-05 2008-06-12 Valtech Cardio, Ltd. Segmented ring placement
US8236045B2 (en) 2006-12-22 2012-08-07 Edwards Lifesciences Corporation Implantable prosthetic valve assembly and method of making the same
US8702692B2 (en) 2007-01-02 2014-04-22 Baylis Medical Company Inc. Cardiac electrosurgery
US9192471B2 (en) 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US20100249920A1 (en) 2007-01-08 2010-09-30 Millipede Llc Reconfiguring heart features
US20100121433A1 (en) 2007-01-08 2010-05-13 Millipede Llc, A Corporation Of Michigan Reconfiguring heart features
JP5313928B2 (en) 2007-02-05 2013-10-09 ボストン サイエンティフィック リミテッド Percutaneous valves and systems
EP2114304B1 (en) 2007-02-14 2017-09-06 Edwards Lifesciences Corporation implantable medical device for repairing heart
US20080208327A1 (en) 2007-02-27 2008-08-28 Rowe Stanton J Method and apparatus for replacing a prosthetic valve
EP2120753B1 (en) 2007-03-05 2022-09-28 Tornier, Inc. Tack anchor systems
US8911461B2 (en) 2007-03-13 2014-12-16 Mitralign, Inc. Suture cutter and method of cutting suture
US8845723B2 (en) 2007-03-13 2014-09-30 Mitralign, Inc. Systems and methods for introducing elements into tissue
US8137381B2 (en) 2007-04-25 2012-03-20 Arthrocare Corporation Knotless suture anchor having discrete polymer components and related methods
US8753373B2 (en) 2007-05-08 2014-06-17 Edwards Lifesciences Corporation Suture-fastening clip
US8480730B2 (en) 2007-05-14 2013-07-09 Cardiosolutions, Inc. Solid construct mitral spacer
US7991484B1 (en) 2007-05-15 2011-08-02 Pacesetter, Inc. Active fixation medical lead and related method and system
WO2008147875A1 (en) 2007-05-31 2008-12-04 Wilson-Cook Medical, Inc. Suture lock
WO2008149355A2 (en) 2007-06-04 2008-12-11 Mor Research Applications Ltd. Cardiac valve leaflet augmentation
US20100228269A1 (en) 2009-02-27 2010-09-09 Garrison Michi E Vessel closure clip device
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8568445B2 (en) 2007-08-21 2013-10-29 St. Jude Medical Puerto Rico Llc Extra-vascular sealing device and method
US8100820B2 (en) 2007-08-22 2012-01-24 Edwards Lifesciences Corporation Implantable device for treatment of ventricular dilation
US8025495B2 (en) 2007-08-27 2011-09-27 Cook Medical Technologies Llc Apparatus and method for making a spider occlusion device
DE102007043830A1 (en) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Heart valve stent
US20090082828A1 (en) 2007-09-20 2009-03-26 Alan Ostroff Leadless Cardiac Pacemaker with Secondary Fixation Capability
US20090082847A1 (en) 2007-09-26 2009-03-26 Boston Scientific Corporation System and method of securing stent barbs
WO2009045334A1 (en) 2007-09-28 2009-04-09 St. Jude Medical, Inc. Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features
WO2009045331A1 (en) 2007-09-28 2009-04-09 St. Jude Medical, Inc. Two-stage collapsible/expandable prosthetic heart valves and anchoring systems
US20090084386A1 (en) 2007-10-01 2009-04-02 Mcclellan Annette M L Tubal ligation
WO2009046343A1 (en) 2007-10-03 2009-04-09 Bioventrix (A Chf Technologies, Inc.) Treating dysfunctional cardiac tissue
JP2010540190A (en) 2007-10-04 2010-12-24 トリバスキュラー・インコーポレイテッド Modular vascular graft for low profile transdermal delivery
EP2209517A4 (en) 2007-10-05 2011-03-30 Maquet Cardiovascular Llc Devices and methods for minimally-invasive surgical procedures
US9414842B2 (en) 2007-10-12 2016-08-16 St. Jude Medical, Cardiology Division, Inc. Multi-component vascular device
WO2009052188A1 (en) 2007-10-15 2009-04-23 Edwards Lifesciences Corporation Transcatheter heart valve with micro-anchors
US8236013B2 (en) 2007-10-19 2012-08-07 Boston Scientific Scimed, Inc. Apparatus for placing medical implants
US8343029B2 (en) 2007-10-24 2013-01-01 Circulite, Inc. Transseptal cannula, tip, delivery system, and method
US8821366B2 (en) 2007-10-24 2014-09-02 Circulite, Inc. Transseptal cannula, tip, delivery system, and method
US8597347B2 (en) 2007-11-15 2013-12-03 Cardiosolutions, Inc. Heart regurgitation method and apparatus
US20090143815A1 (en) 2007-11-30 2009-06-04 Boston Scientific Scimed, Inc. Apparatus and Method for Sealing a Vessel Puncture Opening
US20100298930A1 (en) 2007-12-02 2010-11-25 Boris Orlov Access to the left atrium and reduction of mitral valve leaflet mobility
US8893947B2 (en) 2007-12-17 2014-11-25 Abbott Laboratories Clip applier and methods of use
US7841502B2 (en) 2007-12-18 2010-11-30 Abbott Laboratories Modular clip applier
EP2231028A2 (en) 2007-12-20 2010-09-29 Mor Research Applications Ltd. Methods and devices for treatment of a heart
WO2010070649A1 (en) 2008-12-21 2010-06-24 Mor Research Applications Ltd. Elongated body for deployment in a coronary sinus
EP3572045B1 (en) 2008-01-24 2022-12-21 Medtronic, Inc. Stents for prosthetic heart valves
EP2520252A1 (en) 2008-02-11 2012-11-07 Corassist Cardiovascular Ltd. Ventricular function assisting devices and methods of use thereof
US8728097B1 (en) 2008-02-26 2014-05-20 Mitralign, Inc. Tissue plication devices and methods for their use
US9131939B1 (en) 2008-02-27 2015-09-15 Mitralign, Inc. Device for percutaneously delivering a cardiac implant through the application of direct actuation forces external to the body
EP2265225B1 (en) 2008-02-29 2013-02-13 Edwards Lifesciences Corporation Expandable member for deploying a prosthetic device
DE102008012113A1 (en) 2008-03-02 2009-09-03 Transcatheter Technologies Gmbh Implant e.g. heart-valve-carrying stent, for e.g. arresting blood vessel, has fiber by which section of implant is reducible according to increasing of implant at extended diameter by unfolding or expansion of diameter with expansion unit
US8382829B1 (en) 2008-03-10 2013-02-26 Mitralign, Inc. Method to reduce mitral regurgitation by cinching the commissure of the mitral valve
US9445804B2 (en) 2008-04-01 2016-09-20 The Lonnie And Shannon Paulos Trust (As Amended And Restated) Suture anchoring assemblies and methods of use
US20100121435A1 (en) 2008-04-16 2010-05-13 Cardiovascular Technologies, Llc Percutaneous transvalvular intrannular band for mitral valve repair
US8262725B2 (en) 2008-04-16 2012-09-11 Cardiovascular Technologies, Llc Transvalvular intraannular band for valve repair
US8128686B2 (en) 2008-04-18 2012-03-06 Cook Medical Technologies Llc Branched vessel prosthesis
FR2930137B1 (en) 2008-04-18 2010-04-23 Corevalve Inc TREATMENT EQUIPMENT FOR A CARDIAC VALVE, IN PARTICULAR A MITRAL VALVE.
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
US8152844B2 (en) 2008-05-09 2012-04-10 Edwards Lifesciences Corporation Quick-release annuloplasty ring holder
US20110071626A1 (en) 2008-05-12 2011-03-24 Wright John T M Device and Method for the Surgical Treatment of Ischemic Mitral Regurgitation
US20090287304A1 (en) 2008-05-13 2009-11-19 Kardium Inc. Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve
US9282965B2 (en) 2008-05-16 2016-03-15 Abbott Laboratories Apparatus and methods for engaging tissue
CA2725736C (en) 2008-06-04 2013-09-17 Gore Enterprise Holdings, Inc. Controlled deployable medical device and method of making the same
US8591460B2 (en) 2008-06-13 2013-11-26 Cardiosolutions, Inc. Steerable catheter and dilator and system and method for implanting a heart implant
US8323335B2 (en) 2008-06-20 2012-12-04 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves and methods for using
US9226820B2 (en) 2008-07-15 2016-01-05 St. Jude Medical, Inc. Axially anchoring collapsible and re-expandable prosthetic heart valves for various disease states
EP3878408A1 (en) 2008-07-21 2021-09-15 Jenesis Surgical, LLC Endoluminal support apparatus
EP2313152B1 (en) 2008-07-21 2022-08-31 Bioventrix Cardiac anchor structures
US20100023118A1 (en) 2008-07-24 2010-01-28 Edwards Lifesciences Corporation Method and apparatus for repairing or replacing chordae tendinae
US7776743B2 (en) 2008-07-30 2010-08-17 Tel Epion Inc. Method of forming semiconductor devices containing metal cap layers
US8777990B2 (en) 2008-09-08 2014-07-15 Howmedica Osteonics Corp. Knotless suture anchor for soft tissue repair and method of use
US8945211B2 (en) 2008-09-12 2015-02-03 Mitralign, Inc. Tissue plication device and method for its use
CA2739961A1 (en) 2008-10-10 2010-04-15 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
AU2009302169B2 (en) 2008-10-10 2016-01-14 Ancora Heart, Inc. Termination devices and related methods
ES2615826T3 (en) * 2008-11-11 2017-06-08 Shifamed Holdings, Llc Low Profile Electrode Set
WO2010071494A1 (en) 2008-12-19 2010-06-24 St.Jude Medical Ab A medical implantable lead and a method for ensuring proper and safe attachment of such a lead to an organ
US8323312B2 (en) 2008-12-22 2012-12-04 Abbott Laboratories Closure device
US8858594B2 (en) 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US8808368B2 (en) 2008-12-22 2014-08-19 Valtech Cardio, Ltd. Implantation of repair chords in the heart
US8545553B2 (en) 2009-05-04 2013-10-01 Valtech Cardio, Ltd. Over-wire rotation tool
US8147542B2 (en) 2008-12-22 2012-04-03 Valtech Cardio, Ltd. Adjustable repair chords and spool mechanism therefor
US8926696B2 (en) 2008-12-22 2015-01-06 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US8241351B2 (en) 2008-12-22 2012-08-14 Valtech Cardio, Ltd. Adjustable partial annuloplasty ring and mechanism therefor
US20110011917A1 (en) 2008-12-31 2011-01-20 Hansen Medical, Inc. Methods, devices, and kits for treating valve prolapse
US20100185278A1 (en) 2009-01-21 2010-07-22 Tendyne Medical Apical Papillary Msucle Attachment for Left Ventricular Reduction
US8108054B2 (en) 2009-02-04 2012-01-31 Pacesetter, Inc. Active fixation implantable medical lead configured to indicate via fluoroscopy embedment of helical anchor in cardiac tissue
US8353956B2 (en) 2009-02-17 2013-01-15 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
US20100217309A1 (en) 2009-02-20 2010-08-26 Boston Scientific Scimed, Inc. Plug for arteriotomy closure and method of use
US8292918B2 (en) 2009-02-20 2012-10-23 Boston Scientific Scimed, Inc. Composite plug for arteriotomy closure and method of use
US20100217382A1 (en) 2009-02-25 2010-08-26 Edwards Lifesciences Mitral valve replacement with atrial anchoring
AU2010218384B2 (en) 2009-02-27 2014-11-20 St. Jude Medical, Inc. Stent features for collapsible prosthetic heart valves
US9980818B2 (en) 2009-03-31 2018-05-29 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
JP5608731B2 (en) 2009-04-15 2014-10-15 マイクロベンション インコーポレイテッド Implant delivery system
CA2961053C (en) 2009-04-15 2019-04-30 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US8292154B2 (en) 2009-04-16 2012-10-23 Tyco Healthcare Group Lp Surgical apparatus for applying tissue fasteners
US20100286628A1 (en) 2009-05-07 2010-11-11 Rainbow Medical Ltd Gastric anchor
US8523881B2 (en) 2010-07-26 2013-09-03 Valtech Cardio, Ltd. Multiple anchor delivery tool
US20110238112A1 (en) 2009-05-29 2011-09-29 Kim Andrew C Suture anchor
US8409269B2 (en) 2009-12-21 2013-04-02 Covidien Lp Procedures for vascular occlusion
US8828040B2 (en) 2009-07-07 2014-09-09 Thomas G. Goff Device and methods for delivery and transfer of temporary radiopaque element
US20110077733A1 (en) 2009-09-25 2011-03-31 Edwards Lifesciences Corporation Leaflet contacting apparatus and method
WO2011041571A2 (en) 2009-10-01 2011-04-07 Kardium Inc. Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve
EP2485689B1 (en) 2009-10-09 2020-03-18 Boston Scientific Scimed, Inc. Stomach bypass
US20110092993A1 (en) 2009-10-20 2011-04-21 Moises Jacobs Tissue approximating device
US20110093002A1 (en) 2009-10-20 2011-04-21 Wilson-Cook Medical Inc. Stent-within-stent arrangements
US20110098732A1 (en) 2009-10-27 2011-04-28 Moises Jacobs Visceral tissue approximating method and device
US9180007B2 (en) 2009-10-29 2015-11-10 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
US8277502B2 (en) 2009-10-29 2012-10-02 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US8690939B2 (en) 2009-10-29 2014-04-08 Valtech Cardio, Ltd. Method for guide-wire based advancement of a rotation assembly
US9011520B2 (en) 2009-10-29 2015-04-21 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US8812134B2 (en) 2009-11-12 2014-08-19 Cardiac Pacemakers Inc. Helix fixation mechanism
WO2011065881A1 (en) 2009-11-30 2011-06-03 St. Jude Medical Ab A medical implantable lead with fixation detection
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
JP2013512765A (en) 2009-12-08 2013-04-18 アヴァロン メディカル リミテッド Devices and systems for transcatheter mitral valve replacement
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
US8475525B2 (en) * 2010-01-22 2013-07-02 4Tech Inc. Tricuspid valve repair using tension
US9307980B2 (en) 2010-01-22 2016-04-12 4Tech Inc. Tricuspid valve repair using tension
US8961596B2 (en) 2010-01-22 2015-02-24 4Tech Inc. Method and apparatus for tricuspid valve repair using tension
US9107749B2 (en) 2010-02-03 2015-08-18 Edwards Lifesciences Corporation Methods for treating a heart
US8444673B2 (en) 2010-02-11 2013-05-21 Boston Scientific Scimed, Inc. Automatic vascular closure deployment devices and methods
DE102010008360A1 (en) 2010-02-17 2011-09-29 Transcatheter Technologies Gmbh Medical implant in which gaps remain during crimping or folding, method and device for moving
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
PL3335670T3 (en) * 2010-03-05 2022-09-05 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
WO2011111047A2 (en) 2010-03-10 2011-09-15 Mitraltech Ltd. Prosthetic mitral valve with tissue anchors
ES2365317B1 (en) 2010-03-19 2012-08-03 Xavier Ruyra Baliarda PROTESTIC BAND, IN PARTICULAR FOR THE REPAIR OF A MITRAL VALVE.
SE535140C2 (en) * 2010-03-25 2012-04-24 Jan Otto Solem An implantable device, kit and system for improving cardiac function, including means for generating longitudinal movement of the mitral valve
US20120046730A1 (en) 2010-04-14 2012-02-23 Abbott Vascular Methods of treating a condition of a vessel in a patient
US9326870B2 (en) 2010-04-23 2016-05-03 Medtronic Vascular, Inc. Biodegradable stent having non-biodegradable end portions and mechanisms for increased stent hoop strength
US9795482B2 (en) 2010-04-27 2017-10-24 Medtronic, Inc. Prosthetic heart valve devices and methods of valve repair
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
CA2798711C (en) 2010-05-10 2019-08-27 Heart Leaflet Technologies, Inc. Stentless support structure
US8790394B2 (en) 2010-05-24 2014-07-29 Valtech Cardio, Ltd. Adjustable artificial chordeae tendineae with suture loops
US9161778B2 (en) 2010-06-11 2015-10-20 Entourage Medical Technologies, Inc. System and method for transapical access and closure
US20130030522A1 (en) 2010-06-16 2013-01-31 Rowe Stanton J Devices and methods for heart treatments
US20120130421A1 (en) 2010-06-18 2012-05-24 The Curators Of The University Of Missouri Ratcheting staple for surgical applications
CN102917654B (en) 2010-06-22 2015-04-15 奥林巴斯医疗株式会社 Method for producing tissue clamp and tissue clamp
US9504802B2 (en) 2010-07-19 2016-11-29 Sukhjit Gill Guiding catheter stabilization system
US9132009B2 (en) 2010-07-21 2015-09-15 Mitraltech Ltd. Guide wires with commissural anchors to advance a prosthetic valve
US8992604B2 (en) 2010-07-21 2015-03-31 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
EP2595569A4 (en) 2010-07-23 2016-02-24 Edwards Lifesciences Corp Retaining mechanisms for prosthetic valves
WO2012019052A2 (en) 2010-08-04 2012-02-09 Micardia Corporation Percutaneous transcatheter repair of heart valves
US20120053680A1 (en) 2010-08-24 2012-03-01 Bolling Steven F Reconfiguring Heart Features
US10105224B2 (en) 2010-09-01 2018-10-23 Mvalve Technologies Ltd. Cardiac valve support structure
US8940002B2 (en) 2010-09-30 2015-01-27 Kardium Inc. Tissue anchor system
CN105380730B (en) 2010-10-05 2018-08-17 爱德华兹生命科学公司 Heart valve prosthesis
EP2632342B1 (en) 2010-10-25 2016-10-05 Boston Scientific Scimed, Inc. Fibrous containment for hemostasis plug
US8968335B2 (en) 2010-10-27 2015-03-03 Mitralign, Inc. Hand operated device for controlled deployment of a tissue anchor and method of using the same
AU2011332225B2 (en) 2010-11-23 2016-05-26 Cc Innovation Surgical implant
US8758402B2 (en) 2010-12-17 2014-06-24 Boston Scientific Scimed, Inc. Tissue puncture closure device
US20120158021A1 (en) 2010-12-19 2012-06-21 Mitralign, Inc. Steerable guide catheter having preformed curved shape
EP2478868A1 (en) 2011-01-25 2012-07-25 The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth Implant device
US9445898B2 (en) 2011-03-01 2016-09-20 Medtronic Ventor Technologies Ltd. Mitral valve repair
WO2012127309A1 (en) 2011-03-21 2012-09-27 Ontorfano Matteo Disk-based valve apparatus and method for the treatment of valve dysfunction
US9072511B2 (en) 2011-03-25 2015-07-07 Kardium Inc. Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve
US8721588B2 (en) 2011-04-15 2014-05-13 DePuy Synthes Products, LLC Noncircular inner lumen guiding catheter with assisted variable support
US20120296349A1 (en) 2011-05-17 2012-11-22 Boston Scientific Scimed, Inc. Percutaneous Mitral Annulus Mini-Plication
US8753357B2 (en) 2011-05-19 2014-06-17 Abbott Cardiovascular Systems, Inc. Devices and methods for suturing tissue
US9289282B2 (en) 2011-05-31 2016-03-22 Edwards Lifesciences Corporation System and method for treating valve insufficiency or vessel dilatation
WO2013003228A1 (en) * 2011-06-27 2013-01-03 University Of Maryland, Baltimore Transapical mitral valve repair device
EP2734157B1 (en) 2011-07-21 2018-09-05 4Tech Inc. Apparatus for tricuspid valve repair using tension
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US20140324164A1 (en) 2011-08-05 2014-10-30 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
AU2012299311B2 (en) 2011-08-11 2016-03-03 Tendyne Holdings, Inc. Improvements for prosthetic valves and related inventions
WO2013028145A1 (en) 2011-08-25 2013-02-28 Scott Stephen J Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input
US20130060279A1 (en) 2011-09-02 2013-03-07 Cardiva Medical, Inc. Catheter with sealed hydratable hemostatic occlusion element
US8945177B2 (en) 2011-09-13 2015-02-03 Abbott Cardiovascular Systems Inc. Gripper pusher mechanism for tissue apposition systems
US9011468B2 (en) 2011-09-13 2015-04-21 Abbott Cardiovascular Systems Inc. Independent gripper
AU2012315597B2 (en) 2011-09-30 2016-01-07 Bioventrix, Inc. Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions
US8764798B2 (en) 2011-10-03 2014-07-01 Smith & Nephew, Inc. Knotless suture anchor
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8858623B2 (en) 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
WO2013078497A1 (en) 2011-12-01 2013-06-06 Milijasevic, Zoran Endoluminal prosthesis
US8968336B2 (en) 2011-12-07 2015-03-03 Edwards Lifesciences Corporation Self-cinching surgical clips and delivery system
EP2886084B1 (en) 2011-12-12 2018-02-14 David Alon Heart valve repair device
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US9078652B2 (en) 2011-12-19 2015-07-14 Edwards Lifesciences Corporation Side-entry knotless suture anchoring clamps and deployment tools
US9078645B2 (en) 2011-12-19 2015-07-14 Edwards Lifesciences Corporation Knotless suture anchoring devices and tools for implants
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US9017347B2 (en) 2011-12-22 2015-04-28 Edwards Lifesciences Corporation Suture clip deployment devices
WO2013123388A1 (en) 2012-02-15 2013-08-22 Children's Hospital- Boston Right ventricular papillary approximation
US20150094802A1 (en) 2012-02-28 2015-04-02 Mvalve Technologies Ltd. Single-ring cardiac valve support
US9474605B2 (en) 2012-05-16 2016-10-25 Edwards Lifesciences Corporation Devices and methods for reducing cardiac valve regurgitation
EP2849680B1 (en) 2012-05-16 2019-01-09 Edwards Lifesciences Corporation Coaptation element for reducing cardiac valve regurgitation
US8961594B2 (en) 2012-05-31 2015-02-24 4Tech Inc. Heart valve repair system
DE102012010798A1 (en) 2012-06-01 2013-12-05 Universität Duisburg-Essen Implantable device for improving or eliminating heart valve insufficiency
US9504571B2 (en) 2012-06-07 2016-11-29 Edwards Lifesciences Corporation Systems for implanting annuloplasty rings with microanchors
US9498202B2 (en) 2012-07-10 2016-11-22 Edwards Lifesciences Corporation Suture securement devices
CN104487026B (en) 2012-07-12 2016-11-02 波士顿科学国际有限公司 Little profile heart valve delivery system
US8992761B2 (en) 2012-07-13 2015-03-31 Abbott Cardiovascular Systems, Inc. Methods for passivating metallic implantable medical devices including radiopaque markers
WO2014022124A1 (en) 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
WO2014035487A1 (en) 2012-08-27 2014-03-06 Cardiac Pacemakers, Inc. Compound-shaped stylet for torque transmission
US20140067048A1 (en) 2012-09-06 2014-03-06 Edwards Lifesciences Corporation Heart Valve Sealing Devices
US9610156B2 (en) 2012-09-14 2017-04-04 Millipede, Inc. Mitral valve inversion prostheses
EP2900150B1 (en) 2012-09-29 2018-04-18 Mitralign, Inc. Plication lock delivery system
US9949828B2 (en) 2012-10-23 2018-04-24 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US9023099B2 (en) 2012-10-31 2015-05-05 Medtronic Vascular Galway Limited Prosthetic mitral valve and delivery method
US8628571B1 (en) 2012-11-13 2014-01-14 Mitraltech Ltd. Percutaneously-deliverable mechanical valve
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
WO2014087402A1 (en) 2012-12-06 2014-06-12 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
EP2740412B1 (en) 2012-12-10 2016-01-20 Peter Osypka Stiftung Implantable closure system with membrane-covered shape-memory braid
US9211203B2 (en) 2012-12-20 2015-12-15 Abbott Cardiovascular Systems, Inc. Hinge for medical device
EP2943132B1 (en) 2013-01-09 2018-03-28 4Tech Inc. Soft tissue anchors
EP2948103B1 (en) 2013-01-24 2022-12-07 Cardiovalve Ltd Ventricularly-anchored prosthetic valves
WO2014134183A1 (en) 2013-02-26 2014-09-04 Mitralign, Inc. Devices and methods for percutaneous tricuspid valve repair
AU2014225916B2 (en) 2013-03-07 2017-10-12 Circulite, Inc. Transseptal cannula, tip, delivery system, and method
US9855033B2 (en) 2013-03-12 2018-01-02 Ziptek LLC. Apparatus and method for securing tissue
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US20140277427A1 (en) 2013-03-14 2014-09-18 Cardiaq Valve Technologies, Inc. Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
EP2967931B8 (en) 2013-03-14 2017-04-12 4Tech Inc. Stent with tether interface
EP2967856B1 (en) 2013-03-14 2020-06-03 Boston Scientific Scimed, Inc. Device and system for reshaping a heart valve
US20140275756A1 (en) * 2013-03-15 2014-09-18 Neotract, Inc. Devices, Systems and Methods for Treating Benign Prostatic Hyperplasia and Other Conditions
US9289297B2 (en) 2013-03-15 2016-03-22 Cardiosolutions, Inc. Mitral valve spacer and system and method for implanting the same
CN105283214B (en) 2013-03-15 2018-10-16 北京泰德制药股份有限公司 Translate conduit, system and its application method
WO2014140684A1 (en) * 2013-03-15 2014-09-18 Microtech Medical Technologies Ltd. Implantable anchor
AU2014227955A1 (en) 2013-03-15 2015-11-12 Hlt, Inc. Low-profile prosthetic valve structure
BR112015029211A2 (en) 2013-05-24 2017-07-25 Bioventrix Inc cardiac tissue penetration devices, methods, and systems for treating congestive heart failure and other conditions
US20140358224A1 (en) 2013-05-30 2014-12-04 Tendyne Holdlings, Inc. Six cell inner stent device for prosthetic mitral valves
JP6731339B2 (en) 2013-06-14 2020-07-29 カーディオソリューションズ インコーポレイテッドCardiosolutions, Inc. Mitral valve spacer and implantation system and method thereof
US20150157329A1 (en) 2013-06-14 2015-06-11 Artventive Medical Group, Inc. Luminal device delivery system
US20140379076A1 (en) 2013-06-25 2014-12-25 Tendyne Holdings, Inc. Halo Wire Fluid Seal Device for Prosthetic Mitral Valves
US9999507B2 (en) 2013-06-25 2018-06-19 Mitralign, Inc. Percutaneous valve repair by reshaping and resizing right ventricle
WO2015006575A1 (en) 2013-07-10 2015-01-15 Medtronic Inc. Helical coil mitral valve annuloplasty systems and methods
EP3027120B1 (en) 2013-07-30 2020-09-30 Arcuro Medical Ltd. Joining device
EP3030161A4 (en) 2013-08-06 2017-03-22 LC Therapeutics, Inc. Synthetic chord for cardiac valve repair applications
CN105451686B (en) 2013-08-14 2018-03-20 索林集团意大利有限责任公司 Apparatus and method for chordae tendineae displacement
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US10117742B2 (en) 2013-09-12 2018-11-06 St. Jude Medical, Cardiology Division, Inc. Stent designs for prosthetic heart valves
US9248018B2 (en) 2013-09-27 2016-02-02 Surendra K. Chawla Valve repair device
US20150100116A1 (en) 2013-10-07 2015-04-09 Medizinische Universitat Wien Implant and method for improving coaptation of an atrioventricular valve
WO2015063580A2 (en) 2013-10-30 2015-05-07 4Tech Inc. Multiple anchoring-point tension system
US10022114B2 (en) 2013-10-30 2018-07-17 4Tech Inc. Percutaneous tether locking
US10052095B2 (en) 2013-10-30 2018-08-21 4Tech Inc. Multiple anchoring-point tension system
US9775591B2 (en) 2013-11-21 2017-10-03 Edwards Lifesciences Corporation Sealing devices and related delivery apparatuses
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
US9986993B2 (en) 2014-02-11 2018-06-05 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
US9072604B1 (en) 2014-02-11 2015-07-07 Gilberto Melnick Modular transcatheter heart valve and implantation method
US20150250590A1 (en) 2014-03-10 2015-09-10 St. Jude Medical, Cardiology Division, Inc. Transapical mitral chordae replacement
ES2908178T3 (en) 2014-06-18 2022-04-28 Polares Medical Inc Mitral valve implants for the treatment of valvular regurgitation
WO2015193728A2 (en) 2014-06-19 2015-12-23 4Tech Inc. Cardiac tissue cinching
WO2016011275A2 (en) 2014-07-16 2016-01-21 Edwards Lifesciences Corporation Devices and methods for suturing a cardiac implant
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
US10195026B2 (en) 2014-07-22 2019-02-05 Edwards Lifesciences Corporation Mitral valve anchoring
US20160081829A1 (en) 2014-09-22 2016-03-24 Edwards Lifesciences Corporation Aortic insufficiency repair device and method
US9700445B2 (en) 2014-11-04 2017-07-11 Abbott Cardiovascular Systems, Inc. One-way actuator knob
EP3284412A1 (en) 2014-12-02 2018-02-21 4Tech Inc. Off-center tissue anchors
EP3226810A4 (en) 2014-12-04 2018-08-15 Edwards Lifesciences Corporation Percutaneous clip for repairing a heart valve
US10188392B2 (en) 2014-12-19 2019-01-29 Abbott Cardiovascular Systems, Inc. Grasping for tissue repair
WO2016115193A1 (en) 2015-01-14 2016-07-21 Shifamed Holdings, Llc Devices and methods for lung volume reduction
US10231834B2 (en) 2015-02-09 2019-03-19 Edwards Lifesciences Corporation Low profile transseptal catheter and implant system for minimally invasive valve procedure
US10105226B2 (en) 2015-02-10 2018-10-23 Edwards Lifesciences Corporation Offset cardiac leaflet coaptation element
EP3256077B1 (en) 2015-02-13 2024-03-27 Boston Scientific Scimed, Inc. Valve replacement using rotational anchors
US20160256269A1 (en) 2015-03-05 2016-09-08 Mitralign, Inc. Devices for treating paravalvular leakage and methods use thereof
US10470759B2 (en) 2015-03-16 2019-11-12 Edwards Lifesciences Corporation Suture securement devices
US10010315B2 (en) 2015-03-18 2018-07-03 Mitralign, Inc. Tissue anchors and percutaneous tricuspid valve repair using a tissue anchor
JP2018512229A (en) 2015-04-01 2018-05-17 エドワーズ ライフサイエンシーズ コーポレイションEdwards Lifesciences Corporation Heart valve repair device
US10524912B2 (en) 2015-04-02 2020-01-07 Abbott Cardiovascular Systems, Inc. Tissue fixation devices and methods
CN107666884B (en) 2015-05-28 2019-11-26 4科技有限公司 Eccentric tissue anchors with tensional element
US20170035433A1 (en) 2015-08-06 2017-02-09 Thomas J. Forbes Left atrial appendage occluder device anchoring system, anchor, and method of attachment
EP3753498B1 (en) 2015-10-02 2023-12-06 Harpoon Medical, Inc. Distal anchor apparatus for mitral valve repair
WO2017066257A1 (en) 2015-10-14 2017-04-20 St. Jude Medical, Cardiology Division, Inc. Vascular sensor implantation devices and methods
WO2018035378A1 (en) 2016-08-18 2018-02-22 4Tech Inc. Tissue anchors with flexible tips for insertion into the pericardial cavity

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6986784B1 (en) * 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US20100312259A1 (en) * 2001-04-24 2010-12-09 Houser Russell A Tissue closure devices, device and systems for delivery, kits and methods therefor
US20070073337A1 (en) * 2001-09-06 2007-03-29 Ryan Abbott Clip-Based Systems And Methods For Treating Septal Defects
US20060212047A1 (en) * 2001-09-06 2006-09-21 Ryan Abbott Systems and Methods for Treating Septal Defects
US20040220596A1 (en) * 2003-02-04 2004-11-04 Frazier Andrew G.C. Patent foramen ovale closure system
US20070010851A1 (en) * 2003-07-14 2007-01-11 Chanduszko Andrzej J Tubular patent foramen ovale (PFO) closure device with catch system
US20130296925A1 (en) * 2003-07-14 2013-11-07 W.L. Gore & Associates, Inc. Tubular Patent Foramen Ovale (PFO) Closure Device with Catch System
US20050273135A1 (en) * 2004-05-07 2005-12-08 Nmt Medical, Inc. Catching mechanisms for tubular septal occluder
US20070055333A1 (en) * 2005-09-06 2007-03-08 Sean Forde Removable intracardiac RF device
US20070250081A1 (en) * 2006-03-31 2007-10-25 Nmt Medical, Inc. Adjustable length patent foramen ovale (PFO) occluder and catch system
US20110152886A1 (en) * 2007-02-26 2011-06-23 Olympus Medical Systems Corp. Applicator and tissue fastening method through natural orifice
US9510833B2 (en) * 2007-02-26 2016-12-06 Olympus Corporation Applicator and tissue fastening method through natural orifice
US8641704B2 (en) * 2007-05-11 2014-02-04 Medtronic Ablation Frontiers Llc Ablation therapy system and method for treating continuous atrial fibrillation
US20120179086A1 (en) * 2009-09-11 2012-07-12 Peter Shank Anchors with open heads
US20140379074A1 (en) * 2012-01-31 2014-12-25 Mitral Valve Technologies Sa Mitral valve docking devices, systems and methods

Also Published As

Publication number Publication date
CN106999178A (en) 2017-08-01
US20170209137A1 (en) 2017-07-27
US20200205800A1 (en) 2020-07-02
US11497485B2 (en) 2022-11-15
US11389152B2 (en) 2022-07-19
US10463358B2 (en) 2019-11-05
US10441267B2 (en) 2019-10-15
JP2020146529A (en) 2020-09-17
EP3068311A1 (en) 2016-09-21
US11006946B2 (en) 2021-05-18
US20160262741A1 (en) 2016-09-15
US20190083085A1 (en) 2019-03-21
WO2016087934A8 (en) 2016-08-18
US11337686B2 (en) 2022-05-24
US20200121312A1 (en) 2020-04-23
US20200275921A1 (en) 2020-09-03
US10588618B2 (en) 2020-03-17
US11484303B2 (en) 2022-11-01
WO2016087934A1 (en) 2016-06-09
US9907547B2 (en) 2018-03-06
CN106999178B (en) 2019-12-24
EP3284412A1 (en) 2018-02-21
US20230210515A1 (en) 2023-07-06
US20170273681A1 (en) 2017-09-28
JP6717820B2 (en) 2020-07-08
US20200022697A1 (en) 2020-01-23
US20190069891A1 (en) 2019-03-07
EP3068311B1 (en) 2017-11-15
JP2017536172A (en) 2017-12-07

Similar Documents

Publication Publication Date Title
US20200129170A1 (en) Tissue Anchors
EP3302297B1 (en) Off-center tissue anchors with tension members
US11534302B2 (en) Device, system, and method for transcatheter treatment of valvular regurgitation
US10052095B2 (en) Multiple anchoring-point tension system
US10039643B2 (en) Multiple anchoring-point tension system
US20180344311A1 (en) Percutaneous Tether Locking
US9592122B2 (en) Annuloplasty ring with intra-ring anchoring
CN111970993A (en) Heart valve docking device and system

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: 4TECH INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GILMORE, MICHAEL;DENTI, PAOLO;LYNN, KEVIN;AND OTHERS;SIGNING DATES FROM 20160608 TO 20160706;REEL/FRAME:051945/0219

Owner name: 4TECH INC., MASSACHUSETTS

Free format text: CHANGE OF ADDRESS;ASSIGNOR:4TECH INC.;REEL/FRAME:051945/0215

Effective date: 20200217

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER